microRNA information: hsa-miR-141-3p
Section | ID | link |
---|---|---|
Mature name: | hsa-miR-141-3p | miRbase |
Accession: | MIMAT0000432 | miRbase |
Precursor name: | hsa-mir-141 | miRbase |
Precursor accession: | MI0000457 | miRbase |
Symbol: | MIR141 | HGNC |
RefSeq ID: | NR_029682 | GenBank |
Sequence: | UAACACUGUCUGGUAAAGAUGG |
Reported expression in cancers: hsa-miR-141-3p
miRNA | cancer | regulation | reporting | PUBMED | method |
---|---|---|---|---|---|
hsa-miR-141-3p | bladder cancer | upregulation | "Increased miR 141 expression is associated with di ......" | 25304156 | qPCR |
hsa-miR-141-3p | breast cancer | downregulation | "Circulating miR 200c and miR 141 and outcomes in p ......" | 25885099 | Reverse transcription PCR |
hsa-miR-141-3p | breast cancer | downregulation | "Expression levels of miR-200a miR-200b miR-200c mi ......" | 26201425 | qPCR |
hsa-miR-141-3p | cervical and endocervical cancer | upregulation | "Vote-counting analysis showed that up-regulation w ......" | 25920605 | |
hsa-miR-141-3p | colorectal cancer | deregulation | "Differential expression of serum miR 126 miR 141 a ......" | 24653631 | qPCR |
hsa-miR-141-3p | endometrial cancer | upregulation | "We evaluated the differential expressions of miRNA ......" | 21035172 | Microarray |
hsa-miR-141-3p | esophageal cancer | downregulation | "The relative expression of some candidate miRNAs w ......" | 24155113 | qPCR |
hsa-miR-141-3p | gastric cancer | downregulation | "Down regulation of miR 141 in gastric cancer and i ......" | 19363643 | qPCR |
hsa-miR-141-3p | gastric cancer | downregulation | "Here we report that the miR-200 family members miR ......" | 25502084 | |
hsa-miR-141-3p | gastric cancer | downregulation | "Prognostic value of miR 141 downregulation in gast ......" | 26681225 | Reverse transcription PCR |
hsa-miR-141-3p | gastric cancer | downregulation | "Anti proliferative role and prognostic implication ......" | 27648145 | |
hsa-miR-141-3p | head and neck cancer | deregulation | "A global miRNA profiling was performed on 12 sampl ......" | 21637912 | qPCR; Microarray |
hsa-miR-141-3p | kidney renal cell cancer | downregulation | "Genome wide microRNA expression profiling in renal ......" | 18925646 | Microarray; qPCR |
hsa-miR-141-3p | kidney renal cell cancer | downregulation | "A possible role for microRNA 141 down regulation i ......" | 23206420 | qPCR; in situ hybridization |
hsa-miR-141-3p | kidney renal cell cancer | downregulation | "Our recent studies of microRNA miRNA expression si ......" | 23635949 | |
hsa-miR-141-3p | kidney renal cell cancer | downregulation | "We performed microarray-based miRNA profiling of c ......" | 24647573 | Microarray |
hsa-miR-141-3p | liver cancer | downregulation | "The expressions of miR-200c and miR-141 were downr ......" | 24135722 | |
hsa-miR-141-3p | liver cancer | downregulation | "Expression of the microRNA-200 family was investig ......" | 26447841 | qPCR |
hsa-miR-141-3p | melanoma | upregulation | "Arsenic exposed Keratinocytes Exhibit Differential ......" | 27054085 | qPCR |
hsa-miR-141-3p | ovarian cancer | deregulation | "Finally five promising differentially miRNAs miR-2 ......" | 23978303 | qPCR |
hsa-miR-141-3p | pancreatic cancer | downregulation | "In this study we explored the role of miR-141 in p ......" | 24013097 | |
hsa-miR-141-3p | prostate cancer | upregulation | "Three of these hsa-miR-141 hsa-miR-298 and hsa-miR ......" | 22052531 | |
hsa-miR-141-3p | prostate cancer | upregulation | "Aberrant expressions of microRNAs including upregu ......" | 22314666 | |
hsa-miR-141-3p | prostate cancer | upregulation | "Exosomal microRNA 141 is upregulated in the serum ......" | 26770063 | Reverse transcription PCR |
hsa-miR-141-3p | thyroid cancer | downregulation | "microRNA-141 miR-141 a member of the miR-200 famil ......" | 27186273 |
Reported cancer pathway affected by hsa-miR-141-3p
miRNA | cancer | pathway | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-141-3p | breast cancer | Apoptosis pathway | "miR 141 confers docetaxel chemoresistance of breas ......" | 25813250 | Luciferase |
hsa-miR-141-3p | colon cancer | Apoptosis pathway | "By performing MTT wound-healing and Transwell migr ......" | 27460529 | Flow cytometry; Cell migration assay |
hsa-miR-141-3p | colorectal cancer | Epithelial mesenchymal transition pathway | "Induction of epithelial mesenchymal transition and ......" | 25757925 | |
hsa-miR-141-3p | colorectal cancer | cell cycle pathway | "MicroRNA 141 regulates the tumour suppressor DLC1 ......" | 26278151 | Transwell assay; Western blot; Luciferase |
hsa-miR-141-3p | esophageal cancer | Apoptosis pathway | "MicroRNA 141 confers resistance to cisplatin induc ......" | 21289630 | |
hsa-miR-141-3p | esophageal cancer | Wnt signaling pathway | "Inhibition of SOX17 by microRNA 141 and methylatio ......" | 22921431 | Western blot; Luciferase; Colony formation |
hsa-miR-141-3p | esophageal cancer | Apoptosis pathway | "Involvement of microRNA 141 3p in 5 fluorouracil a ......" | 27644195 | MTT assay; Luciferase; Western blot |
hsa-miR-141-3p | gastric cancer | cell cycle pathway; Apoptosis pathway | "MiR 141 Inhibits Gastric Cancer Proliferation by I ......" | 26233544 | Flow cytometry; Western blot; Luciferase |
hsa-miR-141-3p | gastric cancer | cell cycle pathway | "Anti proliferative role and prognostic implication ......" | 27648145 | Colony formation |
hsa-miR-141-3p | kidney renal cell cancer | Epithelial mesenchymal transition pathway | "Our recent studies of microRNA miRNA expression si ......" | 23635949 | |
hsa-miR-141-3p | liver cancer | Apoptosis pathway | "microRNA 141 inhibits cell proliferation and invas ......" | 25425543 | Western blot; Luciferase |
hsa-miR-141-3p | liver cancer | Apoptosis pathway | "MiR 141 Activates Nrf2 Dependent Antioxidant Pathw ......" | 25896253 | |
hsa-miR-141-3p | lung squamous cell cancer | PI3K/Akt signaling pathway | "MicroRNA 141 promotes the proliferation of non sma ......" | 24945731 | |
hsa-miR-141-3p | lung squamous cell cancer | Epithelial mesenchymal transition pathway | "The difference in miRNA expression profiles betwee ......" | 26783187 | |
hsa-miR-141-3p | lung squamous cell cancer | Apoptosis pathway | "Inhibition of miR 141 reverses cisplatin resistanc ......" | 27383306 | Western blot; MTT assay; Luciferase |
hsa-miR-141-3p | ovarian cancer | Epithelial mesenchymal transition pathway | "Both resistant variants display a strong epithelia ......" | 26025631 | |
hsa-miR-141-3p | pancreatic cancer | Apoptosis pathway | "In this study we explored the role of miR-141 in p ......" | 24013097 | Luciferase; Western blot |
hsa-miR-141-3p | pancreatic cancer | cell cycle pathway; Apoptosis pathway | "hsa miR 141 downregulates TM4SF1 to inhibit pancre ......" | 24285464 | Western blot; Flow cytometry; Luciferase |
hsa-miR-141-3p | sarcoma | Apoptosis pathway | "Tumor suppressing effects of miR 141 in human oste ......" | 24307282 | |
hsa-miR-141-3p | thyroid cancer | Apoptosis pathway | "microRNA 141 inhibits thyroid cancer cell growth a ......" | 27186273 |
Reported cancer prognosis affected by hsa-miR-141-3p
miRNA | cancer | prognosis | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-141-3p | bladder cancer | worse prognosis | "Quantitative real-time PCR was applied to measure ......" | 23266581 | |
hsa-miR-141-3p | bladder cancer | malignant trasformation; poor survival | "We screened 723 miRNAs by microarray and selected ......" | 23945108 | |
hsa-miR-141-3p | bladder cancer | worse prognosis; staging; malignant trasformation; poor survival; progression | "Increased miR 141 expression is associated with di ......" | 25304156 | |
hsa-miR-141-3p | bladder cancer | malignant trasformation | "Association between tissue miR 141 miR 200c and mi ......" | 25703910 | |
hsa-miR-141-3p | bladder cancer | malignant trasformation | "Evaluation of miR 141 miR 200c miR 30b Expression ......" | 25815280 | |
hsa-miR-141-3p | bladder cancer | poor survival | "We identified an eight-miRNA signature including t ......" | 25991007 | |
hsa-miR-141-3p | breast cancer | drug resistance | "MiRNA microarray analysis identified 299 and 226 m ......" | 21399894 | |
hsa-miR-141-3p | breast cancer | metastasis | "Whole genome miR array analysis using PELP1-overex ......" | 23975430 | |
hsa-miR-141-3p | breast cancer | differentiation | "Progesterone downregulation of miR 141 contributes ......" | 25241899 | |
hsa-miR-141-3p | breast cancer | drug resistance | "We created a doxorubicin-resistant MCF-7 MCF-/Adr ......" | 25451164 | MTT assay |
hsa-miR-141-3p | breast cancer | drug resistance | "miR 141 confers docetaxel chemoresistance of breas ......" | 25813250 | Luciferase |
hsa-miR-141-3p | breast cancer | staging; metastasis; progression; poor survival | "Circulating miR 200c and miR 141 and outcomes in p ......" | 25885099 | |
hsa-miR-141-3p | breast cancer | metastasis | "We also revealed that KLF8 directly represses the ......" | 26025929 | |
hsa-miR-141-3p | breast cancer | metastasis; progression; poor survival | "miR 141 Mediated Regulation of Brain Metastasis Fr ......" | 27075851 | |
hsa-miR-141-3p | colon cancer | worse prognosis; staging; poor survival; metastasis | "Circulating plasma MiR 141 is a novel biomarker fo ......" | 21445232 | |
hsa-miR-141-3p | colorectal cancer | cell migration | "MicroRNA 141 regulates Smad interacting protein 1 ......" | 19830559 | Western blot; Wound Healing Assay; Luciferase |
hsa-miR-141-3p | colorectal cancer | metastasis | "Applying real-time PCR we detected the expression ......" | 21827717 | |
hsa-miR-141-3p | colorectal cancer | metastasis | "Liver metastasis tissues showed higher expression ......" | 22735571 | |
hsa-miR-141-3p | colorectal cancer | staging | "Genome-wide microarray analysis of miRNA expressio ......" | 23673725 | |
hsa-miR-141-3p | colorectal cancer | staging | "Tumor tissue samples were obtained from 127 surgic ......" | 24510588 | |
hsa-miR-141-3p | colorectal cancer | metastasis; staging | "Differential expression of serum miR 126 miR 141 a ......" | 24653631 | |
hsa-miR-141-3p | colorectal cancer | drug resistance | "Induction of epithelial mesenchymal transition and ......" | 25757925 | |
hsa-miR-141-3p | colorectal cancer | progression | "Cancer biopsy colonic mucosa from the resected spe ......" | 25989926 | |
hsa-miR-141-3p | colorectal cancer | progression | "MicroRNA 141 regulates the tumour suppressor DLC1 ......" | 26278151 | Transwell assay; Western blot; Luciferase |
hsa-miR-141-3p | colorectal cancer | staging; worse prognosis | "Comprehensive analyses showed that plasma miR-96 d ......" | 26863633 | |
hsa-miR-141-3p | colorectal cancer | poor survival | "In this study ten candidates were identified using ......" | 27126129 | |
hsa-miR-141-3p | endometrial cancer | tumorigenesis | "The miRNA profiles were analyzed by miRNA microarr ......" | 24742567 | |
hsa-miR-141-3p | esophageal cancer | drug resistance | "MicroRNA 141 confers resistance to cisplatin induc ......" | 21289630 | |
hsa-miR-141-3p | esophageal cancer | drug resistance; staging; differentiation | "Involvement of microRNA 141 3p in 5 fluorouracil a ......" | 27644195 | MTT assay; Luciferase; Western blot |
hsa-miR-141-3p | gastric cancer | motility; progression | "miR 141 suppresses proliferation and motility of g ......" | 24276755 | Colony formation |
hsa-miR-141-3p | gastric cancer | drug resistance | "Helicobacter pylori modulates cisplatin sensitivit ......" | 24628843 | Western blot; Luciferase |
hsa-miR-141-3p | gastric cancer | staging; poor survival | "Here we report that the miR-200 family members miR ......" | 25502084 | Wound Healing Assay |
hsa-miR-141-3p | gastric cancer | metastasis | "MicroRNA 141 inhibits tumor growth and metastasis ......" | 25633292 | |
hsa-miR-141-3p | gastric cancer | cell migration | "MicroRNA 141 inhibits migration of gastric cancer ......" | 25975736 | Western blot; Wound Healing Assay; Luciferase |
hsa-miR-141-3p | gastric cancer | staging; metastasis | "In the first step of this study preliminary experi ......" | 26233325 | |
hsa-miR-141-3p | gastric cancer | malignant trasformation; progression | "MiR 141 Inhibits Gastric Cancer Proliferation by I ......" | 26233544 | Flow cytometry; Western blot; Luciferase |
hsa-miR-141-3p | gastric cancer | poor survival; staging; metastasis; differentiation; progression; worse prognosis | "Prognostic value of miR 141 downregulation in gast ......" | 26681225 | |
hsa-miR-141-3p | gastric cancer | worse prognosis; tumor size | "Anti proliferative role and prognostic implication ......" | 27648145 | Colony formation |
hsa-miR-141-3p | head and neck cancer | malignant trasformation | "A global miRNA profiling was performed on 12 sampl ......" | 21637912 | |
hsa-miR-141-3p | kidney papillary renal cell cancer | staging; poor survival | "In the training stage the expression levels of 12 ......" | 25906110 | |
hsa-miR-141-3p | kidney renal cell cancer | malignant trasformation | "We performed genome-wide expression profiling of m ......" | 19228262 | |
hsa-miR-141-3p | kidney renal cell cancer | metastasis; malignant trasformation | "miR-122 miR-141 miR-155 miR-184 miR-200c miR-210 m ......" | 23178446 | |
hsa-miR-141-3p | kidney renal cell cancer | drug resistance | "A possible role for microRNA 141 down regulation i ......" | 23206420 | |
hsa-miR-141-3p | kidney renal cell cancer | metastasis | "miR 141 is a key regulator of renal cell carcinoma ......" | 24647573 | |
hsa-miR-141-3p | kidney renal cell cancer | poor survival | "Using vote-counting strategy and robust rank aggre ......" | 25974855 | |
hsa-miR-141-3p | liver cancer | poor survival | "The expressions of miR-200c and miR-141 were downr ......" | 24135722 | |
hsa-miR-141-3p | liver cancer | drug resistance | "MiR 141 Activates Nrf2 Dependent Antioxidant Pathw ......" | 25896253 | |
hsa-miR-141-3p | liver cancer | metastasis; progression; tumorigenesis | "Direct targeting sperm associated antigen 9 by miR ......" | 26790956 | Western blot; Luciferase; Cell migration assay |
hsa-miR-141-3p | lung squamous cell cancer | tumorigenesis | "MicroRNA 141 promotes the proliferation of non sma ......" | 24945731 | |
hsa-miR-141-3p | lung squamous cell cancer | staging; poor survival; cell migration | "miR 141 and miR 200c as markers of overall surviva ......" | 25003366 | |
hsa-miR-141-3p | lung squamous cell cancer | drug resistance | "The difference in miRNA expression profiles betwee ......" | 26783187 | |
hsa-miR-141-3p | lung squamous cell cancer | drug resistance | "Inhibition of miR 141 reverses cisplatin resistanc ......" | 27383306 | Western blot; MTT assay; Luciferase |
hsa-miR-141-3p | melanoma | tumorigenesis | "Arsenic exposed Keratinocytes Exhibit Differential ......" | 27054085 | |
hsa-miR-141-3p | ovarian cancer | worse prognosis | "The microRNA expression profiles were examined usi ......" | 18451233 | |
hsa-miR-141-3p | ovarian cancer | staging | "Levels of 8 microRNAs miR-21 miR-141 miR-200a miR- ......" | 18589210 | |
hsa-miR-141-3p | ovarian cancer | drug resistance | "miR 141 regulates KEAP1 and modulates cisplatin se ......" | 23045278 | |
hsa-miR-141-3p | ovarian cancer | progression | "The aberrant expression of the miR-200 family miR- ......" | 24952258 | |
hsa-miR-141-3p | ovarian cancer | staging; poor survival; worse prognosis | "MicroRNA 200c and microRNA 141 as potential diagno ......" | 25636451 | |
hsa-miR-141-3p | ovarian cancer | drug resistance | "The authors utilized a microRNA miRNA array to com ......" | 25872328 | |
hsa-miR-141-3p | ovarian cancer | drug resistance | "Both resistant variants display a strong epithelia ......" | 26025631 | |
hsa-miR-141-3p | ovarian cancer | drug resistance | "Analysis of microarray identified genes and microR ......" | 26261572 | |
hsa-miR-141-3p | ovarian cancer | progression | "Suppression of SIK1 by miR 141 in human ovarian ca ......" | 27081781 | |
hsa-miR-141-3p | pancreatic cancer | staging; metastasis; tumor size; poor survival | "In this study we explored the role of miR-141 in p ......" | 24013097 | Luciferase; Western blot |
hsa-miR-141-3p | pancreatic cancer | progression | "hsa miR 141 downregulates TM4SF1 to inhibit pancre ......" | 24285464 | Western blot; Flow cytometry; Luciferase |
hsa-miR-141-3p | pancreatic cancer | staging | "In addition from 10 to 50 weeks of age stage-speci ......" | 26516699 | |
hsa-miR-141-3p | prostate cancer | staging | "Investigation of miR 21 miR 141 and miR 221 in blo ......" | 21274675 | |
hsa-miR-141-3p | prostate cancer | drug resistance; progression | "Comparison of circulating MicroRNA 141 to circulat ......" | 21723797 | |
hsa-miR-141-3p | prostate cancer | progression | "Three of these hsa-miR-141 hsa-miR-298 and hsa-miR ......" | 22052531 | |
hsa-miR-141-3p | prostate cancer | tumorigenesis; malignant trasformation | "miR 141 modulates androgen receptor transcriptiona ......" | 22314666 | |
hsa-miR-141-3p | prostate cancer | metastasis | "An elevated serum miR 141 level in patients with b ......" | 23377530 | |
hsa-miR-141-3p | prostate cancer | drug resistance | "Label free and reagentless electrochemical detecti ......" | 23743328 | |
hsa-miR-141-3p | prostate cancer | recurrence; progression | "MicroRNAs in the serum of patients who had experie ......" | 23846169 | |
hsa-miR-141-3p | prostate cancer | recurrence | "Investigation of miR 21 miR 141 and miR 221 expres ......" | 25252191 | |
hsa-miR-141-3p | prostate cancer | worse prognosis | "Promising preliminary results were published conce ......" | 26751899 | |
hsa-miR-141-3p | prostate cancer | staging | "Expression levels of five miRNAs miR-19b miR-21 mi ......" | 27753010 | |
hsa-miR-141-3p | sarcoma | tumorigenesis | "Tumor suppressing effects of miR 141 in human oste ......" | 24307282 | |
hsa-miR-141-3p | sarcoma | metastasis; motility | "Paeonol suppresses chondrosarcoma metastasis throu ......" | 24992595 | |
hsa-miR-141-3p | thyroid cancer | metastasis; staging | "microRNA 141 inhibits thyroid cancer cell growth a ......" | 27186273 |
Reported gene related to hsa-miR-141-3p
miRNA | cancer | gene | reporting | PUBMED |
---|---|---|---|---|
hsa-miR-141-3p | gastric cancer | KEAP1 | "We also demonstrated that miR-141 directly targets ......" | 24628843 |
hsa-miR-141-3p | liver cancer | KEAP1 | "MiR 141 Activates Nrf2 Dependent Antioxidant Pathw ......" | 25896253 |
hsa-miR-141-3p | ovarian cancer | KEAP1 | "miR 141 regulates KEAP1 and modulates cisplatin se ......" | 23045278 |
hsa-miR-141-3p | head and neck cancer | ZEB1 | "Accordingly the enforced expression of miR-200c an ......" | 24424572 |
hsa-miR-141-3p | lung squamous cell cancer | ZEB1 | "Nintedanib was able to reverse TGF-β1-induced EMT ......" | 26783187 |
hsa-miR-141-3p | sarcoma | ZEB1 | "It is estimated that miR-141 played its role via Z ......" | 24307282 |
hsa-miR-141-3p | gastric cancer | ZEB2 | "These results suggest that miR‑141 may be involv ......" | 25975736 |
hsa-miR-141-3p | kidney renal cell cancer | ZEB2 | "TargetScan algorithm revealed that ZFHX1B mRNA is ......" | 18925646 |
hsa-miR-141-3p | sarcoma | ZEB2 | "It is estimated that miR-141 played its role via Z ......" | 24307282 |
hsa-miR-141-3p | prostate cancer | AR | "miR 141 3p regulates the expression of androgen re ......" | 26062412 |
hsa-miR-141-3p | prostate cancer | AR | "miR 141 modulates androgen receptor transcriptiona ......" | 22314666 |
hsa-miR-141-3p | gastric cancer | CDH1 | "We also found that miR-200c and miR-141 directly t ......" | 25502084 |
hsa-miR-141-3p | head and neck cancer | CDH1 | "Accordingly the enforced expression of miR-200c an ......" | 24424572 |
hsa-miR-141-3p | endometrial cancer | PTEN | "PTEN might be a potential target of miR-141 and mi ......" | 24742567 |
hsa-miR-141-3p | esophageal cancer | PTEN | "Involvement of microRNA 141 3p in 5 fluorouracil a ......" | 27644195 |
hsa-miR-141-3p | melanoma | CDH5 | "Ectopic expression of either a synthetic miRNA mim ......" | 27616325 |
hsa-miR-141-3p | colon cancer | CEACAM5 | "We observed that combination of miR-141 and carcin ......" | 21445232 |
hsa-miR-141-3p | prostate cancer | CTAG1B | "Prostate cancer antigen 3 PCA3 and microRNA-141 mi ......" | 25685739 |
hsa-miR-141-3p | breast cancer | CTNNB1 | "miR-141 expression level was downregulated in MDA- ......" | 26164002 |
hsa-miR-141-3p | colorectal cancer | DICER1 | "In liver metastases Dicer was positively related t ......" | 21827717 |
hsa-miR-141-3p | colorectal cancer | DLC1 | "MicroRNA 141 regulates the tumour suppressor DLC1 ......" | 26278151 |
hsa-miR-141-3p | prostate cancer | DNMT1 | "In PC3 cells miR-200c and miR-141 expression is su ......" | 27198154 |
hsa-miR-141-3p | prostate cancer | DNMT3A | "The biological significance of miR-200c and miR-14 ......" | 27198154 |
hsa-miR-141-3p | gastric cancer | E2F3 | "MiR 141 Inhibits Gastric Cancer Proliferation by I ......" | 26233544 |
hsa-miR-141-3p | breast cancer | EGFR | "Treatment with the EGFR inhibitor AG1478 or overex ......" | 26025929 |
hsa-miR-141-3p | breast cancer | EIF4E | "miR 141 confers docetaxel chemoresistance of breas ......" | 25813250 |
hsa-miR-141-3p | kidney renal cell cancer | EPHA2 | "miR 141 is a key regulator of renal cell carcinoma ......" | 24647573 |
hsa-miR-141-3p | ovarian cancer | EPHA7 | "Among those the expression of EPHA7 and PI15 were ......" | 26261572 |
hsa-miR-141-3p | breast cancer | ERBB2 | "MiR-141 was significantly higher in the blood of p ......" | 25885099 |
hsa-miR-141-3p | gastric cancer | H19 | "The Interaction Between MiR 141 and lncRNA H19 in ......" | 26160158 |
hsa-miR-141-3p | esophageal cancer | HCRT | "EC9706R xenograft mouse model became sensitized to ......" | 27644195 |
hsa-miR-141-3p | gastric cancer | HDGF | "miR 141 suppresses proliferation and motility of g ......" | 24276755 |
hsa-miR-141-3p | prostate cancer | HK3 | "miR-21 and miR-141 were quantified through real-ti ......" | 24288670 |
hsa-miR-141-3p | gastric cancer | IGF1R | "Insulin-like growth factor 1 receptor IGF1R was ov ......" | 27648145 |
hsa-miR-141-3p | breast cancer | IL6 | "In addition dysregulated miR-200b/c and miR-141 et ......" | 25270211 |
hsa-miR-141-3p | thyroid cancer | INSR | "microRNA 141 inhibits thyroid cancer cell growth a ......" | 27186273 |
hsa-miR-141-3p | thyroid cancer | IRS2 | "Forced expression of IRS2 reversed the inhibition ......" | 27186273 |
hsa-miR-141-3p | prostate cancer | KLK11 | "The aim of our study was to monitor serum levels o ......" | 24288670 |
hsa-miR-141-3p | pancreatic cancer | MAP4K4 | "To understand how miR-141 mediates the phenotype o ......" | 24013097 |
hsa-miR-141-3p | liver cancer | MAPK8 | "Direct targeting sperm associated antigen 9 by miR ......" | 26790956 |
hsa-miR-141-3p | gastric cancer | MEG3 | "MiR 141 Inhibits Gastric Cancer Proliferation by I ......" | 26233544 |
hsa-miR-141-3p | prostate cancer | NR0B2 | "miR 141 modulates androgen receptor transcriptiona ......" | 22314666 |
hsa-miR-141-3p | prostate cancer | PCA3 | "Androgen Stimulation of PCA3 and miR 141 and Their ......" | 25685739 |
hsa-miR-141-3p | lung squamous cell cancer | PDCD4 | "Luciferase activity assay was employed to validate ......" | 27383306 |
hsa-miR-141-3p | breast cancer | PELP1 | "Whole genome miR array analysis using PELP1-overex ......" | 23975430 |
hsa-miR-141-3p | breast cancer | PGR | "Progesterone downregulation of miR 141 contributes ......" | 25241899 |
hsa-miR-141-3p | lung squamous cell cancer | PHLPP1 | "MicroRNA 141 promotes the proliferation of non sma ......" | 24945731 |
hsa-miR-141-3p | lung squamous cell cancer | PHLPP2 | "MicroRNA 141 promotes the proliferation of non sma ......" | 24945731 |
hsa-miR-141-3p | ovarian cancer | PI15 | "Among those the expression of EPHA7 and PI15 were ......" | 26261572 |
hsa-miR-141-3p | sarcoma | PRKCD | "Since paeonol inhibits migration and invasion of h ......" | 24992595 |
hsa-miR-141-3p | kidney renal cell cancer | SEMA6A | "The regulation of SEMA6A by miR-141 was verified b ......" | 20420713 |
hsa-miR-141-3p | ovarian cancer | SIK1 | "Suppression of SIK1 by miR 141 in human ovarian ca ......" | 27081781 |
hsa-miR-141-3p | breast cancer | SLC10A4 | "Here we investigated P4 downregulation of miR-141 ......" | 25241899 |
hsa-miR-141-3p | esophageal cancer | SOX17 | "Inhibition of SOX17 by microRNA 141 and methylatio ......" | 22921431 |
hsa-miR-141-3p | liver cancer | SPAG9 | "SPAG9 and miR-141 expression were detected in HCC ......" | 26790956 |
hsa-miR-141-3p | sarcoma | SRC | "Paeonol suppresses chondrosarcoma metastasis throu ......" | 24992595 |
hsa-miR-141-3p | gastric cancer | STAT4 | "Down regulation of miR 141 induced by helicobacter ......" | 24732377 |
hsa-miR-141-3p | breast cancer | STAT5A | "Progesterone downregulation of miR 141 contributes ......" | 25241899 |
hsa-miR-141-3p | gastric cancer | TAZ | "MicroRNA 141 inhibits tumor growth and metastasis ......" | 25633292 |
hsa-miR-141-3p | pancreatic cancer | TM4SF1 | "hsa miR 141 downregulates TM4SF1 to inhibit pancre ......" | 24285464 |
hsa-miR-141-3p | melanoma | TNC | "Based on epidemiological studies of melanoma our d ......" | 27616325 |
hsa-miR-141-3p | kidney renal cell cancer | VEGFA | "We also found strong anti-correlation between VEGF ......" | 20420713 |
hsa-miR-141-3p | esophageal cancer | YAP1 | "MicroRNA 141 confers resistance to cisplatin induc ......" | 21289630 |
Expression profile in cancer corhorts:
Putative target regulations
miRNA | Gene | Cancer | Interaction | Correlation beta |
---|---|---|---|---|
hsa-miR-141-3p | KLF11 | 11 cancers: BLCA; BRCA; COAD; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; MirTarget | TCGA BLCA -0.109; TCGA BRCA -0.181; TCGA COAD -0.123; TCGA LIHC -0.053; TCGA LUAD -0.135; TCGA LUSC -0.09; TCGA PRAD -0.213; TCGA SARC -0.061; TCGA THCA -0.073; TCGA STAD -0.193; TCGA UCEC -0.167 |
hsa-miR-141-3p | KLHL20 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.081; TCGA BRCA -0.132; TCGA CESC -0.105; TCGA COAD -0.117; TCGA ESCA -0.052; TCGA HNSC -0.107; TCGA LGG -0.1; TCGA PAAD -0.102; TCGA PRAD -0.221; TCGA SARC -0.077; TCGA THCA -0.071; TCGA STAD -0.096; TCGA UCEC -0.136 |
hsa-miR-141-3p | PTEN | 11 cancers: BLCA; BRCA; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate; miRTarBase; TargetScan; miRNATAP | TCGA BLCA -0.061; TCGA BRCA -0.127; TCGA ESCA -0.064; TCGA HNSC -0.126; TCGA LUAD -0.104; TCGA LUSC -0.24; TCGA PAAD -0.119; TCGA PRAD -0.155; TCGA THCA -0.086; TCGA STAD -0.091; TCGA UCEC -0.101 |
hsa-miR-141-3p | PTPRD | 16 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; TargetScan; miRNATAP | TCGA BLCA -0.584; TCGA BRCA -0.253; TCGA CESC -0.545; TCGA ESCA -0.294; TCGA HNSC -0.486; TCGA KIRP -0.353; TCGA LGG -0.137; TCGA LUAD -0.299; TCGA LUSC -0.315; TCGA OV -0.57; TCGA PAAD -0.195; TCGA PRAD -0.261; TCGA SARC -0.261; TCGA THCA -0.646; TCGA STAD -0.288; TCGA UCEC -0.382 |
hsa-miR-141-3p | RASSF2 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.158; TCGA BRCA -0.136; TCGA CESC -0.257; TCGA COAD -0.583; TCGA ESCA -0.372; TCGA HNSC -0.361; TCGA KIRC -0.302; TCGA LGG -0.266; TCGA LUAD -0.261; TCGA LUSC -0.714; TCGA PAAD -0.512; TCGA PRAD -0.293; TCGA SARC -0.177; TCGA THCA -0.513; TCGA STAD -0.275; TCGA UCEC -0.235 |
hsa-miR-141-3p | RIN2 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.091; TCGA BRCA -0.083; TCGA CESC -0.112; TCGA COAD -0.104; TCGA HNSC -0.109; TCGA KIRP -0.055; TCGA LGG -0.082; TCGA LUAD -0.144; TCGA LUSC -0.173; TCGA PAAD -0.059; TCGA PRAD -0.198; TCGA THCA -0.11; TCGA UCEC -0.088 |
hsa-miR-141-3p | SEPT7 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate; MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.093; TCGA BRCA -0.066; TCGA CESC -0.114; TCGA COAD -0.098; TCGA ESCA -0.088; TCGA HNSC -0.056; TCGA LUAD -0.128; TCGA LUSC -0.051; TCGA OV -0.112; TCGA PAAD -0.139; TCGA PRAD -0.158; TCGA THCA -0.106; TCGA STAD -0.129; TCGA UCEC -0.145 |
hsa-miR-141-3p | TCF7L1 | 9 cancers: BLCA; BRCA; COAD; ESCA; OV; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.293; TCGA BRCA -0.2; TCGA COAD -0.389; TCGA ESCA -0.297; TCGA OV -0.261; TCGA PAAD -0.155; TCGA PRAD -0.405; TCGA STAD -0.407; TCGA UCEC -0.077 |
hsa-miR-141-3p | TGFB2 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.361; TCGA BRCA -0.201; TCGA CESC -0.216; TCGA COAD -0.453; TCGA ESCA -0.311; TCGA HNSC -0.265; TCGA LUAD -0.399; TCGA LUSC -0.461; TCGA PRAD -0.351; TCGA THCA -0.147; TCGA STAD -0.208; TCGA UCEC -0.182 |
hsa-miR-141-3p | ZEB1 | 18 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.455; TCGA BRCA -0.372; TCGA CESC -0.429; TCGA COAD -0.694; TCGA ESCA -0.437; TCGA HNSC -0.509; TCGA KIRC -0.098; TCGA LGG -0.168; TCGA LIHC -0.056; TCGA LUAD -0.312; TCGA LUSC -0.486; TCGA OV -0.288; TCGA PAAD -0.355; TCGA PRAD -0.47; TCGA SARC -0.088; TCGA THCA -0.356; TCGA STAD -0.501; TCGA UCEC -0.478 |
hsa-miR-141-3p | ZEB2 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | TCGA BLCA -0.457; TCGA BRCA -0.415; TCGA CESC -0.399; TCGA COAD -0.613; TCGA ESCA -0.375; TCGA HNSC -0.548; TCGA KIRC -0.106; TCGA LGG -0.09; TCGA LUAD -0.342; TCGA LUSC -0.722; TCGA PAAD -0.428; TCGA PRAD -0.515; TCGA SARC -0.185; TCGA THCA -0.395; TCGA STAD -0.289; TCGA UCEC -0.354 |
hsa-miR-141-3p | ZFPM2 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; miRTarBase | TCGA BLCA -0.592; TCGA BRCA -0.424; TCGA CESC -0.475; TCGA COAD -0.811; TCGA ESCA -0.515; TCGA HNSC -0.639; TCGA KIRC -0.074; TCGA LGG -0.269; TCGA LUAD -0.424; TCGA LUSC -0.773; TCGA PAAD -0.529; TCGA PRAD -0.617; TCGA SARC -0.241; TCGA THCA -0.484; TCGA STAD -0.557; TCGA UCEC -0.645 |
hsa-miR-141-3p | MIB1 | 9 cancers: BLCA; CESC; COAD; HNSC; LGG; OV; PRAD; THCA; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.052; TCGA CESC -0.073; TCGA COAD -0.075; TCGA HNSC -0.054; TCGA LGG -0.118; TCGA OV -0.107; TCGA PRAD -0.163; TCGA THCA -0.103; TCGA UCEC -0.109 |
hsa-miR-141-3p | WIPF1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.371; TCGA BRCA -0.183; TCGA CESC -0.224; TCGA COAD -0.47; TCGA ESCA -0.308; TCGA HNSC -0.356; TCGA KIRC -0.201; TCGA KIRP -0.079; TCGA LUAD -0.226; TCGA LUSC -0.44; TCGA PAAD -0.403; TCGA PRAD -0.366; TCGA THCA -0.333; TCGA STAD -0.213; TCGA UCEC -0.206 |
hsa-miR-141-3p | TMEFF1 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; PAAD; PRAD; UCEC | MirTarget | TCGA BLCA -0.15; TCGA CESC -0.101; TCGA COAD -0.365; TCGA ESCA -0.132; TCGA HNSC -0.132; TCGA KIRC -0.092; TCGA LGG -0.071; TCGA LUAD -0.156; TCGA PAAD -0.202; TCGA PRAD -0.204; TCGA UCEC -0.102 |
hsa-miR-141-3p | ABL2 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUSC; PAAD; THCA; STAD | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.134; TCGA CESC -0.06; TCGA COAD -0.131; TCGA ESCA -0.095; TCGA HNSC -0.163; TCGA KIRC -0.108; TCGA LGG -0.117; TCGA LUSC -0.093; TCGA PAAD -0.161; TCGA THCA -0.171; TCGA STAD -0.054 |
hsa-miR-141-3p | CBL | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan; mirMAP | TCGA BLCA -0.088; TCGA BRCA -0.115; TCGA CESC -0.086; TCGA COAD -0.087; TCGA ESCA -0.065; TCGA HNSC -0.117; TCGA KIRC -0.055; TCGA LUAD -0.146; TCGA LUSC -0.059; TCGA PAAD -0.17; TCGA PRAD -0.206; TCGA THCA -0.173; TCGA STAD -0.104; TCGA UCEC -0.116 |
hsa-miR-141-3p | TCF4 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.305; TCGA BRCA -0.337; TCGA CESC -0.273; TCGA COAD -0.57; TCGA ESCA -0.193; TCGA HNSC -0.286; TCGA KIRC -0.152; TCGA LGG -0.154; TCGA LUAD -0.284; TCGA LUSC -0.23; TCGA OV -0.109; TCGA PAAD -0.382; TCGA PRAD -0.33; TCGA THCA -0.236; TCGA STAD -0.251; TCGA UCEC -0.221 |
hsa-miR-141-3p | CLIC4 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.405; TCGA BRCA -0.131; TCGA CESC -0.195; TCGA COAD -0.419; TCGA ESCA -0.272; TCGA HNSC -0.165; TCGA KIRC -0.069; TCGA KIRP -0.183; TCGA LUAD -0.259; TCGA LUSC -0.28; TCGA PAAD -0.302; TCGA PRAD -0.409; TCGA SARC -0.147; TCGA THCA -0.155; TCGA STAD -0.377; TCGA UCEC -0.26 |
hsa-miR-141-3p | KIF17 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.298; TCGA BRCA -0.279; TCGA CESC -0.256; TCGA COAD -0.616; TCGA ESCA -0.324; TCGA LIHC -0.059; TCGA LUAD -0.32; TCGA LUSC -0.499; TCGA PAAD -0.327; TCGA PRAD -0.291; TCGA STAD -0.172; TCGA UCEC -0.145 |
hsa-miR-141-3p | KLF12 | 15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.307; TCGA BRCA -0.139; TCGA COAD -0.382; TCGA ESCA -0.235; TCGA HNSC -0.215; TCGA LGG -0.201; TCGA LIHC -0.132; TCGA LUAD -0.186; TCGA LUSC -0.25; TCGA OV -0.101; TCGA PAAD -0.259; TCGA PRAD -0.318; TCGA THCA -0.277; TCGA STAD -0.303; TCGA UCEC -0.185 |
hsa-miR-141-3p | RAB11FIP2 | 15 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.095; TCGA BRCA -0.154; TCGA CESC -0.16; TCGA COAD -0.153; TCGA HNSC -0.151; TCGA KIRP -0.054; TCGA LGG -0.09; TCGA LIHC -0.056; TCGA LUAD -0.144; TCGA LUSC -0.242; TCGA OV -0.08; TCGA PAAD -0.113; TCGA PRAD -0.224; TCGA STAD -0.149; TCGA UCEC -0.212 |
hsa-miR-141-3p | WWTR1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.306; TCGA BRCA -0.184; TCGA CESC -0.09; TCGA COAD -0.724; TCGA ESCA -0.249; TCGA HNSC -0.226; TCGA LUAD -0.179; TCGA LUSC -0.086; TCGA PAAD -0.205; TCGA PRAD -0.439; TCGA SARC -0.097; TCGA THCA -0.248; TCGA STAD -0.4; TCGA UCEC -0.115 |
hsa-miR-141-3p | CADM1 | 12 cancers: BLCA; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; THCA; STAD | MirTarget; TargetScan | TCGA BLCA -0.158; TCGA COAD -0.641; TCGA ESCA -0.233; TCGA HNSC -0.226; TCGA LGG -0.063; TCGA LIHC -0.181; TCGA LUAD -0.236; TCGA LUSC -0.682; TCGA OV -0.135; TCGA PAAD -0.154; TCGA THCA -0.216; TCGA STAD -0.228 |
hsa-miR-141-3p | ARRB1 | 10 cancers: BLCA; BRCA; ESCA; HNSC; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.095; TCGA BRCA -0.169; TCGA ESCA -0.175; TCGA HNSC -0.235; TCGA LUSC -0.687; TCGA PAAD -0.072; TCGA PRAD -0.074; TCGA THCA -0.232; TCGA STAD -0.144; TCGA UCEC -0.173 |
hsa-miR-141-3p | GEM | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.588; TCGA BRCA -0.349; TCGA CESC -0.345; TCGA COAD -0.561; TCGA ESCA -0.352; TCGA HNSC -0.365; TCGA LUSC -0.523; TCGA OV -0.322; TCGA PAAD -0.395; TCGA PRAD -0.472; TCGA SARC -0.184; TCGA THCA -0.421; TCGA STAD -0.433; TCGA UCEC -0.377 |
hsa-miR-141-3p | CCPG1 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; LIHC; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.188; TCGA BRCA -0.121; TCGA CESC -0.069; TCGA COAD -0.112; TCGA HNSC -0.158; TCGA LIHC -0.06; TCGA LUSC -0.31; TCGA PRAD -0.115; TCGA SARC -0.069; TCGA THCA -0.065; TCGA STAD -0.055; TCGA UCEC -0.08 |
hsa-miR-141-3p | THSD4 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PRAD; STAD | MirTarget | TCGA BLCA -0.193; TCGA CESC -0.226; TCGA COAD -0.132; TCGA ESCA -0.157; TCGA HNSC -0.153; TCGA LGG -0.294; TCGA LUAD -0.186; TCGA LUSC -0.221; TCGA PRAD -0.479; TCGA STAD -0.182 |
hsa-miR-141-3p | RSAD2 | 9 cancers: BLCA; COAD; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | MirTarget | TCGA BLCA -0.133; TCGA COAD -0.427; TCGA KIRC -0.061; TCGA LUAD -0.211; TCGA LUSC -0.466; TCGA PAAD -0.335; TCGA PRAD -0.192; TCGA SARC -0.18; TCGA THCA -0.18 |
hsa-miR-141-3p | CCND2 | 11 cancers: BLCA; BRCA; CESC; ESCA; KIRC; KIRP; LUAD; LUSC; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.337; TCGA BRCA -0.301; TCGA CESC -0.24; TCGA ESCA -0.214; TCGA KIRC -0.139; TCGA KIRP -0.253; TCGA LUAD -0.24; TCGA LUSC -0.144; TCGA PRAD -0.432; TCGA STAD -0.256; TCGA UCEC -0.368 |
hsa-miR-141-3p | AKAP11 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.06; TCGA BRCA -0.144; TCGA CESC -0.081; TCGA ESCA -0.067; TCGA HNSC -0.149; TCGA LGG -0.126; TCGA LUAD -0.066; TCGA LUSC -0.164; TCGA PRAD -0.257; TCGA THCA -0.107; TCGA STAD -0.106; TCGA UCEC -0.131 |
hsa-miR-141-3p | CHD9 | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.059; TCGA BRCA -0.182; TCGA CESC -0.119; TCGA COAD -0.114; TCGA HNSC -0.116; TCGA LGG -0.149; TCGA LIHC -0.055; TCGA LUAD -0.062; TCGA LUSC -0.101; TCGA PAAD -0.068; TCGA PRAD -0.252; TCGA THCA -0.109; TCGA STAD -0.111; TCGA UCEC -0.154 |
hsa-miR-141-3p | STAT4 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA | MirTarget; TargetScan | TCGA BLCA -0.226; TCGA BRCA -0.241; TCGA CESC -0.141; TCGA COAD -0.335; TCGA ESCA -0.238; TCGA HNSC -0.153; TCGA KIRC -0.288; TCGA LUAD -0.095; TCGA LUSC -0.485; TCGA PAAD -0.333; TCGA PRAD -0.111; TCGA THCA -0.51 |
hsa-miR-141-3p | RFTN1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.228; TCGA BRCA -0.27; TCGA CESC -0.27; TCGA COAD -0.499; TCGA ESCA -0.359; TCGA HNSC -0.289; TCGA KIRC -0.148; TCGA LUAD -0.089; TCGA LUSC -0.684; TCGA PAAD -0.376; TCGA PRAD -0.286; TCGA SARC -0.072; TCGA THCA -0.163; TCGA STAD -0.184; TCGA UCEC -0.273 |
hsa-miR-141-3p | VCAN | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.369; TCGA BRCA -0.086; TCGA CESC -0.439; TCGA COAD -0.667; TCGA ESCA -0.248; TCGA HNSC -0.628; TCGA KIRC -0.252; TCGA KIRP -0.325; TCGA LGG -0.213; TCGA LUAD -0.193; TCGA LUSC -0.343; TCGA OV -0.44; TCGA PAAD -0.421; TCGA PRAD -0.367; TCGA THCA -0.62; TCGA STAD -0.116; TCGA UCEC -0.109 |
hsa-miR-141-3p | DSTYK | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.053; TCGA CESC -0.115; TCGA COAD -0.133; TCGA ESCA -0.087; TCGA HNSC -0.091; TCGA LGG -0.079; TCGA PAAD -0.096; TCGA PRAD -0.118; TCGA THCA -0.053; TCGA STAD -0.149; TCGA UCEC -0.114 |
hsa-miR-141-3p | ZBTB20 | 13 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget; TargetScan | TCGA BLCA -0.123; TCGA BRCA -0.289; TCGA ESCA -0.235; TCGA HNSC -0.365; TCGA KIRP -0.093; TCGA LGG -0.225; TCGA LIHC -0.06; TCGA LUSC -0.258; TCGA PAAD -0.119; TCGA PRAD -0.369; TCGA SARC -0.117; TCGA THCA -0.238; TCGA STAD -0.294 |
hsa-miR-141-3p | CDC42EP3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.223; TCGA BRCA -0.172; TCGA CESC -0.198; TCGA COAD -0.284; TCGA ESCA -0.324; TCGA HNSC -0.251; TCGA LUAD -0.15; TCGA LUSC -0.211; TCGA OV -0.087; TCGA PAAD -0.124; TCGA PRAD -0.451; TCGA THCA -0.164; TCGA STAD -0.359; TCGA UCEC -0.256 |
hsa-miR-141-3p | TBC1D1 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.061; TCGA CESC -0.129; TCGA COAD -0.148; TCGA ESCA -0.208; TCGA HNSC -0.217; TCGA LUAD -0.191; TCGA LUSC -0.261; TCGA PAAD -0.123; TCGA PRAD -0.329; TCGA SARC -0.098; TCGA STAD -0.256; TCGA UCEC -0.112 |
hsa-miR-141-3p | ERG | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.253; TCGA BRCA -0.413; TCGA CESC -0.346; TCGA COAD -0.564; TCGA ESCA -0.257; TCGA HNSC -0.306; TCGA KIRC -0.085; TCGA LUAD -0.301; TCGA LUSC -0.56; TCGA OV -0.202; TCGA PAAD -0.369; TCGA THCA -0.187; TCGA STAD -0.225; TCGA UCEC -0.205 |
hsa-miR-141-3p | SV2B | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.545; TCGA BRCA -0.491; TCGA CESC -0.314; TCGA COAD -1.088; TCGA ESCA -0.533; TCGA HNSC -0.391; TCGA LUAD -0.37; TCGA OV -0.228; TCGA PRAD -0.496; TCGA SARC -0.187; TCGA THCA -0.738; TCGA STAD -0.43; TCGA UCEC -0.335 |
hsa-miR-141-3p | DUSP3 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.154; TCGA BRCA -0.119; TCGA COAD -0.113; TCGA ESCA -0.129; TCGA HNSC -0.176; TCGA KIRP -0.077; TCGA LUAD -0.106; TCGA LUSC -0.142; TCGA PAAD -0.057; TCGA PRAD -0.234; TCGA SARC -0.095; TCGA THCA -0.083; TCGA STAD -0.225; TCGA UCEC -0.121 |
hsa-miR-141-3p | PAPPA | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.347; TCGA BRCA -0.257; TCGA CESC -0.304; TCGA COAD -0.514; TCGA ESCA -0.229; TCGA HNSC -0.42; TCGA KIRP -0.073; TCGA LGG -0.352; TCGA LUSC -0.432; TCGA OV -0.3; TCGA PAAD -0.329; TCGA PRAD -0.531; TCGA SARC -0.172; TCGA THCA -0.605; TCGA STAD -0.188; TCGA UCEC -0.515 |
hsa-miR-141-3p | UNC5C | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.49; TCGA BRCA -0.303; TCGA CESC -0.282; TCGA COAD -0.511; TCGA ESCA -0.277; TCGA HNSC -0.654; TCGA LUAD -0.397; TCGA LUSC -0.929; TCGA OV -0.42; TCGA PAAD -0.396; TCGA PRAD -0.556; TCGA THCA -0.308; TCGA STAD -0.105; TCGA UCEC -0.16 |
hsa-miR-141-3p | ASTN1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.142; TCGA BRCA -0.525; TCGA CESC -0.434; TCGA COAD -1.059; TCGA ESCA -0.831; TCGA HNSC -0.206; TCGA LGG -0.245; TCGA LUAD -0.477; TCGA LUSC -0.432; TCGA PAAD -0.247; TCGA PRAD -0.618; TCGA STAD -0.905; TCGA UCEC -0.239 |
hsa-miR-141-3p | MAP7D1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.139; TCGA BRCA -0.118; TCGA CESC -0.082; TCGA COAD -0.218; TCGA ESCA -0.177; TCGA HNSC -0.132; TCGA LUAD -0.142; TCGA LUSC -0.188; TCGA PAAD -0.1; TCGA THCA -0.067; TCGA STAD -0.241; TCGA UCEC -0.075 |
hsa-miR-141-3p | ADARB1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.338; TCGA BRCA -0.127; TCGA CESC -0.17; TCGA COAD -0.268; TCGA ESCA -0.366; TCGA HNSC -0.185; TCGA KIRC -0.078; TCGA LUAD -0.261; TCGA LUSC -0.566; TCGA PAAD -0.287; TCGA THCA -0.143; TCGA STAD -0.345; TCGA UCEC -0.227 |
hsa-miR-141-3p | GNG7 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.304; TCGA BRCA -0.161; TCGA CESC -0.364; TCGA COAD -0.427; TCGA ESCA -0.496; TCGA HNSC -0.279; TCGA LIHC -0.142; TCGA LUAD -0.189; TCGA LUSC -0.616; TCGA PAAD -0.152; TCGA STAD -0.448; TCGA UCEC -0.421 |
hsa-miR-141-3p | YAP1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.108; TCGA BRCA -0.225; TCGA CESC -0.13; TCGA COAD -0.074; TCGA ESCA -0.073; TCGA HNSC -0.125; TCGA LUAD -0.078; TCGA LUSC -0.084; TCGA PAAD -0.188; TCGA PRAD -0.285; TCGA SARC -0.086; TCGA THCA -0.058; TCGA STAD -0.123; TCGA UCEC -0.122 |
hsa-miR-141-3p | RORA | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.21; TCGA BRCA -0.2; TCGA CESC -0.114; TCGA COAD -0.483; TCGA ESCA -0.218; TCGA HNSC -0.121; TCGA KIRC -0.082; TCGA KIRP -0.083; TCGA LGG -0.091; TCGA LIHC -0.116; TCGA LUAD -0.097; TCGA LUSC -0.139; TCGA PAAD -0.189; TCGA PRAD -0.2; TCGA STAD -0.279; TCGA UCEC -0.192 |
hsa-miR-141-3p | ZCCHC24 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.431; TCGA BRCA -0.436; TCGA CESC -0.369; TCGA COAD -0.551; TCGA ESCA -0.529; TCGA HNSC -0.494; TCGA LGG -0.173; TCGA LIHC -0.115; TCGA LUAD -0.227; TCGA LUSC -0.612; TCGA OV -0.298; TCGA PAAD -0.389; TCGA PRAD -0.253; TCGA SARC -0.093; TCGA THCA -0.238; TCGA STAD -0.505; TCGA UCEC -0.451 |
hsa-miR-141-3p | ANGPTL1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.762; TCGA BRCA -0.825; TCGA CESC -0.596; TCGA COAD -1.706; TCGA ESCA -0.779; TCGA HNSC -0.907; TCGA LUAD -0.406; TCGA LUSC -1.02; TCGA OV -0.377; TCGA PAAD -0.522; TCGA PRAD -0.782; TCGA SARC -0.383; TCGA THCA -0.309; TCGA STAD -0.961; TCGA UCEC -0.63 |
hsa-miR-141-3p | TTBK2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.139; TCGA BRCA -0.266; TCGA CESC -0.15; TCGA COAD -0.285; TCGA ESCA -0.152; TCGA HNSC -0.216; TCGA LGG -0.133; TCGA LUAD -0.162; TCGA PAAD -0.199; TCGA PRAD -0.392; TCGA SARC -0.094; TCGA THCA -0.369; TCGA STAD -0.259; TCGA UCEC -0.166 |
hsa-miR-141-3p | PLCL1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.386; TCGA BRCA -0.22; TCGA CESC -0.467; TCGA COAD -0.487; TCGA ESCA -0.382; TCGA HNSC -0.508; TCGA LGG -0.066; TCGA LUAD -0.261; TCGA LUSC -0.583; TCGA PAAD -0.332; TCGA PRAD -0.65; TCGA SARC -0.14; TCGA THCA -0.298; TCGA STAD -0.42; TCGA UCEC -0.459 |
hsa-miR-141-3p | DYNC1I1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; OV; PAAD; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.213; TCGA BRCA -0.29; TCGA CESC -0.272; TCGA COAD -0.828; TCGA ESCA -0.218; TCGA HNSC -0.196; TCGA LIHC -0.184; TCGA OV -0.264; TCGA PAAD -0.178; TCGA PRAD -0.526; TCGA THCA -0.237; TCGA STAD -0.593 |
hsa-miR-141-3p | GNE | 9 cancers: BLCA; BRCA; KIRP; LGG; LIHC; LUSC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.129; TCGA BRCA -0.145; TCGA KIRP -0.087; TCGA LGG -0.059; TCGA LIHC -0.161; TCGA LUSC -0.098; TCGA THCA -0.161; TCGA STAD -0.095; TCGA UCEC -0.153 |
hsa-miR-141-3p | PRKACB | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.131; TCGA BRCA -0.15; TCGA CESC -0.18; TCGA COAD -0.158; TCGA ESCA -0.198; TCGA HNSC -0.268; TCGA LIHC -0.065; TCGA LUAD -0.128; TCGA LUSC -0.233; TCGA OV -0.148; TCGA PAAD -0.107; TCGA PRAD -0.129; TCGA STAD -0.256; TCGA UCEC -0.213 |
hsa-miR-141-3p | CCDC80 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.694; TCGA BRCA -0.522; TCGA CESC -0.482; TCGA COAD -1.011; TCGA ESCA -0.706; TCGA HNSC -0.538; TCGA LUAD -0.347; TCGA LUSC -0.459; TCGA OV -0.365; TCGA PAAD -0.566; TCGA PRAD -0.507; TCGA SARC -0.191; TCGA THCA -0.348; TCGA STAD -0.59; TCGA UCEC -0.42 |
hsa-miR-141-3p | LHFP | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.333; TCGA BRCA -0.477; TCGA CESC -0.335; TCGA COAD -0.619; TCGA ESCA -0.439; TCGA HNSC -0.362; TCGA KIRC -0.114; TCGA LUAD -0.265; TCGA LUSC -0.553; TCGA OV -0.299; TCGA PAAD -0.369; TCGA PRAD -0.195; TCGA THCA -0.212; TCGA STAD -0.339; TCGA UCEC -0.364 |
hsa-miR-141-3p | ACO1 | 12 cancers: BLCA; BRCA; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.13; TCGA BRCA -0.32; TCGA ESCA -0.092; TCGA HNSC -0.138; TCGA LGG -0.066; TCGA LIHC -0.118; TCGA LUAD -0.065; TCGA LUSC -0.198; TCGA OV -0.131; TCGA PAAD -0.064; TCGA PRAD -0.171; TCGA UCEC -0.102 |
hsa-miR-141-3p | ZDHHC15 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.377; TCGA BRCA -0.25; TCGA CESC -0.457; TCGA COAD -0.906; TCGA ESCA -0.431; TCGA HNSC -0.334; TCGA LUAD -0.339; TCGA LUSC -0.604; TCGA PAAD -0.17; TCGA PRAD -0.527; TCGA STAD -0.521; TCGA UCEC -0.301 |
hsa-miR-141-3p | PHYHIPL | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUSC; PRAD; STAD | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.246; TCGA BRCA -0.334; TCGA CESC -0.227; TCGA COAD -0.544; TCGA ESCA -0.424; TCGA HNSC -0.147; TCGA KIRP -0.374; TCGA LGG -0.332; TCGA LIHC -0.113; TCGA LUSC -0.267; TCGA PRAD -0.265; TCGA STAD -0.366 |
hsa-miR-141-3p | TTLL7 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PRAD; SARC; STAD | MirTarget; TargetScan | TCGA BLCA -0.339; TCGA BRCA -0.24; TCGA CESC -0.241; TCGA COAD -0.711; TCGA ESCA -0.318; TCGA HNSC -0.238; TCGA KIRC -0.158; TCGA LUAD -0.2; TCGA LUSC -0.275; TCGA OV -0.28; TCGA PRAD -0.274; TCGA SARC -0.21; TCGA STAD -0.517 |
hsa-miR-141-3p | RSPO2 | 9 cancers: BLCA; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; PRAD; STAD | MirTarget | TCGA BLCA -0.69; TCGA COAD -1.015; TCGA ESCA -0.779; TCGA LIHC -0.272; TCGA LUAD -0.475; TCGA LUSC -0.891; TCGA PAAD -0.489; TCGA PRAD -0.61; TCGA STAD -0.727 |
hsa-miR-141-3p | NECAB1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.491; TCGA BRCA -0.464; TCGA CESC -0.503; TCGA COAD -0.87; TCGA ESCA -0.553; TCGA HNSC -0.249; TCGA KIRP -0.157; TCGA LUAD -0.399; TCGA LUSC -0.658; TCGA PAAD -0.263; TCGA PRAD -0.599; TCGA SARC -0.162; TCGA THCA -0.209; TCGA STAD -0.754; TCGA UCEC -0.615 |
hsa-miR-141-3p | ATXN1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.242; TCGA BRCA -0.103; TCGA CESC -0.182; TCGA COAD -0.184; TCGA ESCA -0.127; TCGA HNSC -0.207; TCGA KIRC -0.079; TCGA LUAD -0.139; TCGA LUSC -0.134; TCGA PAAD -0.184; TCGA PRAD -0.223; TCGA THCA -0.11; TCGA STAD -0.218; TCGA UCEC -0.105 |
hsa-miR-141-3p | GSN | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.264; TCGA BRCA -0.429; TCGA CESC -0.154; TCGA COAD -0.224; TCGA ESCA -0.286; TCGA HNSC -0.09; TCGA KIRC -0.069; TCGA LUAD -0.117; TCGA LUSC -0.128; TCGA PRAD -0.302; TCGA SARC -0.248; TCGA THCA -0.17; TCGA STAD -0.344; TCGA UCEC -0.214 |
hsa-miR-141-3p | MBNL3 | 9 cancers: BLCA; BRCA; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; THCA | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.118; TCGA BRCA -0.327; TCGA HNSC -0.179; TCGA LIHC -0.077; TCGA LUAD -0.204; TCGA LUSC -0.175; TCGA PRAD -0.489; TCGA SARC -0.124; TCGA THCA -0.405 |
hsa-miR-141-3p | CLIP2 | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LUAD; LUSC; PRAD; THCA; UCEC | MirTarget; TargetScan | TCGA BLCA -0.153; TCGA BRCA -0.098; TCGA CESC -0.114; TCGA HNSC -0.163; TCGA KIRP -0.079; TCGA LUAD -0.234; TCGA LUSC -0.144; TCGA PRAD -0.243; TCGA THCA -0.179; TCGA UCEC -0.211 |
hsa-miR-141-3p | CRMP1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LUAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.226; TCGA BRCA -0.129; TCGA CESC -0.236; TCGA COAD -0.538; TCGA ESCA -0.197; TCGA KIRC -0.054; TCGA KIRP -0.157; TCGA LGG -0.147; TCGA LUAD -0.124; TCGA PRAD -0.153; TCGA THCA -0.109; TCGA STAD -0.24; TCGA UCEC -0.282 |
hsa-miR-141-3p | ST3GAL3 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; OV; PAAD; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.174; TCGA BRCA -0.175; TCGA CESC -0.104; TCGA COAD -0.226; TCGA ESCA -0.254; TCGA LIHC -0.136; TCGA OV -0.081; TCGA PAAD -0.133; TCGA STAD -0.343; TCGA UCEC -0.145 |
hsa-miR-141-3p | GIT2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.067; TCGA BRCA -0.083; TCGA CESC -0.06; TCGA COAD -0.09; TCGA ESCA -0.098; TCGA HNSC -0.128; TCGA KIRC -0.183; TCGA LUAD -0.075; TCGA LUSC -0.153; TCGA PAAD -0.139; TCGA PRAD -0.113; TCGA THCA -0.074; TCGA STAD -0.138; TCGA UCEC -0.086 |
hsa-miR-141-3p | DCUN1D3 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.09; TCGA BRCA -0.2; TCGA CESC -0.064; TCGA COAD -0.064; TCGA HNSC -0.066; TCGA KIRC -0.08; TCGA LUAD -0.123; TCGA LUSC -0.227; TCGA PAAD -0.129; TCGA PRAD -0.133; TCGA THCA -0.086; TCGA STAD -0.061; TCGA UCEC -0.052 |
hsa-miR-141-3p | TMEM170B | 15 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.132; TCGA BRCA -0.263; TCGA CESC -0.123; TCGA COAD -0.209; TCGA HNSC -0.284; TCGA LGG -0.157; TCGA LIHC -0.09; TCGA LUAD -0.091; TCGA LUSC -0.228; TCGA OV -0.145; TCGA PAAD -0.157; TCGA PRAD -0.08; TCGA THCA -0.082; TCGA STAD -0.295; TCGA UCEC -0.175 |
hsa-miR-141-3p | SPAG9 | 13 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.054; TCGA BRCA -0.124; TCGA CESC -0.065; TCGA HNSC -0.091; TCGA KIRP -0.065; TCGA LGG -0.094; TCGA LUAD -0.081; TCGA LUSC -0.056; TCGA PAAD -0.077; TCGA PRAD -0.162; TCGA THCA -0.092; TCGA STAD -0.1; TCGA UCEC -0.138 |
hsa-miR-141-3p | PXK | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.193; TCGA BRCA -0.153; TCGA CESC -0.148; TCGA COAD -0.138; TCGA ESCA -0.116; TCGA HNSC -0.246; TCGA LUAD -0.222; TCGA LUSC -0.292; TCGA PAAD -0.27; TCGA PRAD -0.289; TCGA SARC -0.159; TCGA THCA -0.125; TCGA STAD -0.109; TCGA UCEC -0.185 |
hsa-miR-141-3p | SDC2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.311; TCGA BRCA -0.232; TCGA CESC -0.322; TCGA COAD -0.539; TCGA ESCA -0.31; TCGA HNSC -0.418; TCGA LIHC -0.11; TCGA LUAD -0.264; TCGA LUSC -0.433; TCGA OV -0.368; TCGA PAAD -0.196; TCGA PRAD -0.258; TCGA SARC -0.082; TCGA STAD -0.286; TCGA UCEC -0.207 |
hsa-miR-141-3p | APBB2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.168; TCGA BRCA -0.112; TCGA CESC -0.131; TCGA COAD -0.075; TCGA ESCA -0.121; TCGA HNSC -0.225; TCGA LGG -0.127; TCGA LIHC -0.064; TCGA LUAD -0.222; TCGA LUSC -0.379; TCGA PAAD -0.142; TCGA PRAD -0.089; TCGA STAD -0.157; TCGA UCEC -0.089 |
hsa-miR-141-3p | EGFR | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LGG; LUAD; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.095; TCGA BRCA -0.587; TCGA CESC -0.163; TCGA HNSC -0.173; TCGA KIRC -0.142; TCGA LGG -0.272; TCGA LUAD -0.182; TCGA PRAD -0.354; TCGA THCA -0.27; TCGA STAD -0.143 |
hsa-miR-141-3p | TSHZ3 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.448; TCGA BRCA -0.283; TCGA CESC -0.375; TCGA COAD -0.624; TCGA ESCA -0.417; TCGA HNSC -0.365; TCGA LUAD -0.298; TCGA LUSC -0.341; TCGA OV -0.182; TCGA PAAD -0.289; TCGA PRAD -0.391; TCGA SARC -0.134; TCGA THCA -0.185; TCGA STAD -0.444; TCGA UCEC -0.434 |
hsa-miR-141-3p | TRIM23 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.088; TCGA BRCA -0.122; TCGA CESC -0.082; TCGA COAD -0.116; TCGA ESCA -0.13; TCGA HNSC -0.148; TCGA LGG -0.131; TCGA LIHC -0.088; TCGA LUAD -0.136; TCGA LUSC -0.16; TCGA OV -0.072; TCGA PAAD -0.089; TCGA PRAD -0.153; TCGA STAD -0.177; TCGA UCEC -0.176 |
hsa-miR-141-3p | TRAM2 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.201; TCGA BRCA -0.138; TCGA CESC -0.092; TCGA COAD -0.11; TCGA ESCA -0.071; TCGA HNSC -0.135; TCGA LUAD -0.104; TCGA LUSC -0.064; TCGA PAAD -0.181; TCGA THCA -0.246; TCGA STAD -0.055; TCGA UCEC -0.139 |
hsa-miR-141-3p | FEM1C | 9 cancers: BLCA; HNSC; KIRC; LUAD; LUSC; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.053; TCGA HNSC -0.091; TCGA KIRC -0.082; TCGA LUAD -0.091; TCGA LUSC -0.118; TCGA PRAD -0.108; TCGA SARC -0.075; TCGA THCA -0.08; TCGA STAD -0.089 |
hsa-miR-141-3p | IL6R | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.238; TCGA BRCA -0.253; TCGA CESC -0.182; TCGA COAD -0.26; TCGA ESCA -0.117; TCGA HNSC -0.208; TCGA KIRC -0.168; TCGA KIRP -0.096; TCGA LIHC -0.143; TCGA LUAD -0.114; TCGA LUSC -0.407; TCGA PAAD -0.172; TCGA PRAD -0.345; TCGA SARC -0.23; TCGA THCA -0.539; TCGA STAD -0.151; TCGA UCEC -0.144 |
hsa-miR-141-3p | RNF38 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan; mirMAP | TCGA BLCA -0.084; TCGA BRCA -0.077; TCGA CESC -0.101; TCGA COAD -0.082; TCGA ESCA -0.095; TCGA HNSC -0.088; TCGA LGG -0.079; TCGA LUAD -0.096; TCGA LUSC -0.111; TCGA PRAD -0.167; TCGA SARC -0.098; TCGA THCA -0.095; TCGA STAD -0.177; TCGA UCEC -0.157 |
hsa-miR-141-3p | LMO3 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.479; TCGA BRCA -0.288; TCGA CESC -0.55; TCGA COAD -1.506; TCGA ESCA -0.548; TCGA LGG -0.217; TCGA LUSC -0.818; TCGA PAAD -0.205; TCGA PRAD -0.59; TCGA STAD -0.755; TCGA UCEC -0.499 |
hsa-miR-141-3p | TNS1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.529; TCGA BRCA -0.547; TCGA CESC -0.254; TCGA COAD -0.94; TCGA ESCA -0.561; TCGA HNSC -0.482; TCGA KIRC -0.068; TCGA LUAD -0.187; TCGA LUSC -0.617; TCGA PAAD -0.279; TCGA PRAD -0.665; TCGA SARC -0.246; TCGA THCA -0.134; TCGA STAD -0.653; TCGA UCEC -0.377 |
hsa-miR-141-3p | ZNF385D | 15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.449; TCGA BRCA -0.36; TCGA COAD -1.161; TCGA ESCA -0.763; TCGA HNSC -0.641; TCGA LIHC -0.283; TCGA LUAD -0.41; TCGA LUSC -0.822; TCGA OV -0.492; TCGA PAAD -0.538; TCGA PRAD -0.442; TCGA SARC -0.156; TCGA THCA -0.545; TCGA STAD -0.52; TCGA UCEC -0.346 |
hsa-miR-141-3p | GAB1 | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.09; TCGA BRCA -0.12; TCGA CESC -0.13; TCGA ESCA -0.126; TCGA HNSC -0.146; TCGA LGG -0.061; TCGA LUAD -0.193; TCGA LUSC -0.161; TCGA PAAD -0.094; TCGA PRAD -0.252; TCGA SARC -0.068; TCGA THCA -0.121; TCGA STAD -0.221; TCGA UCEC -0.188 |
hsa-miR-141-3p | SOBP | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.383; TCGA BRCA -0.419; TCGA CESC -0.206; TCGA COAD -0.472; TCGA ESCA -0.373; TCGA HNSC -0.405; TCGA LGG -0.113; TCGA LUAD -0.302; TCGA LUSC -0.369; TCGA OV -0.213; TCGA PAAD -0.203; TCGA PRAD -0.247; TCGA STAD -0.468; TCGA UCEC -0.342 |
hsa-miR-141-3p | ULK2 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.072; TCGA BRCA -0.056; TCGA CESC -0.081; TCGA COAD -0.18; TCGA ESCA -0.179; TCGA HNSC -0.066; TCGA KIRP -0.088; TCGA LUSC -0.127; TCGA PAAD -0.111; TCGA STAD -0.267; TCGA UCEC -0.104 |
hsa-miR-141-3p | CRYBG3 | 10 cancers: BLCA; BRCA; COAD; HNSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.086; TCGA BRCA -0.442; TCGA COAD -0.212; TCGA HNSC -0.163; TCGA PAAD -0.165; TCGA PRAD -0.305; TCGA SARC -0.141; TCGA THCA -0.108; TCGA STAD -0.17; TCGA UCEC -0.254 |
hsa-miR-141-3p | SH2B3 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.226; TCGA BRCA -0.167; TCGA CESC -0.16; TCGA COAD -0.171; TCGA ESCA -0.095; TCGA HNSC -0.286; TCGA KIRC -0.189; TCGA LUAD -0.261; TCGA LUSC -0.491; TCGA PAAD -0.222; TCGA PRAD -0.205; TCGA THCA -0.202; TCGA UCEC -0.152 |
hsa-miR-141-3p | PTPRG | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.201; TCGA BRCA -0.334; TCGA CESC -0.191; TCGA COAD -0.084; TCGA HNSC -0.36; TCGA LGG -0.117; TCGA LUAD -0.365; TCGA LUSC -0.387; TCGA PAAD -0.216; TCGA PRAD -0.351; TCGA SARC -0.106; TCGA THCA -0.242; TCGA STAD -0.082; TCGA UCEC -0.057 |
hsa-miR-141-3p | SIRT1 | 11 cancers: BLCA; BRCA; ESCA; HNSC; LGG; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.061; TCGA BRCA -0.059; TCGA ESCA -0.057; TCGA HNSC -0.089; TCGA LGG -0.125; TCGA LUSC -0.128; TCGA PAAD -0.065; TCGA PRAD -0.11; TCGA THCA -0.087; TCGA STAD -0.079; TCGA UCEC -0.133 |
hsa-miR-141-3p | LCP2 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA | MirTarget | TCGA BLCA -0.292; TCGA BRCA -0.056; TCGA CESC -0.185; TCGA COAD -0.359; TCGA ESCA -0.162; TCGA HNSC -0.339; TCGA KIRC -0.296; TCGA LUAD -0.281; TCGA LUSC -0.59; TCGA PAAD -0.432; TCGA PRAD -0.287; TCGA THCA -0.337 |
hsa-miR-141-3p | HAS2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.365; TCGA BRCA -0.397; TCGA CESC -0.585; TCGA COAD -0.273; TCGA ESCA -0.333; TCGA HNSC -0.463; TCGA LUAD -0.343; TCGA LUSC -0.623; TCGA OV -0.384; TCGA PAAD -0.412; TCGA PRAD -0.594; TCGA THCA -0.83; TCGA STAD -0.117; TCGA UCEC -0.199 |
hsa-miR-141-3p | CDK17 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.087; TCGA CESC -0.116; TCGA COAD -0.117; TCGA ESCA -0.147; TCGA HNSC -0.068; TCGA KIRC -0.095; TCGA LUAD -0.097; TCGA LUSC -0.093; TCGA PAAD -0.099; TCGA PRAD -0.061; TCGA SARC -0.082; TCGA THCA -0.078; TCGA STAD -0.128; TCGA UCEC -0.158 |
hsa-miR-141-3p | LHX6 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.193; TCGA BRCA -0.346; TCGA CESC -0.278; TCGA COAD -0.506; TCGA ESCA -0.243; TCGA HNSC -0.173; TCGA KIRC -0.097; TCGA LUAD -0.26; TCGA LUSC -0.194; TCGA PAAD -0.209; TCGA SARC -0.134; TCGA THCA -0.242; TCGA STAD -0.239; TCGA UCEC -0.143 |
hsa-miR-141-3p | ABL1 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUSC; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.175; TCGA BRCA -0.077; TCGA CESC -0.07; TCGA ESCA -0.186; TCGA HNSC -0.196; TCGA LGG -0.054; TCGA LUSC -0.071; TCGA PAAD -0.117; TCGA SARC -0.06; TCGA THCA -0.058; TCGA STAD -0.218; TCGA UCEC -0.14 |
hsa-miR-141-3p | ITGAV | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.126; TCGA BRCA -0.108; TCGA CESC -0.1; TCGA COAD -0.281; TCGA ESCA -0.095; TCGA HNSC -0.152; TCGA LUAD -0.096; TCGA PAAD -0.126; TCGA PRAD -0.177; TCGA SARC -0.119; TCGA THCA -0.093; TCGA STAD -0.113; TCGA UCEC -0.15 |
hsa-miR-141-3p | FAT3 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.243; TCGA BRCA -0.499; TCGA CESC -0.391; TCGA COAD -0.641; TCGA ESCA -0.563; TCGA HNSC -0.402; TCGA LGG -0.163; TCGA LUAD -0.442; TCGA LUSC -0.64; TCGA OV -0.468; TCGA PAAD -0.446; TCGA PRAD -0.905; TCGA SARC -0.267; TCGA STAD -0.875; TCGA UCEC -0.361 |
hsa-miR-141-3p | KIAA0408 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD | MirTarget; TargetScan | TCGA BLCA -0.604; TCGA BRCA -1.113; TCGA COAD -0.892; TCGA ESCA -1.028; TCGA HNSC -0.607; TCGA LGG -0.22; TCGA LUAD -0.498; TCGA LUSC -1.285; TCGA PAAD -0.645; TCGA PRAD -0.739; TCGA SARC -0.479; TCGA STAD -0.682 |
hsa-miR-141-3p | RAB8B | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.069; TCGA BRCA -0.176; TCGA CESC -0.137; TCGA COAD -0.238; TCGA ESCA -0.176; TCGA HNSC -0.207; TCGA KIRC -0.051; TCGA LUAD -0.246; TCGA LUSC -0.409; TCGA PAAD -0.219; TCGA PRAD -0.149; TCGA THCA -0.155; TCGA STAD -0.091; TCGA UCEC -0.253 |
hsa-miR-141-3p | PRKD1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.237; TCGA BRCA -0.406; TCGA CESC -0.365; TCGA COAD -0.84; TCGA ESCA -0.43; TCGA HNSC -0.304; TCGA LUAD -0.179; TCGA LUSC -0.381; TCGA OV -0.176; TCGA PAAD -0.254; TCGA PRAD -0.084; TCGA SARC -0.218; TCGA THCA -0.138; TCGA STAD -0.385; TCGA UCEC -0.244 |
hsa-miR-141-3p | TCF12 | 11 cancers: BLCA; BRCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.069; TCGA BRCA -0.07; TCGA HNSC -0.185; TCGA LGG -0.306; TCGA LUAD -0.059; TCGA LUSC -0.103; TCGA PAAD -0.138; TCGA PRAD -0.176; TCGA THCA -0.152; TCGA STAD -0.051; TCGA UCEC -0.087 |
hsa-miR-141-3p | CD274 | 10 cancers: BLCA; BRCA; COAD; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.219; TCGA BRCA -0.099; TCGA COAD -0.246; TCGA HNSC -0.242; TCGA LUAD -0.433; TCGA LUSC -0.277; TCGA PAAD -0.228; TCGA PRAD -0.389; TCGA THCA -0.526; TCGA UCEC -0.079 |
hsa-miR-141-3p | STX2 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.387; TCGA BRCA -0.152; TCGA CESC -0.099; TCGA COAD -0.185; TCGA ESCA -0.228; TCGA HNSC -0.169; TCGA KIRC -0.052; TCGA KIRP -0.076; TCGA LUAD -0.129; TCGA LUSC -0.36; TCGA PAAD -0.109; TCGA PRAD -0.204; TCGA SARC -0.062; TCGA THCA -0.123; TCGA STAD -0.266; TCGA UCEC -0.23 |
hsa-miR-141-3p | PLEK | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA | MirTarget; TargetScan | TCGA BLCA -0.417; TCGA BRCA -0.1; TCGA CESC -0.204; TCGA COAD -0.427; TCGA ESCA -0.247; TCGA HNSC -0.378; TCGA KIRC -0.305; TCGA KIRP -0.079; TCGA LUAD -0.299; TCGA LUSC -0.607; TCGA PAAD -0.584; TCGA PRAD -0.236; TCGA THCA -0.593 |
hsa-miR-141-3p | SLC16A7 | 14 cancers: BLCA; BRCA; COAD; HNSC; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.212; TCGA BRCA -0.672; TCGA COAD -0.651; TCGA HNSC -0.365; TCGA LGG -0.237; TCGA LIHC -0.104; TCGA LUAD -0.129; TCGA LUSC -0.309; TCGA OV -0.289; TCGA PRAD -0.728; TCGA SARC -0.206; TCGA THCA -0.503; TCGA STAD -0.306; TCGA UCEC -0.377 |
hsa-miR-141-3p | SORBS2 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; PRAD; SARC; STAD | MirTarget; TargetScan | TCGA BLCA -0.29; TCGA BRCA -0.147; TCGA COAD -0.31; TCGA ESCA -0.244; TCGA HNSC -0.371; TCGA KIRC -0.055; TCGA KIRP -0.083; TCGA LIHC -0.128; TCGA LUSC -0.655; TCGA PRAD -0.27; TCGA SARC -0.13; TCGA STAD -0.448 |
hsa-miR-141-3p | STAT5B | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.091; TCGA BRCA -0.21; TCGA CESC -0.152; TCGA COAD -0.124; TCGA ESCA -0.147; TCGA HNSC -0.178; TCGA LIHC -0.058; TCGA LUAD -0.098; TCGA LUSC -0.167; TCGA PAAD -0.116; TCGA PRAD -0.166; TCGA SARC -0.1; TCGA STAD -0.205; TCGA UCEC -0.22 |
hsa-miR-141-3p | PPM1K | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.233; TCGA BRCA -0.118; TCGA CESC -0.215; TCGA COAD -0.227; TCGA ESCA -0.225; TCGA HNSC -0.208; TCGA LGG -0.075; TCGA LIHC -0.089; TCGA LUAD -0.171; TCGA LUSC -0.476; TCGA PAAD -0.257; TCGA SARC -0.121; TCGA THCA -0.211; TCGA STAD -0.28; TCGA UCEC -0.245 |
hsa-miR-141-3p | GJC1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.252; TCGA BRCA -0.128; TCGA CESC -0.135; TCGA COAD -0.494; TCGA ESCA -0.27; TCGA HNSC -0.222; TCGA KIRC -0.331; TCGA LUAD -0.159; TCGA OV -0.238; TCGA PAAD -0.272; TCGA PRAD -0.477; TCGA SARC -0.126; TCGA THCA -0.145; TCGA STAD -0.486; TCGA UCEC -0.389 |
hsa-miR-141-3p | SCHIP1 | 12 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LGG; LUAD; OV; PAAD; PRAD; SARC; UCEC | MirTarget; TargetScan | TCGA BLCA -0.214; TCGA BRCA -0.165; TCGA COAD -0.511; TCGA ESCA -0.206; TCGA KIRP -0.235; TCGA LGG -0.091; TCGA LUAD -0.144; TCGA OV -0.244; TCGA PAAD -0.237; TCGA PRAD -0.45; TCGA SARC -0.108; TCGA UCEC -0.209 |
hsa-miR-141-3p | FRMD4A | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; THCA; STAD | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.076; TCGA BRCA -0.155; TCGA CESC -0.078; TCGA COAD -0.244; TCGA ESCA -0.177; TCGA HNSC -0.129; TCGA LGG -0.053; TCGA LUAD -0.22; TCGA LUSC -0.331; TCGA PAAD -0.235; TCGA THCA -0.171; TCGA STAD -0.228 |
hsa-miR-141-3p | FAM20C | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LIHC; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.463; TCGA BRCA -0.14; TCGA COAD -0.517; TCGA ESCA -0.265; TCGA HNSC -0.201; TCGA KIRP -0.086; TCGA LIHC -0.066; TCGA LUSC -0.155; TCGA PAAD -0.135; TCGA THCA -0.126; TCGA STAD -0.239; TCGA UCEC -0.068 |
hsa-miR-141-3p | MBNL1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.146; TCGA BRCA -0.175; TCGA CESC -0.09; TCGA COAD -0.098; TCGA ESCA -0.09; TCGA HNSC -0.081; TCGA KIRC -0.078; TCGA LUAD -0.123; TCGA LUSC -0.082; TCGA PAAD -0.193; TCGA PRAD -0.226; TCGA SARC -0.132; TCGA THCA -0.131; TCGA STAD -0.205; TCGA UCEC -0.149 |
hsa-miR-141-3p | TNS3 | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; THCA | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.117; TCGA BRCA -0.154; TCGA CESC -0.141; TCGA COAD -0.157; TCGA HNSC -0.417; TCGA LIHC -0.066; TCGA LUAD -0.247; TCGA LUSC -0.597; TCGA PAAD -0.12; TCGA PRAD -0.181; TCGA THCA -0.252 |
hsa-miR-141-3p | SULF2 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; OV; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.376; TCGA CESC -0.255; TCGA COAD -0.287; TCGA ESCA -0.192; TCGA HNSC -0.259; TCGA KIRC -0.143; TCGA KIRP -0.199; TCGA LGG -0.25; TCGA LUAD -0.182; TCGA OV -0.346; TCGA PAAD -0.226; TCGA PRAD -0.422; TCGA THCA -0.274; TCGA UCEC -0.259 |
hsa-miR-141-3p | KIAA2022 | 9 cancers: BLCA; CESC; COAD; ESCA; LGG; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.439; TCGA CESC -0.337; TCGA COAD -1.193; TCGA ESCA -0.766; TCGA LGG -0.196; TCGA PAAD -0.31; TCGA PRAD -0.212; TCGA STAD -0.772; TCGA UCEC -0.131 |
hsa-miR-141-3p | OSBPL8 | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.087; TCGA BRCA -0.104; TCGA CESC -0.098; TCGA COAD -0.099; TCGA HNSC -0.147; TCGA LGG -0.154; TCGA LUAD -0.128; TCGA LUSC -0.098; TCGA OV -0.056; TCGA PAAD -0.164; TCGA PRAD -0.214; TCGA THCA -0.184; TCGA STAD -0.063; TCGA UCEC -0.151 |
hsa-miR-141-3p | LBR | 10 cancers: BLCA; BRCA; KIRP; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.088; TCGA BRCA -0.067; TCGA KIRP -0.058; TCGA OV -0.129; TCGA PAAD -0.096; TCGA PRAD -0.065; TCGA SARC -0.12; TCGA THCA -0.194; TCGA STAD -0.054; TCGA UCEC -0.12 |
hsa-miR-141-3p | JAZF1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.377; TCGA BRCA -0.218; TCGA CESC -0.216; TCGA COAD -0.502; TCGA ESCA -0.275; TCGA HNSC -0.231; TCGA KIRC -0.11; TCGA KIRP -0.112; TCGA LIHC -0.059; TCGA LUAD -0.17; TCGA LUSC -0.309; TCGA PAAD -0.136; TCGA PRAD -0.493; TCGA SARC -0.085; TCGA THCA -0.095; TCGA STAD -0.291; TCGA UCEC -0.199 |
hsa-miR-141-3p | GNAQ | 9 cancers: BLCA; BRCA; HNSC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.097; TCGA BRCA -0.117; TCGA HNSC -0.092; TCGA LUAD -0.095; TCGA LUSC -0.228; TCGA PRAD -0.101; TCGA SARC -0.07; TCGA STAD -0.071; TCGA UCEC -0.078 |
hsa-miR-141-3p | BICD2 | 9 cancers: BLCA; BRCA; COAD; LUAD; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.062; TCGA BRCA -0.069; TCGA COAD -0.109; TCGA LUAD -0.118; TCGA PAAD -0.18; TCGA PRAD -0.17; TCGA THCA -0.098; TCGA STAD -0.178; TCGA UCEC -0.1 |
hsa-miR-141-3p | SAMD8 | 11 cancers: BLCA; BRCA; COAD; HNSC; LGG; LUAD; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.071; TCGA BRCA -0.182; TCGA COAD -0.125; TCGA HNSC -0.09; TCGA LGG -0.167; TCGA LUAD -0.122; TCGA PAAD -0.102; TCGA PRAD -0.265; TCGA THCA -0.216; TCGA STAD -0.11; TCGA UCEC -0.06 |
hsa-miR-141-3p | WDR44 | 10 cancers: BLCA; BRCA; HNSC; LIHC; LUAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.101; TCGA BRCA -0.068; TCGA HNSC -0.091; TCGA LIHC -0.074; TCGA LUAD -0.06; TCGA PRAD -0.192; TCGA SARC -0.101; TCGA THCA -0.178; TCGA STAD -0.052; TCGA UCEC -0.101 |
hsa-miR-141-3p | GLI2 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.491; TCGA BRCA -0.334; TCGA CESC -0.269; TCGA COAD -0.699; TCGA ESCA -0.284; TCGA KIRC -0.105; TCGA LUAD -0.114; TCGA PAAD -0.361; TCGA PRAD -0.466; TCGA THCA -0.467; TCGA STAD -0.308; TCGA UCEC -0.394 |
hsa-miR-141-3p | IFFO2 | 9 cancers: BLCA; BRCA; CESC; KIRC; LUAD; OV; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.102; TCGA BRCA -0.125; TCGA CESC -0.148; TCGA KIRC -0.1; TCGA LUAD -0.067; TCGA OV -0.132; TCGA PRAD -0.195; TCGA STAD -0.073; TCGA UCEC -0.079 |
hsa-miR-141-3p | STAT5A | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.106; TCGA BRCA -0.249; TCGA CESC -0.127; TCGA COAD -0.091; TCGA ESCA -0.138; TCGA HNSC -0.12; TCGA KIRP -0.058; TCGA LUAD -0.19; TCGA LUSC -0.413; TCGA PAAD -0.155; TCGA PRAD -0.181; TCGA THCA -0.115; TCGA STAD -0.1; TCGA UCEC -0.105 |
hsa-miR-141-3p | PDGFRA | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.38; TCGA BRCA -0.466; TCGA CESC -0.459; TCGA COAD -0.558; TCGA ESCA -0.273; TCGA HNSC -0.506; TCGA LGG -0.213; TCGA LUAD -0.328; TCGA LUSC -0.554; TCGA OV -0.318; TCGA PAAD -0.544; TCGA PRAD -0.466; TCGA THCA -0.789; TCGA STAD -0.149; TCGA UCEC -0.378 |
hsa-miR-141-3p | PPFIBP1 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.125; TCGA BRCA -0.15; TCGA COAD -0.125; TCGA ESCA -0.082; TCGA HNSC -0.176; TCGA KIRC -0.053; TCGA KIRP -0.149; TCGA LUAD -0.247; TCGA LUSC -0.1; TCGA PAAD -0.073; TCGA PRAD -0.16; TCGA THCA -0.116; TCGA STAD -0.117; TCGA UCEC -0.103 |
hsa-miR-141-3p | KCTD20 | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.115; TCGA BRCA -0.129; TCGA CESC -0.097; TCGA COAD -0.092; TCGA HNSC -0.174; TCGA KIRC -0.059; TCGA LGG -0.075; TCGA LUAD -0.09; TCGA LUSC -0.143; TCGA PAAD -0.223; TCGA PRAD -0.163; TCGA THCA -0.228; TCGA STAD -0.137; TCGA UCEC -0.144 |
hsa-miR-141-3p | CHRDL1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.9; TCGA BRCA -0.939; TCGA CESC -0.9; TCGA COAD -1.812; TCGA ESCA -1.149; TCGA HNSC -0.873; TCGA LGG -0.222; TCGA LUAD -0.471; TCGA LUSC -1.079; TCGA PAAD -0.895; TCGA PRAD -0.831; TCGA SARC -0.265; TCGA THCA -1.298; TCGA STAD -0.98; TCGA UCEC -0.721 |
hsa-miR-141-3p | GLRX | 9 cancers: BLCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.134; TCGA HNSC -0.152; TCGA LIHC -0.115; TCGA LUAD -0.152; TCGA LUSC -0.47; TCGA PAAD -0.135; TCGA PRAD -0.206; TCGA SARC -0.138; TCGA THCA -0.138 |
hsa-miR-141-3p | SCN2B | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.638; TCGA BRCA -0.802; TCGA CESC -0.472; TCGA COAD -1.3; TCGA ESCA -0.595; TCGA HNSC -0.579; TCGA LGG -0.157; TCGA LUAD -0.454; TCGA LUSC -0.857; TCGA PAAD -0.484; TCGA PRAD -0.677; TCGA THCA -0.253; TCGA STAD -0.839; TCGA UCEC -0.614 |
hsa-miR-141-3p | SP4 | 11 cancers: BLCA; BRCA; CESC; HNSC; LGG; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.058; TCGA BRCA -0.066; TCGA CESC -0.075; TCGA HNSC -0.11; TCGA LGG -0.066; TCGA LUAD -0.126; TCGA LUSC -0.078; TCGA PRAD -0.195; TCGA THCA -0.082; TCGA STAD -0.058; TCGA UCEC -0.109 |
hsa-miR-141-3p | PHLPP2 | 10 cancers: BLCA; ESCA; HNSC; LGG; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.105; TCGA ESCA -0.08; TCGA HNSC -0.067; TCGA LGG -0.13; TCGA LUAD -0.117; TCGA LUSC -0.1; TCGA PRAD -0.117; TCGA THCA -0.099; TCGA STAD -0.053; TCGA UCEC -0.141 |
hsa-miR-141-3p | SLC25A46 | 11 cancers: BLCA; BRCA; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.077; TCGA BRCA -0.101; TCGA HNSC -0.158; TCGA LGG -0.092; TCGA LIHC -0.075; TCGA LUAD -0.127; TCGA LUSC -0.106; TCGA PRAD -0.186; TCGA SARC -0.055; TCGA THCA -0.117; TCGA UCEC -0.061 |
hsa-miR-141-3p | NFASC | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.304; TCGA BRCA -0.102; TCGA CESC -0.409; TCGA COAD -0.496; TCGA ESCA -0.583; TCGA HNSC -0.169; TCGA LUAD -0.205; TCGA LUSC -0.401; TCGA PRAD -0.457; TCGA SARC -0.226; TCGA THCA -0.293; TCGA STAD -0.67; TCGA UCEC -0.301 |
hsa-miR-141-3p | COL15A1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.341; TCGA BRCA -0.283; TCGA CESC -0.326; TCGA COAD -0.513; TCGA ESCA -0.269; TCGA HNSC -0.476; TCGA KIRC -0.231; TCGA LUAD -0.275; TCGA LUSC -0.511; TCGA OV -0.227; TCGA PAAD -0.323; TCGA PRAD -0.282; TCGA SARC -0.165; TCGA THCA -0.247; TCGA STAD -0.25; TCGA UCEC -0.311 |
hsa-miR-141-3p | HGF | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.677; TCGA BRCA -0.461; TCGA CESC -0.408; TCGA COAD -0.731; TCGA ESCA -0.487; TCGA HNSC -0.561; TCGA LUAD -0.401; TCGA LUSC -0.929; TCGA PAAD -0.571; TCGA PRAD -0.575; TCGA THCA -0.661; TCGA STAD -0.213; TCGA UCEC -0.312 |
hsa-miR-141-3p | IL18R1 | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA | MirTarget | TCGA BLCA -0.134; TCGA BRCA -0.224; TCGA COAD -0.235; TCGA HNSC -0.1; TCGA KIRC -0.216; TCGA KIRP -0.09; TCGA LUAD -0.218; TCGA LUSC -0.336; TCGA PAAD -0.249; TCGA PRAD -0.129; TCGA THCA -0.632 |
hsa-miR-141-3p | SLC1A7 | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.16; TCGA BRCA -0.544; TCGA CESC -0.375; TCGA ESCA -0.294; TCGA HNSC -0.64; TCGA KIRC -0.124; TCGA LUAD -0.233; TCGA LUSC -0.8; TCGA PAAD -0.329; TCGA PRAD -0.287; TCGA SARC -0.266; TCGA THCA -0.596; TCGA STAD -0.292; TCGA UCEC -0.537 |
hsa-miR-141-3p | CYP26B1 | 11 cancers: BLCA; BRCA; COAD; HNSC; LUAD; LUSC; OV; PAAD; PRAD; THCA; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.38; TCGA BRCA -0.468; TCGA COAD -0.329; TCGA HNSC -0.328; TCGA LUAD -0.158; TCGA LUSC -0.223; TCGA OV -0.375; TCGA PAAD -0.326; TCGA PRAD -0.332; TCGA THCA -0.471; TCGA UCEC -0.33 |
hsa-miR-141-3p | CNTN1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.748; TCGA BRCA -0.521; TCGA CESC -0.458; TCGA COAD -1.401; TCGA ESCA -0.567; TCGA HNSC -0.195; TCGA LGG -0.193; TCGA LUAD -0.375; TCGA PAAD -0.288; TCGA PRAD -0.902; TCGA THCA -1.13; TCGA STAD -0.928; TCGA UCEC -0.256 |
hsa-miR-141-3p | NRXN1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.667; TCGA BRCA -0.411; TCGA CESC -0.318; TCGA COAD -1.437; TCGA ESCA -0.85; TCGA HNSC -0.186; TCGA LGG -0.355; TCGA LUAD -0.315; TCGA PAAD -0.256; TCGA PRAD -0.571; TCGA STAD -0.946; TCGA UCEC -0.479 |
hsa-miR-141-3p | DOCK4 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.182; TCGA BRCA -0.21; TCGA CESC -0.287; TCGA COAD -0.356; TCGA ESCA -0.156; TCGA HNSC -0.293; TCGA KIRC -0.138; TCGA KIRP -0.053; TCGA LUAD -0.279; TCGA LUSC -0.542; TCGA PAAD -0.181; TCGA THCA -0.248; TCGA STAD -0.155; TCGA UCEC -0.24 |
hsa-miR-141-3p | OSBPL6 | 12 cancers: BLCA; BRCA; COAD; ESCA; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.543; TCGA BRCA -0.088; TCGA COAD -0.482; TCGA ESCA -0.362; TCGA LUAD -0.233; TCGA LUSC -0.128; TCGA OV -0.338; TCGA PAAD -0.138; TCGA PRAD -0.094; TCGA SARC -0.116; TCGA THCA -0.184; TCGA STAD -0.362 |
hsa-miR-141-3p | ZC3H12C | 10 cancers: BLCA; BRCA; HNSC; LGG; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.072; TCGA BRCA -0.282; TCGA HNSC -0.134; TCGA LGG -0.052; TCGA LUAD -0.105; TCGA LUSC -0.143; TCGA PRAD -0.2; TCGA THCA -0.101; TCGA STAD -0.161; TCGA UCEC -0.191 |
hsa-miR-141-3p | FRMD6 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.117; TCGA BRCA -0.211; TCGA CESC -0.345; TCGA COAD -0.696; TCGA ESCA -0.27; TCGA HNSC -0.091; TCGA LUAD -0.29; TCGA OV -0.275; TCGA PAAD -0.329; TCGA PRAD -0.584; TCGA SARC -0.11; TCGA THCA -0.239; TCGA STAD -0.397; TCGA UCEC -0.404 |
hsa-miR-141-3p | TMEM130 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.334; TCGA BRCA -0.155; TCGA CESC -0.447; TCGA COAD -1.059; TCGA ESCA -0.538; TCGA HNSC -0.365; TCGA KIRP -0.181; TCGA LUAD -0.313; TCGA LUSC -0.756; TCGA PAAD -0.204; TCGA THCA -0.554; TCGA STAD -0.593; TCGA UCEC -0.158 |
hsa-miR-141-3p | RAPGEF5 | 10 cancers: BLCA; BRCA; CESC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; UCEC | MirTarget | TCGA BLCA -0.141; TCGA BRCA -0.081; TCGA CESC -0.149; TCGA KIRC -0.144; TCGA LUAD -0.111; TCGA LUSC -0.126; TCGA PAAD -0.077; TCGA PRAD -0.088; TCGA SARC -0.223; TCGA UCEC -0.085 |
hsa-miR-141-3p | LTBP1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.211; TCGA BRCA -0.141; TCGA CESC -0.124; TCGA COAD -0.591; TCGA ESCA -0.394; TCGA HNSC -0.31; TCGA LUAD -0.266; TCGA LUSC -0.158; TCGA PAAD -0.358; TCGA PRAD -0.424; TCGA SARC -0.197; TCGA THCA -0.359; TCGA STAD -0.403; TCGA UCEC -0.088 |
hsa-miR-141-3p | EXOC5 | 9 cancers: BLCA; LGG; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.068; TCGA LGG -0.074; TCGA LUAD -0.086; TCGA OV -0.093; TCGA PAAD -0.063; TCGA PRAD -0.121; TCGA THCA -0.104; TCGA STAD -0.081; TCGA UCEC -0.056 |
hsa-miR-141-3p | OLFM1 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LUAD; PAAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.457; TCGA BRCA -0.203; TCGA CESC -0.33; TCGA COAD -0.728; TCGA ESCA -0.298; TCGA LGG -0.217; TCGA LUAD -0.266; TCGA PAAD -0.172; TCGA THCA -0.384; TCGA STAD -0.338; TCGA UCEC -0.487 |
hsa-miR-141-3p | LRRC8A | 12 cancers: BLCA; BRCA; CESC; COAD; KIRC; LGG; LUAD; OV; PRAD; SARC; THCA; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.076; TCGA BRCA -0.059; TCGA CESC -0.083; TCGA COAD -0.082; TCGA KIRC -0.094; TCGA LGG -0.222; TCGA LUAD -0.1; TCGA OV -0.105; TCGA PRAD -0.062; TCGA SARC -0.062; TCGA THCA -0.065; TCGA UCEC -0.078 |
hsa-miR-141-3p | HIPK3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.221; TCGA BRCA -0.249; TCGA CESC -0.148; TCGA COAD -0.225; TCGA ESCA -0.108; TCGA HNSC -0.411; TCGA LUAD -0.191; TCGA LUSC -0.223; TCGA PAAD -0.193; TCGA PRAD -0.532; TCGA SARC -0.167; TCGA THCA -0.301; TCGA STAD -0.228; TCGA UCEC -0.166 |
hsa-miR-141-3p | PCDH9 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.59; TCGA BRCA -0.681; TCGA CESC -0.368; TCGA COAD -0.848; TCGA ESCA -0.635; TCGA HNSC -0.59; TCGA LGG -0.101; TCGA LUAD -0.356; TCGA LUSC -0.788; TCGA OV -0.332; TCGA PAAD -0.39; TCGA PRAD -0.527; TCGA THCA -0.352; TCGA STAD -0.789; TCGA UCEC -0.291 |
hsa-miR-141-3p | FOXN3 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BLCA -0.144; TCGA BRCA -0.346; TCGA CESC -0.085; TCGA COAD -0.172; TCGA ESCA -0.195; TCGA HNSC -0.177; TCGA LGG -0.084; TCGA LIHC -0.087; TCGA LUAD -0.169; TCGA LUSC -0.087; TCGA PAAD -0.2; TCGA PRAD -0.202; TCGA SARC -0.085; TCGA THCA -0.225; TCGA STAD -0.244; TCGA UCEC -0.204 |
hsa-miR-141-3p | AKAP2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | TargetScan | TCGA BLCA -0.592; TCGA BRCA -0.428; TCGA CESC -0.408; TCGA COAD -0.488; TCGA ESCA -0.37; TCGA HNSC -0.761; TCGA LUAD -0.445; TCGA LUSC -0.928; TCGA PAAD -0.478; TCGA PRAD -0.669; TCGA SARC -0.244; TCGA THCA -0.549; TCGA UCEC -0.46 |
hsa-miR-141-3p | AMOTL1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.264; TCGA BRCA -0.361; TCGA CESC -0.17; TCGA COAD -0.783; TCGA ESCA -0.256; TCGA HNSC -0.163; TCGA KIRC -0.06; TCGA LGG -0.079; TCGA LUAD -0.259; TCGA LUSC -0.191; TCGA OV -0.179; TCGA PAAD -0.255; TCGA PRAD -0.184; TCGA SARC -0.103; TCGA THCA -0.195; TCGA STAD -0.447; TCGA UCEC -0.179 |
hsa-miR-141-3p | ANK2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.684; TCGA BRCA -0.569; TCGA CESC -0.538; TCGA COAD -1.058; TCGA ESCA -0.706; TCGA HNSC -0.72; TCGA LUAD -0.276; TCGA LUSC -0.745; TCGA PAAD -0.477; TCGA PRAD -0.667; TCGA SARC -0.209; TCGA THCA -0.666; TCGA STAD -0.682; TCGA UCEC -0.272 |
hsa-miR-141-3p | ANKRD44 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.345; TCGA BRCA -0.208; TCGA CESC -0.18; TCGA COAD -0.368; TCGA ESCA -0.269; TCGA HNSC -0.365; TCGA LGG -0.108; TCGA LUAD -0.315; TCGA LUSC -0.672; TCGA PAAD -0.397; TCGA PRAD -0.417; TCGA SARC -0.099; TCGA THCA -0.592; TCGA STAD -0.206; TCGA UCEC -0.134 |
hsa-miR-141-3p | APOLD1 | 16 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.244; TCGA BRCA -0.327; TCGA CESC -0.174; TCGA ESCA -0.199; TCGA HNSC -0.239; TCGA KIRC -0.275; TCGA LGG -0.077; TCGA LIHC -0.141; TCGA LUAD -0.236; TCGA LUSC -0.4; TCGA PAAD -0.29; TCGA PRAD -0.28; TCGA SARC -0.17; TCGA THCA -0.228; TCGA STAD -0.222; TCGA UCEC -0.31 |
hsa-miR-141-3p | ARHGAP24 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.384; TCGA BRCA -0.328; TCGA CESC -0.183; TCGA COAD -0.404; TCGA ESCA -0.122; TCGA HNSC -0.111; TCGA KIRP -0.056; TCGA LGG -0.064; TCGA LUAD -0.199; TCGA LUSC -0.116; TCGA OV -0.159; TCGA PAAD -0.164; TCGA PRAD -0.371; TCGA SARC -0.129; TCGA STAD -0.24; TCGA UCEC -0.222 |
hsa-miR-141-3p | ARID5B | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.164; TCGA BRCA -0.281; TCGA CESC -0.125; TCGA COAD -0.139; TCGA ESCA -0.227; TCGA HNSC -0.174; TCGA LUAD -0.086; TCGA LUSC -0.14; TCGA PAAD -0.314; TCGA PRAD -0.12; TCGA SARC -0.074; TCGA THCA -0.436; TCGA STAD -0.1; TCGA UCEC -0.144 |
hsa-miR-141-3p | ARL4A | 9 cancers: BLCA; BRCA; KIRC; LGG; LUAD; PRAD; SARC; THCA; UCEC | TargetScan | TCGA BLCA -0.102; TCGA BRCA -0.228; TCGA KIRC -0.131; TCGA LGG -0.138; TCGA LUAD -0.082; TCGA PRAD -0.162; TCGA SARC -0.068; TCGA THCA -0.123; TCGA UCEC -0.077 |
hsa-miR-141-3p | ASXL3 | 11 cancers: BLCA; BRCA; CESC; ESCA; LGG; LUAD; LUSC; OV; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.31; TCGA BRCA -0.488; TCGA CESC -0.217; TCGA ESCA -0.315; TCGA LGG -0.127; TCGA LUAD -0.242; TCGA LUSC -0.666; TCGA OV -0.343; TCGA PRAD -0.659; TCGA STAD -0.46; TCGA UCEC -0.457 |
hsa-miR-141-3p | ATP8A2 | 11 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.097; TCGA BRCA -0.184; TCGA ESCA -0.234; TCGA HNSC -0.25; TCGA KIRP -0.192; TCGA LGG -0.278; TCGA LUAD -0.15; TCGA LUSC -0.467; TCGA PAAD -0.182; TCGA STAD -0.305; TCGA UCEC -0.101 |
hsa-miR-141-3p | BACE1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.22; TCGA BRCA -0.172; TCGA CESC -0.123; TCGA COAD -0.26; TCGA ESCA -0.163; TCGA HNSC -0.182; TCGA LIHC -0.064; TCGA LUAD -0.241; TCGA LUSC -0.194; TCGA PRAD -0.122; TCGA THCA -0.079; TCGA STAD -0.219; TCGA UCEC -0.1 |
hsa-miR-141-3p | BACH2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.486; TCGA BRCA -0.351; TCGA CESC -0.292; TCGA COAD -0.714; TCGA ESCA -0.351; TCGA HNSC -0.308; TCGA LGG -0.092; TCGA LUAD -0.213; TCGA LUSC -0.119; TCGA OV -0.168; TCGA PAAD -0.428; TCGA PRAD -0.256; TCGA THCA -0.291; TCGA STAD -0.298; TCGA UCEC -0.348 |
hsa-miR-141-3p | BBX | 11 cancers: BLCA; BRCA; COAD; HNSC; LGG; LUAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan; mirMAP; miRNATAP | TCGA BLCA -0.067; TCGA BRCA -0.059; TCGA COAD -0.121; TCGA HNSC -0.116; TCGA LGG -0.061; TCGA LUAD -0.085; TCGA PRAD -0.27; TCGA SARC -0.064; TCGA THCA -0.121; TCGA STAD -0.141; TCGA UCEC -0.069 |
hsa-miR-141-3p | BCAP29 | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LUAD; LUSC; STAD; UCEC | TargetScan | TCGA BLCA -0.058; TCGA BRCA -0.07; TCGA CESC -0.062; TCGA COAD -0.054; TCGA HNSC -0.063; TCGA KIRC -0.065; TCGA LUAD -0.099; TCGA LUSC -0.102; TCGA STAD -0.101; TCGA UCEC -0.133 |
hsa-miR-141-3p | BEND4 | 10 cancers: BLCA; COAD; ESCA; LGG; LUAD; LUSC; PAAD; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.29; TCGA COAD -0.553; TCGA ESCA -0.243; TCGA LGG -0.337; TCGA LUAD -0.242; TCGA LUSC -0.321; TCGA PAAD -0.508; TCGA THCA -0.592; TCGA STAD -0.166; TCGA UCEC -0.28 |
hsa-miR-141-3p | BNC2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.635; TCGA BRCA -0.386; TCGA CESC -0.584; TCGA COAD -0.944; TCGA ESCA -0.549; TCGA HNSC -0.659; TCGA KIRP -0.1; TCGA LUAD -0.396; TCGA LUSC -0.636; TCGA PAAD -0.573; TCGA PRAD -0.605; TCGA SARC -0.079; TCGA THCA -0.694; TCGA STAD -0.571; TCGA UCEC -0.62 |
hsa-miR-141-3p | BRMS1L | 9 cancers: BLCA; BRCA; CESC; LGG; OV; PAAD; PRAD; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.085; TCGA BRCA -0.061; TCGA CESC -0.066; TCGA LGG -0.108; TCGA OV -0.128; TCGA PAAD -0.083; TCGA PRAD -0.077; TCGA STAD -0.097; TCGA UCEC -0.126 |
hsa-miR-141-3p | C1orf21 | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; SARC; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.08; TCGA BRCA -0.1; TCGA CESC -0.169; TCGA ESCA -0.106; TCGA HNSC -0.07; TCGA LGG -0.057; TCGA LIHC -0.138; TCGA LUAD -0.086; TCGA LUSC -0.085; TCGA OV -0.155; TCGA PAAD -0.091; TCGA SARC -0.193; TCGA STAD -0.205; TCGA UCEC -0.201 |
hsa-miR-141-3p | CACNA2D1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.713; TCGA BRCA -0.687; TCGA CESC -0.363; TCGA COAD -1.237; TCGA ESCA -0.326; TCGA HNSC -0.584; TCGA LGG -0.338; TCGA LUAD -0.466; TCGA LUSC -0.343; TCGA OV -0.297; TCGA PAAD -0.492; TCGA PRAD -0.88; TCGA SARC -0.202; TCGA THCA -0.504; TCGA STAD -0.454; TCGA UCEC -0.513 |
hsa-miR-141-3p | CADM2 | 11 cancers: BLCA; BRCA; COAD; ESCA; LGG; LUAD; OV; SARC; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.296; TCGA BRCA -0.404; TCGA COAD -0.827; TCGA ESCA -0.681; TCGA LGG -0.285; TCGA LUAD -0.303; TCGA OV -0.462; TCGA SARC -0.191; TCGA THCA -0.319; TCGA STAD -0.892; TCGA UCEC -0.185 |
hsa-miR-141-3p | CALU | 15 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.196; TCGA CESC -0.093; TCGA COAD -0.212; TCGA ESCA -0.135; TCGA HNSC -0.22; TCGA KIRC -0.076; TCGA KIRP -0.055; TCGA LUAD -0.074; TCGA OV -0.102; TCGA PAAD -0.184; TCGA PRAD -0.155; TCGA SARC -0.095; TCGA THCA -0.132; TCGA STAD -0.097; TCGA UCEC -0.098 |
hsa-miR-141-3p | CDK6 | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LIHC; LUAD; PRAD; THCA; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.281; TCGA BRCA -0.155; TCGA CESC -0.205; TCGA HNSC -0.145; TCGA KIRP -0.081; TCGA LIHC -0.141; TCGA LUAD -0.161; TCGA PRAD -0.086; TCGA THCA -0.314; TCGA UCEC -0.2 |
hsa-miR-141-3p | CDON | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; LUAD; PAAD; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.4; TCGA BRCA -0.172; TCGA COAD -0.381; TCGA ESCA -0.215; TCGA HNSC -0.147; TCGA KIRC -0.318; TCGA LGG -0.206; TCGA LUAD -0.085; TCGA PAAD -0.18; TCGA STAD -0.531; TCGA UCEC -0.324 |
hsa-miR-141-3p | CEP170 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.144; TCGA CESC -0.115; TCGA COAD -0.279; TCGA ESCA -0.075; TCGA HNSC -0.212; TCGA KIRC -0.135; TCGA LGG -0.083; TCGA LUAD -0.115; TCGA LUSC -0.116; TCGA PAAD -0.203; TCGA PRAD -0.144; TCGA THCA -0.151; TCGA STAD -0.119; TCGA UCEC -0.085 |
hsa-miR-141-3p | CFL2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.423; TCGA BRCA -0.327; TCGA CESC -0.189; TCGA COAD -0.544; TCGA ESCA -0.403; TCGA HNSC -0.373; TCGA LIHC -0.149; TCGA LUAD -0.25; TCGA LUSC -0.356; TCGA OV -0.146; TCGA PAAD -0.205; TCGA PRAD -0.421; TCGA SARC -0.17; TCGA STAD -0.583; TCGA UCEC -0.307 |
hsa-miR-141-3p | CORO1C | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.248; TCGA BRCA -0.133; TCGA CESC -0.065; TCGA COAD -0.073; TCGA ESCA -0.094; TCGA KIRC -0.152; TCGA KIRP -0.131; TCGA LGG -0.114; TCGA LUAD -0.246; TCGA PAAD -0.173; TCGA PRAD -0.351; TCGA SARC -0.095; TCGA THCA -0.189; TCGA STAD -0.195; TCGA UCEC -0.175 |
hsa-miR-141-3p | CPEB4 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LIHC; LUSC; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.124; TCGA BRCA -0.095; TCGA CESC -0.09; TCGA COAD -0.117; TCGA HNSC -0.247; TCGA LGG -0.127; TCGA LIHC -0.067; TCGA LUSC -0.344; TCGA PRAD -0.226; TCGA SARC -0.122; TCGA STAD -0.082; TCGA UCEC -0.078 |
hsa-miR-141-3p | DLC1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.206; TCGA BRCA -0.433; TCGA CESC -0.345; TCGA COAD -0.447; TCGA ESCA -0.339; TCGA HNSC -0.427; TCGA LIHC -0.063; TCGA LUAD -0.197; TCGA LUSC -0.932; TCGA OV -0.165; TCGA PAAD -0.324; TCGA PRAD -0.316; TCGA THCA -0.258; TCGA STAD -0.343; TCGA UCEC -0.234 |
hsa-miR-141-3p | DPYSL3 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.539; TCGA BRCA -0.288; TCGA CESC -0.372; TCGA COAD -0.805; TCGA ESCA -0.575; TCGA HNSC -0.331; TCGA KIRC -0.161; TCGA LGG -0.113; TCGA LUAD -0.206; TCGA LUSC -0.276; TCGA PAAD -0.31; TCGA PRAD -0.458; TCGA SARC -0.185; TCGA STAD -0.555; TCGA UCEC -0.285 |
hsa-miR-141-3p | DSEL | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.293; TCGA BRCA -0.367; TCGA CESC -0.216; TCGA COAD -0.678; TCGA ESCA -0.353; TCGA HNSC -0.382; TCGA KIRC -0.086; TCGA LUAD -0.174; TCGA LUSC -0.434; TCGA OV -0.187; TCGA PAAD -0.225; TCGA SARC -0.15; TCGA THCA -0.255; TCGA STAD -0.376; TCGA UCEC -0.332 |
hsa-miR-141-3p | DUSP1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.342; TCGA BRCA -0.441; TCGA CESC -0.203; TCGA COAD -0.317; TCGA ESCA -0.268; TCGA KIRC -0.139; TCGA LIHC -0.073; TCGA LUAD -0.207; TCGA LUSC -0.615; TCGA PAAD -0.332; TCGA PRAD -0.333; TCGA SARC -0.111; TCGA THCA -0.231; TCGA STAD -0.315; TCGA UCEC -0.329 |
hsa-miR-141-3p | DZIP1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.294; TCGA BRCA -0.227; TCGA CESC -0.26; TCGA COAD -0.718; TCGA ESCA -0.388; TCGA HNSC -0.076; TCGA KIRP -0.064; TCGA LGG -0.109; TCGA LUAD -0.184; TCGA OV -0.271; TCGA PAAD -0.212; TCGA PRAD -0.435; TCGA THCA -0.501; TCGA STAD -0.465; TCGA UCEC -0.318 |
hsa-miR-141-3p | EGR2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.47; TCGA BRCA -0.347; TCGA CESC -0.265; TCGA COAD -0.586; TCGA ESCA -0.259; TCGA HNSC -0.238; TCGA LUAD -0.264; TCGA LUSC -0.389; TCGA PAAD -0.394; TCGA PRAD -0.299; TCGA THCA -0.414; TCGA STAD -0.186; TCGA UCEC -0.242 |
hsa-miR-141-3p | ELK3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.186; TCGA BRCA -0.25; TCGA CESC -0.292; TCGA COAD -0.409; TCGA ESCA -0.129; TCGA HNSC -0.319; TCGA KIRC -0.079; TCGA LUAD -0.269; TCGA LUSC -0.352; TCGA PAAD -0.261; TCGA PRAD -0.428; TCGA THCA -0.323; TCGA STAD -0.128; TCGA UCEC -0.257 |
hsa-miR-141-3p | ELL2 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LIHC; LUSC; OV; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.132; TCGA BRCA -0.08; TCGA COAD -0.122; TCGA ESCA -0.123; TCGA HNSC -0.096; TCGA KIRC -0.076; TCGA LIHC -0.128; TCGA LUSC -0.124; TCGA OV -0.166; TCGA SARC -0.102; TCGA THCA -0.142; TCGA STAD -0.168; TCGA UCEC -0.093 |
hsa-miR-141-3p | EPHA7 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; OV; PRAD; STAD | TargetScan; miRNATAP | TCGA BLCA -0.331; TCGA BRCA -0.202; TCGA CESC -0.288; TCGA COAD -0.785; TCGA ESCA -0.533; TCGA KIRC -0.092; TCGA KIRP -0.374; TCGA OV -0.42; TCGA PRAD -0.384; TCGA STAD -0.863 |
hsa-miR-141-3p | FAM160B1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUSC; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.056; TCGA BRCA -0.123; TCGA CESC -0.097; TCGA COAD -0.116; TCGA ESCA -0.064; TCGA HNSC -0.13; TCGA LGG -0.053; TCGA LIHC -0.059; TCGA LUSC -0.088; TCGA PAAD -0.082; TCGA PRAD -0.081; TCGA STAD -0.12; TCGA UCEC -0.078 |
hsa-miR-141-3p | FAM168A | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD | TargetScan | TCGA BLCA -0.17; TCGA BRCA -0.103; TCGA COAD -0.236; TCGA ESCA -0.127; TCGA HNSC -0.211; TCGA LGG -0.209; TCGA LUAD -0.183; TCGA LUSC -0.125; TCGA PAAD -0.218; TCGA PRAD -0.338; TCGA THCA -0.354; TCGA STAD -0.142 |
hsa-miR-141-3p | FAM8A1 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUSC; OV; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.067; TCGA BRCA -0.055; TCGA CESC -0.086; TCGA ESCA -0.058; TCGA HNSC -0.087; TCGA LIHC -0.094; TCGA LUSC -0.13; TCGA OV -0.07; TCGA PRAD -0.096; TCGA SARC -0.06; TCGA STAD -0.121; TCGA UCEC -0.154 |
hsa-miR-141-3p | FGF13 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; PAAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.303; TCGA BRCA -0.151; TCGA CESC -0.377; TCGA COAD -0.417; TCGA ESCA -0.419; TCGA HNSC -0.217; TCGA LGG -0.225; TCGA LUAD -0.2; TCGA PAAD -0.149; TCGA SARC -0.16; TCGA THCA -0.44; TCGA STAD -0.407; TCGA UCEC -0.274 |
hsa-miR-141-3p | FKBP5 | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.389; TCGA BRCA -0.181; TCGA CESC -0.128; TCGA ESCA -0.265; TCGA HNSC -0.096; TCGA LIHC -0.118; TCGA LUAD -0.209; TCGA LUSC -0.261; TCGA PAAD -0.32; TCGA SARC -0.16; TCGA THCA -0.29; TCGA STAD -0.359; TCGA UCEC -0.225 |
hsa-miR-141-3p | FLI1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.285; TCGA BRCA -0.323; TCGA CESC -0.284; TCGA COAD -0.507; TCGA ESCA -0.296; TCGA HNSC -0.374; TCGA KIRC -0.179; TCGA LUAD -0.315; TCGA LUSC -0.732; TCGA PAAD -0.449; TCGA PRAD -0.259; TCGA THCA -0.215; TCGA STAD -0.17; TCGA UCEC -0.263 |
hsa-miR-141-3p | FNIP2 | 10 cancers: BLCA; BRCA; CESC; HNSC; LUAD; LUSC; PRAD; SARC; THCA; UCEC | TargetScan | TCGA BLCA -0.153; TCGA BRCA -0.281; TCGA CESC -0.128; TCGA HNSC -0.373; TCGA LUAD -0.176; TCGA LUSC -0.484; TCGA PRAD -0.168; TCGA SARC -0.151; TCGA THCA -0.215; TCGA UCEC -0.153 |
hsa-miR-141-3p | FOXP2 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.492; TCGA BRCA -0.613; TCGA CESC -0.275; TCGA COAD -0.998; TCGA ESCA -0.402; TCGA KIRP -0.168; TCGA PAAD -0.343; TCGA PRAD -0.792; TCGA STAD -0.79; TCGA UCEC -0.577 |
hsa-miR-141-3p | FZD4 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.113; TCGA BRCA -0.485; TCGA CESC -0.146; TCGA COAD -0.349; TCGA ESCA -0.211; TCGA HNSC -0.385; TCGA KIRC -0.098; TCGA KIRP -0.062; TCGA LIHC -0.079; TCGA LUAD -0.185; TCGA LUSC -0.542; TCGA PAAD -0.278; TCGA THCA -0.093; TCGA STAD -0.234; TCGA UCEC -0.242 |
hsa-miR-141-3p | GDF6 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.341; TCGA BRCA -0.246; TCGA CESC -0.301; TCGA COAD -1.078; TCGA ESCA -0.619; TCGA HNSC -0.281; TCGA KIRC -0.574; TCGA LUAD -0.427; TCGA LUSC -0.335; TCGA OV -0.533; TCGA PAAD -0.463; TCGA PRAD -0.265; TCGA STAD -0.608; TCGA UCEC -0.337 |
hsa-miR-141-3p | GPC6 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.642; TCGA BRCA -0.364; TCGA CESC -0.424; TCGA COAD -0.758; TCGA ESCA -0.362; TCGA HNSC -0.693; TCGA KIRC -0.114; TCGA KIRP -0.188; TCGA LUAD -0.345; TCGA LUSC -0.691; TCGA OV -0.323; TCGA PAAD -0.303; TCGA PRAD -0.297; TCGA SARC -0.156; TCGA THCA -0.331; TCGA STAD -0.281; TCGA UCEC -0.228 |
hsa-miR-141-3p | GPD1 | 9 cancers: BLCA; BRCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PRAD | TargetScan | TCGA BLCA -0.193; TCGA BRCA -1.019; TCGA HNSC -0.423; TCGA KIRP -0.143; TCGA LIHC -0.175; TCGA LUAD -0.428; TCGA LUSC -0.888; TCGA OV -0.272; TCGA PRAD -0.133 |
hsa-miR-141-3p | GPM6B | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD | TargetScan; miRNATAP | TCGA BLCA -0.298; TCGA BRCA -0.245; TCGA COAD -0.543; TCGA ESCA -0.354; TCGA HNSC -0.227; TCGA LGG -0.135; TCGA LUAD -0.175; TCGA LUSC -0.362; TCGA PAAD -0.379; TCGA PRAD -0.331; TCGA THCA -0.141; TCGA STAD -0.554 |
hsa-miR-141-3p | GPR174 | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; THCA | TargetScan | TCGA BLCA -0.282; TCGA BRCA -0.185; TCGA CESC -0.164; TCGA COAD -0.382; TCGA HNSC -0.394; TCGA KIRC -0.331; TCGA LUAD -0.171; TCGA LUSC -0.558; TCGA PAAD -0.66; TCGA THCA -0.644 |
hsa-miR-141-3p | GRIN3A | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; THCA; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.19; TCGA BRCA -0.094; TCGA CESC -0.127; TCGA ESCA -0.106; TCGA HNSC -0.179; TCGA KIRC -0.058; TCGA LGG -0.573; TCGA LUAD -0.168; TCGA LUSC -0.288; TCGA PAAD -0.15; TCGA THCA -0.216; TCGA UCEC -0.145 |
hsa-miR-141-3p | HDAC4 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; PAAD; PRAD; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.224; TCGA BRCA -0.161; TCGA COAD -0.108; TCGA ESCA -0.074; TCGA HNSC -0.096; TCGA LGG -0.236; TCGA PAAD -0.094; TCGA PRAD -0.114; TCGA THCA -0.124; TCGA STAD -0.264; TCGA UCEC -0.162 |
hsa-miR-141-3p | HECW1 | 9 cancers: BLCA; BRCA; COAD; HNSC; LGG; PAAD; PRAD; THCA; STAD | TargetScan | TCGA BLCA -0.232; TCGA BRCA -0.187; TCGA COAD -0.794; TCGA HNSC -0.499; TCGA LGG -0.386; TCGA PAAD -0.403; TCGA PRAD -0.652; TCGA THCA -0.338; TCGA STAD -0.099 |
hsa-miR-141-3p | HLF | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.59; TCGA BRCA -0.575; TCGA CESC -0.335; TCGA COAD -0.433; TCGA ESCA -0.343; TCGA KIRP -0.124; TCGA LGG -0.134; TCGA LIHC -0.306; TCGA LUAD -0.192; TCGA PAAD -0.17; TCGA PRAD -0.493; TCGA STAD -0.677; TCGA UCEC -0.544 |
hsa-miR-141-3p | HSPA13 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | TargetScan | TCGA BLCA -0.134; TCGA CESC -0.076; TCGA COAD -0.061; TCGA ESCA -0.061; TCGA HNSC -0.136; TCGA LGG -0.128; TCGA LUAD -0.116; TCGA LUSC -0.145; TCGA OV -0.167; TCGA PAAD -0.101; TCGA PRAD -0.152; TCGA SARC -0.06; TCGA THCA -0.13; TCGA UCEC -0.127 |
hsa-miR-141-3p | IDS | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.057; TCGA BRCA -0.087; TCGA CESC -0.122; TCGA COAD -0.194; TCGA ESCA -0.128; TCGA HNSC -0.104; TCGA LUAD -0.183; TCGA LUSC -0.125; TCGA PRAD -0.165; TCGA THCA -0.086; TCGA STAD -0.171; TCGA UCEC -0.106 |
hsa-miR-141-3p | IGDCC4 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.351; TCGA BRCA -0.298; TCGA CESC -0.38; TCGA COAD -0.358; TCGA ESCA -0.302; TCGA HNSC -0.629; TCGA KIRP -0.265; TCGA LUAD -0.18; TCGA LUSC -0.29; TCGA OV -0.221; TCGA PAAD -0.54; TCGA PRAD -0.519; TCGA STAD -0.193; TCGA UCEC -0.289 |
hsa-miR-141-3p | IGSF6 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA | TargetScan | TCGA BLCA -0.262; TCGA CESC -0.213; TCGA COAD -0.377; TCGA ESCA -0.184; TCGA HNSC -0.369; TCGA KIRC -0.377; TCGA KIRP -0.23; TCGA LUAD -0.343; TCGA LUSC -0.702; TCGA PAAD -0.459; TCGA PRAD -0.176; TCGA THCA -0.486 |
hsa-miR-141-3p | IGSF9B | 9 cancers: BLCA; CESC; COAD; ESCA; LGG; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.381; TCGA CESC -0.227; TCGA COAD -0.406; TCGA ESCA -0.307; TCGA LGG -0.184; TCGA PRAD -0.349; TCGA SARC -0.297; TCGA STAD -0.391; TCGA UCEC -0.467 |
hsa-miR-141-3p | ITSN1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | TargetScan; mirMAP | TCGA BLCA -0.103; TCGA BRCA -0.315; TCGA CESC -0.091; TCGA COAD -0.138; TCGA ESCA -0.062; TCGA HNSC -0.176; TCGA LUAD -0.113; TCGA LUSC -0.157; TCGA PAAD -0.178; TCGA PRAD -0.256; TCGA THCA -0.094; TCGA STAD -0.112; TCGA UCEC -0.129 |
hsa-miR-141-3p | JMJD1C | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.072; TCGA BRCA -0.113; TCGA CESC -0.085; TCGA ESCA -0.061; TCGA HNSC -0.17; TCGA LGG -0.115; TCGA LUAD -0.05; TCGA LUSC -0.231; TCGA PAAD -0.07; TCGA PRAD -0.134; TCGA THCA -0.108; TCGA STAD -0.07; TCGA UCEC -0.132 |
hsa-miR-141-3p | KATNAL1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.399; TCGA BRCA -0.179; TCGA CESC -0.175; TCGA COAD -0.335; TCGA ESCA -0.263; TCGA HNSC -0.233; TCGA KIRC -0.082; TCGA KIRP -0.083; TCGA LUAD -0.146; TCGA LUSC -0.214; TCGA OV -0.114; TCGA PAAD -0.135; TCGA PRAD -0.378; TCGA THCA -0.152; TCGA STAD -0.373; TCGA UCEC -0.273 |
hsa-miR-141-3p | KCTD12 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.356; TCGA BRCA -0.386; TCGA CESC -0.296; TCGA COAD -0.503; TCGA ESCA -0.292; TCGA HNSC -0.403; TCGA KIRP -0.068; TCGA LUAD -0.365; TCGA LUSC -0.626; TCGA PAAD -0.214; TCGA PRAD -0.241; TCGA THCA -0.367; TCGA STAD -0.233; TCGA UCEC -0.397 |
hsa-miR-141-3p | KHDRBS3 | 11 cancers: BLCA; BRCA; ESCA; KIRP; LGG; LIHC; LUSC; OV; SARC; THCA; STAD | TargetScan | TCGA BLCA -0.237; TCGA BRCA -0.115; TCGA ESCA -0.193; TCGA KIRP -0.132; TCGA LGG -0.122; TCGA LIHC -0.096; TCGA LUSC -0.244; TCGA OV -0.299; TCGA SARC -0.16; TCGA THCA -0.136; TCGA STAD -0.12 |
hsa-miR-141-3p | KIF1C | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; STAD | TargetScan; miRNATAP | TCGA BLCA -0.059; TCGA BRCA -0.132; TCGA ESCA -0.105; TCGA HNSC -0.164; TCGA KIRP -0.061; TCGA LIHC -0.052; TCGA LUAD -0.075; TCGA LUSC -0.261; TCGA STAD -0.06 |
hsa-miR-141-3p | KLF6 | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.109; TCGA BRCA -0.238; TCGA CESC -0.154; TCGA ESCA -0.097; TCGA HNSC -0.156; TCGA KIRC -0.089; TCGA KIRP -0.082; TCGA LUAD -0.23; TCGA LUSC -0.478; TCGA PAAD -0.134; TCGA PRAD -0.288; TCGA SARC -0.079; TCGA THCA -0.239; TCGA UCEC -0.2 |
hsa-miR-141-3p | LPP | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.229; TCGA BRCA -0.172; TCGA CESC -0.093; TCGA COAD -0.266; TCGA ESCA -0.21; TCGA HNSC -0.169; TCGA PAAD -0.177; TCGA PRAD -0.539; TCGA SARC -0.18; TCGA THCA -0.375; TCGA STAD -0.426; TCGA UCEC -0.139 |
hsa-miR-141-3p | LSAMP | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.277; TCGA BRCA -0.317; TCGA CESC -0.416; TCGA COAD -0.788; TCGA ESCA -0.162; TCGA HNSC -0.243; TCGA LGG -0.197; TCGA LUAD -0.321; TCGA LUSC -0.647; TCGA OV -0.267; TCGA PAAD -0.37; TCGA PRAD -0.441; TCGA THCA -0.523; TCGA STAD -0.415; TCGA UCEC -0.405 |
hsa-miR-141-3p | LYSMD3 | 12 cancers: BLCA; BRCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.066; TCGA BRCA -0.06; TCGA HNSC -0.143; TCGA LIHC -0.064; TCGA LUAD -0.06; TCGA LUSC -0.252; TCGA OV -0.092; TCGA PAAD -0.076; TCGA PRAD -0.167; TCGA SARC -0.06; TCGA THCA -0.1; TCGA UCEC -0.102 |
hsa-miR-141-3p | MACF1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.173; TCGA BRCA -0.089; TCGA CESC -0.125; TCGA COAD -0.168; TCGA ESCA -0.17; TCGA HNSC -0.157; TCGA LUAD -0.122; TCGA LUSC -0.305; TCGA PAAD -0.133; TCGA PRAD -0.204; TCGA SARC -0.108; TCGA THCA -0.186; TCGA STAD -0.26; TCGA UCEC -0.17 |
hsa-miR-141-3p | MAGI2 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LGG; LUAD; PRAD; SARC; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.157; TCGA BRCA -0.152; TCGA CESC -0.21; TCGA COAD -0.256; TCGA ESCA -0.249; TCGA KIRP -0.053; TCGA LGG -0.085; TCGA LUAD -0.139; TCGA PRAD -0.181; TCGA SARC -0.102; TCGA STAD -0.475; TCGA UCEC -0.228 |
hsa-miR-141-3p | MAP4K4 | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LGG; LUAD; OV; PAAD; THCA | TargetScan | TCGA BLCA -0.133; TCGA BRCA -0.134; TCGA COAD -0.147; TCGA HNSC -0.109; TCGA KIRC -0.164; TCGA KIRP -0.053; TCGA LGG -0.058; TCGA LUAD -0.059; TCGA OV -0.088; TCGA PAAD -0.095; TCGA THCA -0.144 |
hsa-miR-141-3p | MAPRE2 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.298; TCGA BRCA -0.127; TCGA CESC -0.162; TCGA COAD -0.114; TCGA ESCA -0.134; TCGA HNSC -0.293; TCGA KIRC -0.134; TCGA LIHC -0.071; TCGA LUAD -0.113; TCGA LUSC -0.427; TCGA PAAD -0.081; TCGA PRAD -0.342; TCGA SARC -0.071; TCGA THCA -0.191; TCGA STAD -0.101; TCGA UCEC -0.2 |
hsa-miR-141-3p | MARCH1 | 15 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | TargetScan; miRNATAP | TCGA BLCA -0.156; TCGA CESC -0.151; TCGA COAD -0.326; TCGA ESCA -0.139; TCGA HNSC -0.345; TCGA KIRC -0.126; TCGA KIRP -0.054; TCGA LGG -0.158; TCGA LUAD -0.294; TCGA LUSC -0.453; TCGA PAAD -0.449; TCGA PRAD -0.187; TCGA SARC -0.101; TCGA THCA -0.358; TCGA STAD -0.067 |
hsa-miR-141-3p | MBD5 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUSC; PAAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.067; TCGA BRCA -0.071; TCGA CESC -0.073; TCGA COAD -0.092; TCGA ESCA -0.103; TCGA HNSC -0.19; TCGA LGG -0.133; TCGA LUSC -0.19; TCGA PAAD -0.09; TCGA PRAD -0.209; TCGA THCA -0.1; TCGA STAD -0.188; TCGA UCEC -0.068 |
hsa-miR-141-3p | MBTPS2 | 9 cancers: BLCA; CESC; HNSC; LGG; LIHC; OV; PRAD; THCA; UCEC | TargetScan | TCGA BLCA -0.087; TCGA CESC -0.061; TCGA HNSC -0.091; TCGA LGG -0.117; TCGA LIHC -0.052; TCGA OV -0.077; TCGA PRAD -0.111; TCGA THCA -0.093; TCGA UCEC -0.104 |
hsa-miR-141-3p | MDGA1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; PAAD; PRAD; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.351; TCGA BRCA -0.193; TCGA CESC -0.236; TCGA COAD -0.582; TCGA ESCA -0.32; TCGA HNSC -0.113; TCGA LGG -0.09; TCGA LUAD -0.374; TCGA PAAD -0.385; TCGA PRAD -0.201; TCGA THCA -0.27; TCGA STAD -0.368; TCGA UCEC -0.315 |
hsa-miR-141-3p | MED13L | 10 cancers: BLCA; CESC; COAD; HNSC; LGG; PAAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.074; TCGA CESC -0.087; TCGA COAD -0.056; TCGA HNSC -0.139; TCGA LGG -0.101; TCGA PAAD -0.102; TCGA PRAD -0.188; TCGA THCA -0.145; TCGA STAD -0.113; TCGA UCEC -0.129 |
hsa-miR-141-3p | MEIS2 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.16; TCGA BRCA -0.364; TCGA CESC -0.154; TCGA COAD -0.798; TCGA ESCA -0.097; TCGA HNSC -0.071; TCGA LGG -0.121; TCGA PRAD -0.612; TCGA SARC -0.324; TCGA STAD -0.251; TCGA UCEC -0.295 |
hsa-miR-141-3p | MGAT5 | 10 cancers: BLCA; BRCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA | TargetScan; mirMAP | TCGA BLCA -0.119; TCGA BRCA -0.159; TCGA HNSC -0.2; TCGA LGG -0.109; TCGA LUAD -0.139; TCGA LUSC -0.139; TCGA PAAD -0.194; TCGA PRAD -0.533; TCGA SARC -0.17; TCGA THCA -0.495 |
hsa-miR-141-3p | MMP16 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.393; TCGA BRCA -0.294; TCGA CESC -0.366; TCGA COAD -0.605; TCGA ESCA -0.244; TCGA HNSC -0.611; TCGA KIRC -0.363; TCGA LGG -0.213; TCGA LUAD -0.254; TCGA LUSC -0.483; TCGA OV -0.434; TCGA PAAD -0.356; TCGA PRAD -0.626; TCGA STAD -0.397; TCGA UCEC -0.263 |
hsa-miR-141-3p | MN1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.47; TCGA BRCA -0.304; TCGA CESC -0.353; TCGA COAD -0.728; TCGA ESCA -0.451; TCGA HNSC -0.382; TCGA KIRC -0.127; TCGA LGG -0.277; TCGA LUAD -0.172; TCGA OV -0.354; TCGA PAAD -0.301; TCGA PRAD -0.506; TCGA THCA -0.206; TCGA STAD -0.522; TCGA UCEC -0.311 |
hsa-miR-141-3p | MPRIP | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.07; TCGA BRCA -0.162; TCGA CESC -0.08; TCGA COAD -0.092; TCGA ESCA -0.101; TCGA HNSC -0.133; TCGA LUAD -0.072; TCGA LUSC -0.211; TCGA PAAD -0.098; TCGA PRAD -0.097; TCGA SARC -0.067; TCGA STAD -0.109; TCGA UCEC -0.157 |
hsa-miR-141-3p | MYH10 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.153; TCGA BRCA -0.169; TCGA CESC -0.143; TCGA COAD -0.527; TCGA ESCA -0.255; TCGA HNSC -0.223; TCGA LUAD -0.255; TCGA LUSC -0.426; TCGA OV -0.121; TCGA PAAD -0.242; TCGA THCA -0.17; TCGA STAD -0.304; TCGA UCEC -0.153 |
hsa-miR-141-3p | MYO5A | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.207; TCGA BRCA -0.103; TCGA CESC -0.227; TCGA COAD -0.556; TCGA ESCA -0.208; TCGA HNSC -0.136; TCGA LGG -0.127; TCGA LUAD -0.204; TCGA LUSC -0.098; TCGA PAAD -0.29; TCGA PRAD -0.135; TCGA SARC -0.068; TCGA THCA -0.207; TCGA STAD -0.226; TCGA UCEC -0.161 |
hsa-miR-141-3p | MYO9A | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.143; TCGA BRCA -0.233; TCGA COAD -0.18; TCGA ESCA -0.143; TCGA HNSC -0.263; TCGA LGG -0.117; TCGA LUAD -0.142; TCGA LUSC -0.21; TCGA PAAD -0.2; TCGA PRAD -0.387; TCGA SARC -0.121; TCGA THCA -0.363; TCGA STAD -0.244; TCGA UCEC -0.133 |
hsa-miR-141-3p | NCAM1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.806; TCGA BRCA -0.495; TCGA CESC -0.471; TCGA COAD -0.684; TCGA ESCA -0.675; TCGA HNSC -0.699; TCGA LGG -0.181; TCGA LUAD -0.244; TCGA LUSC -0.257; TCGA PRAD -0.798; TCGA STAD -0.671; TCGA UCEC -0.569 |
hsa-miR-141-3p | NFIA | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; PAAD; PRAD; STAD | TargetScan; miRNATAP | TCGA BLCA -0.211; TCGA BRCA -0.15; TCGA CESC -0.124; TCGA ESCA -0.165; TCGA HNSC -0.086; TCGA KIRC -0.106; TCGA KIRP -0.137; TCGA LIHC -0.135; TCGA LUSC -0.114; TCGA PAAD -0.153; TCGA PRAD -0.113; TCGA STAD -0.294 |
hsa-miR-141-3p | NPAS3 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUSC; PRAD; THCA; STAD | TargetScan; miRNATAP | TCGA BLCA -0.311; TCGA BRCA -0.242; TCGA CESC -0.336; TCGA COAD -0.763; TCGA ESCA -0.407; TCGA HNSC -0.365; TCGA KIRP -0.099; TCGA LGG -0.162; TCGA LUSC -0.422; TCGA PRAD -0.245; TCGA THCA -0.131; TCGA STAD -0.511 |
hsa-miR-141-3p | NPTX1 | 11 cancers: BLCA; BRCA; COAD; ESCA; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.317; TCGA BRCA -0.17; TCGA COAD -1.415; TCGA ESCA -0.81; TCGA LUSC -0.329; TCGA OV -0.276; TCGA PAAD -0.289; TCGA PRAD -0.337; TCGA THCA -0.567; TCGA STAD -0.987; TCGA UCEC -0.197 |
hsa-miR-141-3p | NR3C1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.295; TCGA BRCA -0.344; TCGA CESC -0.089; TCGA COAD -0.558; TCGA ESCA -0.182; TCGA HNSC -0.144; TCGA KIRC -0.111; TCGA LGG -0.107; TCGA LIHC -0.089; TCGA LUAD -0.115; TCGA LUSC -0.216; TCGA PAAD -0.199; TCGA PRAD -0.402; TCGA SARC -0.061; TCGA THCA -0.116; TCGA STAD -0.263; TCGA UCEC -0.317 |
hsa-miR-141-3p | NRP1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.255; TCGA BRCA -0.323; TCGA CESC -0.267; TCGA COAD -0.461; TCGA ESCA -0.241; TCGA HNSC -0.405; TCGA KIRC -0.188; TCGA KIRP -0.063; TCGA LUAD -0.227; TCGA LUSC -0.523; TCGA PAAD -0.18; TCGA PRAD -0.117; TCGA THCA -0.154; TCGA STAD -0.16; TCGA UCEC -0.179 |
hsa-miR-141-3p | NRP2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.502; TCGA BRCA -0.204; TCGA CESC -0.323; TCGA COAD -0.657; TCGA ESCA -0.362; TCGA HNSC -0.203; TCGA KIRC -0.246; TCGA LUAD -0.282; TCGA LUSC -0.4; TCGA OV -0.178; TCGA PAAD -0.267; TCGA PRAD -0.555; TCGA THCA -0.222; TCGA STAD -0.481; TCGA UCEC -0.316 |
hsa-miR-141-3p | NUMBL | 9 cancers: BLCA; CESC; COAD; ESCA; KIRC; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.151; TCGA CESC -0.092; TCGA COAD -0.264; TCGA ESCA -0.129; TCGA KIRC -0.083; TCGA PAAD -0.167; TCGA PRAD -0.056; TCGA STAD -0.23; TCGA UCEC -0.102 |
hsa-miR-141-3p | OGFRL1 | 9 cancers: BLCA; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD | TargetScan | TCGA BLCA -0.266; TCGA KIRC -0.098; TCGA KIRP -0.14; TCGA LUAD -0.237; TCGA PAAD -0.242; TCGA PRAD -0.203; TCGA SARC -0.111; TCGA THCA -0.253; TCGA STAD -0.185 |
hsa-miR-141-3p | OSBPL1A | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.181; TCGA BRCA -0.121; TCGA CESC -0.166; TCGA COAD -0.293; TCGA ESCA -0.124; TCGA HNSC -0.093; TCGA KIRP -0.054; TCGA LUSC -0.077; TCGA PRAD -0.166; TCGA STAD -0.264; TCGA UCEC -0.219 |
hsa-miR-141-3p | P2RY1 | 12 cancers: BLCA; BRCA; CESC; KIRC; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.132; TCGA BRCA -0.269; TCGA CESC -0.389; TCGA KIRC -0.33; TCGA LGG -0.169; TCGA LUAD -0.324; TCGA PAAD -0.284; TCGA PRAD -0.321; TCGA SARC -0.305; TCGA THCA -0.301; TCGA STAD -0.248; TCGA UCEC -0.23 |
hsa-miR-141-3p | PALM2-AKAP2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.379; TCGA BRCA -0.413; TCGA CESC -0.261; TCGA COAD -0.409; TCGA ESCA -0.283; TCGA HNSC -0.412; TCGA LUAD -0.334; TCGA LUSC -0.689; TCGA PAAD -0.325; TCGA PRAD -0.25; TCGA SARC -0.07; TCGA THCA -0.176; TCGA STAD -0.278; TCGA UCEC -0.309 |
hsa-miR-141-3p | PAPLN | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; PAAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.193; TCGA BRCA -0.251; TCGA COAD -0.492; TCGA ESCA -0.36; TCGA HNSC -0.141; TCGA KIRC -0.057; TCGA KIRP -0.265; TCGA LGG -0.177; TCGA LUSC -0.14; TCGA PAAD -0.328; TCGA PRAD -0.301; TCGA THCA -0.128; TCGA STAD -0.348; TCGA UCEC -0.214 |
hsa-miR-141-3p | PDZD2 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.182; TCGA BRCA -0.522; TCGA COAD -0.426; TCGA ESCA -0.212; TCGA HNSC -0.253; TCGA LGG -0.216; TCGA LUAD -0.127; TCGA LUSC -0.582; TCGA PAAD -0.162; TCGA PRAD -0.213; TCGA THCA -0.123; TCGA STAD -0.297; TCGA UCEC -0.191 |
hsa-miR-141-3p | PEG3 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.347; TCGA BRCA -0.246; TCGA CESC -0.61; TCGA COAD -0.924; TCGA ESCA -0.543; TCGA HNSC -0.641; TCGA LUAD -0.284; TCGA LUSC -0.795; TCGA PRAD -0.411; TCGA STAD -0.685; TCGA UCEC -0.696 |
hsa-miR-141-3p | PLCXD3 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.327; TCGA BRCA -0.82; TCGA CESC -0.457; TCGA COAD -1.217; TCGA ESCA -0.637; TCGA LUAD -0.243; TCGA LUSC -0.847; TCGA PRAD -0.381; TCGA SARC -0.226; TCGA THCA -0.419; TCGA STAD -0.655; TCGA UCEC -0.549 |
hsa-miR-141-3p | PLXDC1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.171; TCGA BRCA -0.159; TCGA CESC -0.223; TCGA COAD -0.344; TCGA ESCA -0.222; TCGA HNSC -0.323; TCGA KIRC -0.329; TCGA LUSC -0.265; TCGA OV -0.254; TCGA PAAD -0.244; TCGA PRAD -0.087; TCGA STAD -0.133; TCGA UCEC -0.272 |
hsa-miR-141-3p | PLXNA4 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD | TargetScan; miRNATAP | TCGA BLCA -0.601; TCGA BRCA -0.638; TCGA CESC -0.345; TCGA COAD -1.024; TCGA ESCA -0.524; TCGA HNSC -0.518; TCGA LGG -0.114; TCGA LUAD -0.279; TCGA LUSC -0.773; TCGA OV -0.323; TCGA PAAD -0.534; TCGA PRAD -0.383; TCGA STAD -0.501 |
hsa-miR-141-3p | PLXNC1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.42; TCGA BRCA -0.197; TCGA CESC -0.392; TCGA COAD -0.749; TCGA ESCA -0.292; TCGA HNSC -0.704; TCGA KIRC -0.201; TCGA KIRP -0.107; TCGA LUAD -0.353; TCGA LUSC -0.888; TCGA PAAD -0.413; TCGA PRAD -0.679; TCGA SARC -0.165; TCGA THCA -0.567; TCGA STAD -0.089; TCGA UCEC -0.278 |
hsa-miR-141-3p | PRICKLE1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.396; TCGA BRCA -0.111; TCGA CESC -0.399; TCGA COAD -0.818; TCGA ESCA -0.279; TCGA HNSC -0.321; TCGA KIRP -0.216; TCGA LGG -0.106; TCGA LUAD -0.347; TCGA LUSC -0.48; TCGA OV -0.219; TCGA PAAD -0.426; TCGA PRAD -0.456; TCGA THCA -0.209; TCGA STAD -0.354; TCGA UCEC -0.31 |
hsa-miR-141-3p | PRKAR1A | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; LIHC; LUSC; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.05; TCGA BRCA -0.076; TCGA CESC -0.091; TCGA COAD -0.112; TCGA HNSC -0.103; TCGA LIHC -0.073; TCGA LUSC -0.143; TCGA PRAD -0.161; TCGA STAD -0.105; TCGA UCEC -0.129 |
hsa-miR-141-3p | QKI | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.132; TCGA BRCA -0.263; TCGA CESC -0.166; TCGA COAD -0.522; TCGA ESCA -0.195; TCGA HNSC -0.229; TCGA LGG -0.092; TCGA LUAD -0.26; TCGA LUSC -0.256; TCGA OV -0.09; TCGA PAAD -0.296; TCGA PRAD -0.211; TCGA THCA -0.179; TCGA STAD -0.279; TCGA UCEC -0.197 |
hsa-miR-141-3p | RAB30 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.233; TCGA BRCA -0.072; TCGA CESC -0.149; TCGA COAD -0.234; TCGA ESCA -0.189; TCGA HNSC -0.236; TCGA LGG -0.147; TCGA LIHC -0.071; TCGA LUAD -0.182; TCGA OV -0.139; TCGA PAAD -0.227; TCGA PRAD -0.218; TCGA SARC -0.103; TCGA THCA -0.302; TCGA STAD -0.153; TCGA UCEC -0.191 |
hsa-miR-141-3p | RAD54L2 | 12 cancers: BLCA; BRCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | TargetScan | TCGA BLCA -0.114; TCGA BRCA -0.136; TCGA HNSC -0.248; TCGA LGG -0.085; TCGA LIHC -0.104; TCGA LUAD -0.076; TCGA LUSC -0.116; TCGA PAAD -0.159; TCGA PRAD -0.315; TCGA SARC -0.129; TCGA THCA -0.348; TCGA UCEC -0.064 |
hsa-miR-141-3p | RARB | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; PAAD; PRAD; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.305; TCGA BRCA -0.152; TCGA CESC -0.231; TCGA COAD -0.501; TCGA ESCA -0.199; TCGA HNSC -0.289; TCGA LUAD -0.104; TCGA PAAD -0.219; TCGA PRAD -0.34; TCGA STAD -0.241; TCGA UCEC -0.191 |
hsa-miR-141-3p | RASSF8 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.311; TCGA BRCA -0.193; TCGA CESC -0.17; TCGA COAD -0.638; TCGA ESCA -0.278; TCGA HNSC -0.368; TCGA LUAD -0.392; TCGA LUSC -0.253; TCGA PAAD -0.297; TCGA PRAD -0.225; TCGA SARC -0.079; TCGA THCA -0.211; TCGA STAD -0.484; TCGA UCEC -0.4 |
hsa-miR-141-3p | RBM20 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.236; TCGA BRCA -0.163; TCGA CESC -0.242; TCGA COAD -0.519; TCGA ESCA -0.229; TCGA HNSC -0.171; TCGA KIRC -0.111; TCGA KIRP -0.161; TCGA PRAD -0.262; TCGA STAD -0.542; TCGA UCEC -0.267 |
hsa-miR-141-3p | RBM24 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.659; TCGA BRCA -0.137; TCGA CESC -0.551; TCGA COAD -0.347; TCGA ESCA -0.607; TCGA HNSC -0.765; TCGA KIRC -0.115; TCGA KIRP -0.197; TCGA LIHC -0.23; TCGA LUAD -0.375; TCGA LUSC -0.343; TCGA PAAD -0.318; TCGA PRAD -0.438; TCGA SARC -0.35; TCGA THCA -0.237; TCGA STAD -0.673; TCGA UCEC -0.274 |
hsa-miR-141-3p | RGS7BP | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD | TargetScan; miRNATAP | TCGA BLCA -0.211; TCGA BRCA -0.527; TCGA COAD -0.734; TCGA ESCA -0.398; TCGA HNSC -0.293; TCGA LGG -0.238; TCGA LUAD -0.319; TCGA LUSC -0.599; TCGA PAAD -0.274; TCGA PRAD -0.768; TCGA SARC -0.266; TCGA STAD -0.35 |
hsa-miR-141-3p | RHOBTB1 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUSC; OV; PAAD; PRAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.113; TCGA BRCA -0.097; TCGA CESC -0.184; TCGA COAD -0.121; TCGA HNSC -0.356; TCGA KIRC -0.197; TCGA KIRP -0.222; TCGA LUSC -0.307; TCGA OV -0.155; TCGA PAAD -0.123; TCGA PRAD -0.118; TCGA UCEC -0.07 |
hsa-miR-141-3p | RNF115 | 9 cancers: BLCA; CESC; ESCA; HNSC; PAAD; PRAD; SARC; THCA; STAD | TargetScan | TCGA BLCA -0.119; TCGA CESC -0.068; TCGA ESCA -0.082; TCGA HNSC -0.138; TCGA PAAD -0.091; TCGA PRAD -0.108; TCGA SARC -0.054; TCGA THCA -0.059; TCGA STAD -0.089 |
hsa-miR-141-3p | RSPO3 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.809; TCGA BRCA -0.522; TCGA CESC -0.686; TCGA COAD -1.177; TCGA ESCA -0.839; TCGA HNSC -0.652; TCGA LUAD -0.324; TCGA LUSC -0.826; TCGA OV -0.415; TCGA PAAD -0.789; TCGA PRAD -0.605; TCGA SARC -0.227; TCGA THCA -0.802; TCGA STAD -0.595; TCGA UCEC -0.56 |
hsa-miR-141-3p | SCN7A | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.646; TCGA BRCA -0.736; TCGA COAD -1.636; TCGA ESCA -0.963; TCGA HNSC -0.69; TCGA LUAD -0.434; TCGA LUSC -1.383; TCGA PAAD -0.516; TCGA PRAD -0.773; TCGA SARC -0.237; TCGA THCA -0.577; TCGA STAD -1.073; TCGA UCEC -0.642 |
hsa-miR-141-3p | SCN9A | 10 cancers: BLCA; BRCA; COAD; ESCA; KIRC; OV; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.284; TCGA BRCA -0.569; TCGA COAD -0.85; TCGA ESCA -0.3; TCGA KIRC -0.178; TCGA OV -0.402; TCGA PRAD -0.436; TCGA THCA -0.629; TCGA STAD -0.485; TCGA UCEC -0.171 |
hsa-miR-141-3p | SERINC1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.13; TCGA BRCA -0.147; TCGA CESC -0.124; TCGA COAD -0.151; TCGA ESCA -0.096; TCGA HNSC -0.173; TCGA LGG -0.061; TCGA LIHC -0.054; TCGA LUAD -0.162; TCGA LUSC -0.26; TCGA PAAD -0.091; TCGA PRAD -0.18; TCGA SARC -0.078; TCGA THCA -0.092; TCGA STAD -0.153; TCGA UCEC -0.22 |
hsa-miR-141-3p | SHROOM4 | 15 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan; mirMAP | TCGA BLCA -0.06; TCGA BRCA -0.322; TCGA CESC -0.28; TCGA ESCA -0.15; TCGA HNSC -0.453; TCGA LIHC -0.056; TCGA LUAD -0.281; TCGA LUSC -0.664; TCGA OV -0.218; TCGA PAAD -0.29; TCGA PRAD -0.416; TCGA SARC -0.073; TCGA THCA -0.184; TCGA STAD -0.162; TCGA UCEC -0.142 |
hsa-miR-141-3p | SLC18A2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | TargetScan | TCGA BLCA -0.333; TCGA BRCA -0.433; TCGA CESC -0.171; TCGA COAD -0.422; TCGA ESCA -0.165; TCGA HNSC -0.296; TCGA KIRC -0.187; TCGA KIRP -0.197; TCGA LUAD -0.339; TCGA LUSC -0.863; TCGA PAAD -0.19; TCGA PRAD -0.814; TCGA THCA -0.529; TCGA UCEC -0.129 |
hsa-miR-141-3p | SNAP25 | 12 cancers: BLCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LUSC; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.415; TCGA CESC -0.298; TCGA COAD -1.128; TCGA ESCA -0.304; TCGA KIRC -0.245; TCGA KIRP -0.362; TCGA LGG -0.224; TCGA LUSC -0.259; TCGA PRAD -0.508; TCGA THCA -0.361; TCGA STAD -0.697; TCGA UCEC -0.55 |
hsa-miR-141-3p | SNRK | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.095; TCGA BRCA -0.194; TCGA CESC -0.108; TCGA COAD -0.132; TCGA ESCA -0.107; TCGA HNSC -0.129; TCGA LGG -0.063; TCGA LUAD -0.141; TCGA LUSC -0.324; TCGA PAAD -0.117; TCGA PRAD -0.132; TCGA SARC -0.103; TCGA THCA -0.08; TCGA STAD -0.143; TCGA UCEC -0.147 |
hsa-miR-141-3p | SNX18 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.082; TCGA BRCA -0.143; TCGA CESC -0.074; TCGA COAD -0.273; TCGA ESCA -0.077; TCGA HNSC -0.109; TCGA LGG -0.074; TCGA LUAD -0.117; TCGA LUSC -0.128; TCGA OV -0.081; TCGA PAAD -0.137; TCGA PRAD -0.156; TCGA SARC -0.102; TCGA STAD -0.116; TCGA UCEC -0.14 |
hsa-miR-141-3p | SOCS5 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.074; TCGA BRCA -0.115; TCGA CESC -0.062; TCGA COAD -0.089; TCGA ESCA -0.06; TCGA HNSC -0.134; TCGA LUAD -0.079; TCGA LUSC -0.053; TCGA OV -0.065; TCGA PAAD -0.146; TCGA PRAD -0.168; TCGA THCA -0.123; TCGA STAD -0.158; TCGA UCEC -0.135 |
hsa-miR-141-3p | SOX17 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; STAD | TargetScan | TCGA BLCA -0.257; TCGA BRCA -0.427; TCGA CESC -0.196; TCGA COAD -0.505; TCGA ESCA -0.328; TCGA HNSC -0.383; TCGA KIRC -0.056; TCGA LUAD -0.286; TCGA LUSC -0.691; TCGA PAAD -0.302; TCGA PRAD -0.26; TCGA SARC -0.123; TCGA STAD -0.332 |
hsa-miR-141-3p | SOX5 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | TargetScan; miRNATAP | TCGA BLCA -0.334; TCGA BRCA -0.43; TCGA CESC -0.239; TCGA COAD -0.572; TCGA ESCA -0.183; TCGA HNSC -0.354; TCGA LIHC -0.082; TCGA LUAD -0.341; TCGA LUSC -0.232; TCGA PAAD -0.203; TCGA PRAD -0.595; TCGA THCA -0.476; TCGA STAD -0.372 |
hsa-miR-141-3p | SPOCK2 | 10 cancers: BLCA; COAD; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD | TargetScan; miRNATAP | TCGA BLCA -0.147; TCGA COAD -0.396; TCGA HNSC -0.225; TCGA LGG -0.093; TCGA LUAD -0.279; TCGA LUSC -0.797; TCGA PAAD -0.2; TCGA PRAD -0.109; TCGA THCA -0.366; TCGA STAD -0.113 |
hsa-miR-141-3p | STAG1 | 10 cancers: BLCA; BRCA; HNSC; LGG; LUAD; PAAD; PRAD; SARC; THCA; UCEC | TargetScan | TCGA BLCA -0.062; TCGA BRCA -0.081; TCGA HNSC -0.093; TCGA LGG -0.081; TCGA LUAD -0.073; TCGA PAAD -0.108; TCGA PRAD -0.211; TCGA SARC -0.085; TCGA THCA -0.193; TCGA UCEC -0.121 |
hsa-miR-141-3p | SYNPO2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.616; TCGA BRCA -0.527; TCGA CESC -0.489; TCGA COAD -1.259; TCGA ESCA -0.759; TCGA HNSC -0.739; TCGA LUAD -0.399; TCGA LUSC -0.621; TCGA PAAD -0.511; TCGA PRAD -0.814; TCGA SARC -0.5; TCGA THCA -0.476; TCGA STAD -0.971; TCGA UCEC -0.535 |
hsa-miR-141-3p | TAB2 | 10 cancers: BLCA; BRCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.058; TCGA BRCA -0.065; TCGA HNSC -0.098; TCGA LUAD -0.075; TCGA LUSC -0.083; TCGA PAAD -0.084; TCGA PRAD -0.101; TCGA THCA -0.112; TCGA STAD -0.121; TCGA UCEC -0.084 |
hsa-miR-141-3p | TCF21 | 12 cancers: BLCA; CESC; COAD; ESCA; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.306; TCGA CESC -0.63; TCGA COAD -0.562; TCGA ESCA -0.401; TCGA LUAD -0.372; TCGA LUSC -1.106; TCGA PAAD -0.405; TCGA PRAD -0.371; TCGA SARC -0.29; TCGA THCA -0.288; TCGA STAD -0.297; TCGA UCEC -0.511 |
hsa-miR-141-3p | THSD7A | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.307; TCGA BRCA -0.47; TCGA CESC -0.449; TCGA COAD -0.89; TCGA ESCA -0.316; TCGA HNSC -0.594; TCGA LGG -0.293; TCGA LUAD -0.222; TCGA LUSC -0.534; TCGA OV -0.258; TCGA PAAD -0.389; TCGA PRAD -0.271; TCGA SARC -0.159; TCGA THCA -0.295; TCGA STAD -0.292; TCGA UCEC -0.117 |
hsa-miR-141-3p | TNFAIP3 | 10 cancers: BLCA; BRCA; CESC; COAD; KIRC; LUAD; LUSC; PAAD; PRAD; THCA | TargetScan | TCGA BLCA -0.222; TCGA BRCA -0.132; TCGA CESC -0.122; TCGA COAD -0.134; TCGA KIRC -0.188; TCGA LUAD -0.215; TCGA LUSC -0.33; TCGA PAAD -0.291; TCGA PRAD -0.369; TCGA THCA -0.457 |
hsa-miR-141-3p | TNIK | 11 cancers: BLCA; CESC; HNSC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; THCA; UCEC | TargetScan | TCGA BLCA -0.221; TCGA CESC -0.183; TCGA HNSC -0.385; TCGA KIRP -0.261; TCGA LGG -0.11; TCGA LUAD -0.258; TCGA LUSC -0.382; TCGA PRAD -0.513; TCGA SARC -0.128; TCGA THCA -0.125; TCGA UCEC -0.243 |
hsa-miR-141-3p | TNRC6C | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; PAAD; THCA; STAD; UCEC | TargetScan; mirMAP | TCGA BLCA -0.115; TCGA BRCA -0.062; TCGA COAD -0.114; TCGA ESCA -0.152; TCGA HNSC -0.075; TCGA LGG -0.099; TCGA PAAD -0.127; TCGA THCA -0.07; TCGA STAD -0.182; TCGA UCEC -0.12 |
hsa-miR-141-3p | TSPAN4 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.33; TCGA BRCA -0.191; TCGA CESC -0.153; TCGA COAD -0.432; TCGA ESCA -0.303; TCGA HNSC -0.252; TCGA KIRC -0.16; TCGA KIRP -0.128; TCGA LUAD -0.196; TCGA LUSC -0.645; TCGA OV -0.086; TCGA PAAD -0.161; TCGA PRAD -0.147; TCGA STAD -0.201; TCGA UCEC -0.201 |
hsa-miR-141-3p | TTC28 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.129; TCGA BRCA -0.341; TCGA CESC -0.16; TCGA COAD -0.465; TCGA ESCA -0.298; TCGA HNSC -0.235; TCGA KIRC -0.097; TCGA KIRP -0.085; TCGA LGG -0.056; TCGA LUAD -0.171; TCGA LUSC -0.26; TCGA PAAD -0.246; TCGA PRAD -0.388; TCGA SARC -0.084; TCGA THCA -0.087; TCGA STAD -0.365; TCGA UCEC -0.115 |
hsa-miR-141-3p | TTYH2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | TargetScan; miRNATAP | TCGA BLCA -0.325; TCGA BRCA -0.162; TCGA CESC -0.251; TCGA COAD -0.352; TCGA ESCA -0.222; TCGA HNSC -0.223; TCGA KIRC -0.135; TCGA LUAD -0.175; TCGA LUSC -0.187; TCGA PAAD -0.29; TCGA PRAD -0.251; TCGA STAD -0.226; TCGA UCEC -0.329 |
hsa-miR-141-3p | WDR81 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; PAAD; PRAD; THCA; UCEC | TargetScan | TCGA BLCA -0.053; TCGA BRCA -0.099; TCGA CESC -0.09; TCGA COAD -0.069; TCGA ESCA -0.085; TCGA HNSC -0.1; TCGA KIRC -0.126; TCGA KIRP -0.073; TCGA LIHC -0.058; TCGA LUSC -0.131; TCGA PAAD -0.182; TCGA PRAD -0.075; TCGA THCA -0.095; TCGA UCEC -0.097 |
hsa-miR-141-3p | ZBTB16 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.483; TCGA BRCA -0.859; TCGA CESC -0.404; TCGA COAD -1.153; TCGA ESCA -0.75; TCGA HNSC -0.638; TCGA LGG -0.226; TCGA LIHC -0.283; TCGA LUAD -0.348; TCGA LUSC -1.083; TCGA PAAD -0.37; TCGA SARC -0.291; TCGA THCA -0.287; TCGA STAD -0.815; TCGA UCEC -0.636 |
hsa-miR-141-3p | ZBTB46 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.15; TCGA BRCA -0.082; TCGA CESC -0.147; TCGA COAD -0.314; TCGA ESCA -0.185; TCGA HNSC -0.231; TCGA KIRC -0.05; TCGA LUAD -0.127; TCGA LUSC -0.425; TCGA PAAD -0.15; TCGA PRAD -0.096; TCGA STAD -0.081; TCGA UCEC -0.232 |
hsa-miR-141-3p | ZNF281 | 10 cancers: BLCA; COAD; HNSC; LGG; LUSC; OV; PAAD; PRAD; SARC; THCA | TargetScan | TCGA BLCA -0.132; TCGA COAD -0.157; TCGA HNSC -0.293; TCGA LGG -0.133; TCGA LUSC -0.159; TCGA OV -0.059; TCGA PAAD -0.166; TCGA PRAD -0.254; TCGA SARC -0.129; TCGA THCA -0.293 |
hsa-miR-141-3p | ZNF641 | 10 cancers: BLCA; BRCA; COAD; HNSC; LGG; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.074; TCGA BRCA -0.106; TCGA COAD -0.101; TCGA HNSC -0.148; TCGA LGG -0.061; TCGA PRAD -0.261; TCGA SARC -0.125; TCGA THCA -0.113; TCGA STAD -0.099; TCGA UCEC -0.087 |
hsa-miR-141-3p | ZNF660 | 13 cancers: BLCA; BRCA; ESCA; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.155; TCGA BRCA -0.321; TCGA ESCA -0.36; TCGA KIRP -0.066; TCGA LGG -0.158; TCGA LUAD -0.256; TCGA LUSC -0.366; TCGA PAAD -0.276; TCGA PRAD -0.515; TCGA SARC -0.146; TCGA THCA -0.179; TCGA STAD -0.389; TCGA UCEC -0.238 |
hsa-miR-141-3p | ZFX | 11 cancers: BLCA; BRCA; HNSC; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.083; TCGA BRCA -0.06; TCGA HNSC -0.102; TCGA LGG -0.072; TCGA LUAD -0.071; TCGA PAAD -0.09; TCGA PRAD -0.173; TCGA SARC -0.093; TCGA THCA -0.156; TCGA STAD -0.089; TCGA UCEC -0.117 |
hsa-miR-141-3p | PAFAH1B1 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.066; TCGA BRCA -0.093; TCGA COAD -0.063; TCGA ESCA -0.064; TCGA HNSC -0.054; TCGA LGG -0.076; TCGA LUAD -0.056; TCGA LUSC -0.119; TCGA PAAD -0.061; TCGA PRAD -0.129; TCGA THCA -0.101; TCGA STAD -0.087; TCGA UCEC -0.082 |
hsa-miR-141-3p | GAB2 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.133; TCGA BRCA -0.085; TCGA CESC -0.167; TCGA ESCA -0.117; TCGA HNSC -0.23; TCGA LUSC -0.511; TCGA PAAD -0.124; TCGA PRAD -0.28; TCGA SARC -0.163; TCGA THCA -0.092; TCGA STAD -0.08; TCGA UCEC -0.209 |
hsa-miR-141-3p | CELF2 | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.468; TCGA BRCA -0.413; TCGA CESC -0.243; TCGA ESCA -0.516; TCGA HNSC -0.416; TCGA KIRC -0.074; TCGA KIRP -0.09; TCGA LUAD -0.14; TCGA LUSC -0.691; TCGA PAAD -0.527; TCGA PRAD -0.486; TCGA THCA -0.384; TCGA STAD -0.438; TCGA UCEC -0.285 |
hsa-miR-141-3p | ASB1 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.12; TCGA BRCA -0.154; TCGA CESC -0.061; TCGA COAD -0.052; TCGA ESCA -0.062; TCGA HNSC -0.11; TCGA LGG -0.127; TCGA PRAD -0.164; TCGA THCA -0.125; TCGA STAD -0.146; TCGA UCEC -0.126 |
hsa-miR-141-3p | NAV3 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.607; TCGA BRCA -0.376; TCGA CESC -0.466; TCGA COAD -0.852; TCGA ESCA -0.482; TCGA HNSC -0.435; TCGA KIRP -0.148; TCGA LUAD -0.414; TCGA LUSC -0.675; TCGA OV -0.174; TCGA PAAD -0.477; TCGA PRAD -0.273; TCGA THCA -0.553; TCGA STAD -0.466; TCGA UCEC -0.409 |
hsa-miR-141-3p | RASAL2 | 9 cancers: BLCA; BRCA; CESC; HNSC; LGG; LUAD; LUSC; PRAD; THCA | mirMAP | TCGA BLCA -0.085; TCGA BRCA -0.093; TCGA CESC -0.128; TCGA HNSC -0.202; TCGA LGG -0.053; TCGA LUAD -0.178; TCGA LUSC -0.14; TCGA PRAD -0.133; TCGA THCA -0.103 |
hsa-miR-141-3p | CYLD | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.14; TCGA BRCA -0.061; TCGA CESC -0.078; TCGA COAD -0.16; TCGA ESCA -0.135; TCGA HNSC -0.161; TCGA LUAD -0.111; TCGA LUSC -0.265; TCGA PAAD -0.119; TCGA PRAD -0.192; TCGA THCA -0.206; TCGA STAD -0.131; TCGA UCEC -0.09 |
hsa-miR-141-3p | CD59 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; STAD | mirMAP | TCGA BLCA -0.105; TCGA BRCA -0.101; TCGA CESC -0.075; TCGA COAD -0.137; TCGA ESCA -0.142; TCGA HNSC -0.119; TCGA LUAD -0.17; TCGA LUSC -0.265; TCGA PRAD -0.186; TCGA STAD -0.119 |
hsa-miR-141-3p | SIGLEC1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; THCA; STAD | mirMAP | TCGA BLCA -0.413; TCGA BRCA -0.107; TCGA CESC -0.233; TCGA COAD -0.636; TCGA ESCA -0.444; TCGA HNSC -0.41; TCGA KIRC -0.38; TCGA KIRP -0.106; TCGA LUAD -0.341; TCGA LUSC -0.665; TCGA PAAD -0.506; TCGA THCA -0.278; TCGA STAD -0.156 |
hsa-miR-141-3p | IRAK3 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.237; TCGA BRCA -0.395; TCGA CESC -0.124; TCGA COAD -0.465; TCGA ESCA -0.164; TCGA HNSC -0.192; TCGA KIRC -0.13; TCGA LUAD -0.146; TCGA LUSC -0.526; TCGA PAAD -0.21; TCGA PRAD -0.5; TCGA THCA -0.317; TCGA UCEC -0.243 |
hsa-miR-141-3p | GRAP2 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.341; TCGA BRCA -0.139; TCGA CESC -0.161; TCGA ESCA -0.146; TCGA HNSC -0.235; TCGA KIRC -0.265; TCGA LUAD -0.202; TCGA LUSC -0.56; TCGA PAAD -0.377; TCGA PRAD -0.29; TCGA THCA -0.625; TCGA UCEC -0.12 |
hsa-miR-141-3p | ZNF423 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.136; TCGA BRCA -0.444; TCGA CESC -0.372; TCGA COAD -0.478; TCGA ESCA -0.512; TCGA HNSC -0.593; TCGA KIRC -0.053; TCGA LGG -0.177; TCGA LUAD -0.35; TCGA LUSC -0.722; TCGA PAAD -0.354; TCGA PRAD -0.464; TCGA THCA -0.268; TCGA STAD -0.455; TCGA UCEC -0.233 |
hsa-miR-141-3p | RASA4 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUSC; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.119; TCGA BRCA -0.162; TCGA CESC -0.211; TCGA COAD -0.278; TCGA ESCA -0.249; TCGA HNSC -0.253; TCGA KIRC -0.114; TCGA LGG -0.064; TCGA LUSC -0.23; TCGA PRAD -0.062; TCGA STAD -0.194; TCGA UCEC -0.187 |
hsa-miR-141-3p | C11orf21 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.24; TCGA BRCA -0.135; TCGA COAD -0.5; TCGA ESCA -0.219; TCGA HNSC -0.219; TCGA KIRC -0.369; TCGA LUAD -0.174; TCGA LUSC -0.573; TCGA PAAD -0.387; TCGA SARC -0.136; TCGA THCA -0.238; TCGA STAD -0.183; TCGA UCEC -0.113 |
hsa-miR-141-3p | BVES | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.482; TCGA BRCA -0.32; TCGA COAD -0.8; TCGA ESCA -0.506; TCGA HNSC -0.491; TCGA LUAD -0.192; TCGA LUSC -0.249; TCGA OV -0.235; TCGA PAAD -0.275; TCGA PRAD -0.406; TCGA SARC -0.27; TCGA THCA -0.278; TCGA STAD -0.655; TCGA UCEC -0.324 |
hsa-miR-141-3p | RIMS3 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.22; TCGA BRCA -0.196; TCGA CESC -0.155; TCGA ESCA -0.212; TCGA HNSC -0.136; TCGA LUAD -0.13; TCGA LUSC -0.352; TCGA PRAD -0.456; TCGA THCA -0.313; TCGA STAD -0.383; TCGA UCEC -0.346 |
hsa-miR-141-3p | BTN2A2 | 9 cancers: BLCA; COAD; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA | mirMAP | TCGA BLCA -0.061; TCGA COAD -0.124; TCGA KIRC -0.16; TCGA KIRP -0.108; TCGA LUAD -0.081; TCGA LUSC -0.19; TCGA PAAD -0.217; TCGA PRAD -0.07; TCGA THCA -0.069 |
hsa-miR-141-3p | HS3ST3B1 | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD | mirMAP | TCGA BLCA -0.383; TCGA BRCA -0.115; TCGA CESC -0.173; TCGA COAD -0.243; TCGA HNSC -0.277; TCGA LIHC -0.156; TCGA LUAD -0.294; TCGA LUSC -0.219; TCGA PAAD -0.172; TCGA PRAD -0.493 |
hsa-miR-141-3p | HIVEP3 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.175; TCGA CESC -0.234; TCGA COAD -0.229; TCGA ESCA -0.16; TCGA HNSC -0.267; TCGA KIRC -0.056; TCGA LUAD -0.228; TCGA LUSC -0.388; TCGA PAAD -0.093; TCGA PRAD -0.136; TCGA STAD -0.067; TCGA UCEC -0.072 |
hsa-miR-141-3p | WDFY4 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.443; TCGA BRCA -0.108; TCGA CESC -0.28; TCGA COAD -0.556; TCGA ESCA -0.41; TCGA HNSC -0.466; TCGA KIRC -0.308; TCGA KIRP -0.126; TCGA LUAD -0.171; TCGA LUSC -0.873; TCGA PAAD -0.73; TCGA PRAD -0.356; TCGA THCA -0.535; TCGA STAD -0.11 |
hsa-miR-141-3p | MAP1B | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.542; TCGA BRCA -0.333; TCGA CESC -0.319; TCGA COAD -0.663; TCGA ESCA -0.445; TCGA HNSC -0.34; TCGA KIRC -0.105; TCGA LUAD -0.241; TCGA PAAD -0.23; TCGA PRAD -0.562; TCGA SARC -0.21; TCGA THCA -0.273; TCGA STAD -0.559; TCGA UCEC -0.211 |
hsa-miR-141-3p | ZBED3 | 10 cancers: BLCA; BRCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; STAD | mirMAP | TCGA BLCA -0.122; TCGA BRCA -0.172; TCGA HNSC -0.195; TCGA KIRP -0.06; TCGA LGG -0.122; TCGA LIHC -0.054; TCGA LUAD -0.09; TCGA LUSC -0.19; TCGA PRAD -0.187; TCGA STAD -0.076 |
hsa-miR-141-3p | ETS1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.136; TCGA BRCA -0.257; TCGA CESC -0.219; TCGA COAD -0.352; TCGA ESCA -0.208; TCGA HNSC -0.363; TCGA KIRC -0.167; TCGA LGG -0.157; TCGA LUAD -0.285; TCGA LUSC -0.663; TCGA OV -0.124; TCGA PAAD -0.308; TCGA PRAD -0.307; TCGA THCA -0.304; TCGA STAD -0.063; TCGA UCEC -0.195 |
hsa-miR-141-3p | ZFP37 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LUAD; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.108; TCGA BRCA -0.163; TCGA CESC -0.192; TCGA COAD -0.195; TCGA ESCA -0.142; TCGA LGG -0.164; TCGA LUAD -0.217; TCGA PAAD -0.17; TCGA PRAD -0.121; TCGA STAD -0.166; TCGA UCEC -0.142 |
hsa-miR-141-3p | MAPKBP1 | 10 cancers: BLCA; BRCA; CESC; COAD; LUAD; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.057; TCGA BRCA -0.089; TCGA CESC -0.101; TCGA COAD -0.106; TCGA LUAD -0.08; TCGA PAAD -0.062; TCGA PRAD -0.151; TCGA SARC -0.067; TCGA STAD -0.149; TCGA UCEC -0.101 |
hsa-miR-141-3p | KIAA1644 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.717; TCGA BRCA -0.131; TCGA CESC -0.556; TCGA COAD -1.017; TCGA ESCA -0.506; TCGA HNSC -0.483; TCGA LGG -0.323; TCGA LUAD -0.171; TCGA LUSC -0.541; TCGA OV -0.346; TCGA PAAD -0.417; TCGA PRAD -0.692; TCGA THCA -0.638; TCGA STAD -0.706; TCGA UCEC -0.572 |
hsa-miR-141-3p | NTRK3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.497; TCGA BRCA -0.458; TCGA CESC -0.609; TCGA COAD -1.096; TCGA ESCA -0.597; TCGA HNSC -0.468; TCGA LGG -0.113; TCGA LUAD -0.349; TCGA LUSC -0.809; TCGA OV -0.354; TCGA PAAD -0.409; TCGA PRAD -0.508; TCGA STAD -0.625; TCGA UCEC -0.416 |
hsa-miR-141-3p | FTO | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.103; TCGA BRCA -0.12; TCGA CESC -0.085; TCGA COAD -0.142; TCGA ESCA -0.131; TCGA HNSC -0.182; TCGA KIRC -0.08; TCGA KIRP -0.054; TCGA LGG -0.052; TCGA LIHC -0.075; TCGA LUAD -0.115; TCGA LUSC -0.177; TCGA PAAD -0.087; TCGA PRAD -0.194; TCGA THCA -0.104; TCGA STAD -0.185; TCGA UCEC -0.125 |
hsa-miR-141-3p | WTIP | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.092; TCGA BRCA -0.226; TCGA COAD -0.459; TCGA ESCA -0.27; TCGA HNSC -0.162; TCGA LUSC -0.279; TCGA PAAD -0.194; TCGA STAD -0.257; TCGA UCEC -0.192 |
hsa-miR-141-3p | OSBPL10 | 9 cancers: BLCA; COAD; HNSC; KIRP; LUSC; PAAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.24; TCGA COAD -0.069; TCGA HNSC -0.112; TCGA KIRP -0.153; TCGA LUSC -0.155; TCGA PAAD -0.081; TCGA PRAD -0.254; TCGA SARC -0.219; TCGA THCA -0.185 |
hsa-miR-141-3p | COL8A1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.375; TCGA BRCA -0.153; TCGA CESC -0.379; TCGA COAD -0.976; TCGA ESCA -0.368; TCGA HNSC -0.627; TCGA KIRC -0.308; TCGA LUAD -0.333; TCGA LUSC -0.785; TCGA OV -0.324; TCGA PAAD -0.503; TCGA PRAD -0.399; TCGA THCA -0.259; TCGA STAD -0.396; TCGA UCEC -0.115 |
hsa-miR-141-3p | TMEM108 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.463; TCGA BRCA -0.132; TCGA CESC -0.372; TCGA COAD -0.503; TCGA ESCA -0.426; TCGA HNSC -0.377; TCGA LGG -0.194; TCGA LUSC -0.422; TCGA PAAD -0.273; TCGA PRAD -0.584; TCGA SARC -0.213; TCGA STAD -0.354; TCGA UCEC -0.148 |
hsa-miR-141-3p | RNF217 | 12 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LIHC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.266; TCGA BRCA -0.242; TCGA COAD -0.318; TCGA ESCA -0.277; TCGA KIRC -0.074; TCGA KIRP -0.085; TCGA LIHC -0.11; TCGA PAAD -0.238; TCGA PRAD -0.244; TCGA SARC -0.07; TCGA THCA -0.114; TCGA STAD -0.382 |
hsa-miR-141-3p | GNA12 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.16; TCGA BRCA -0.063; TCGA CESC -0.104; TCGA COAD -0.13; TCGA ESCA -0.083; TCGA HNSC -0.127; TCGA LUAD -0.132; TCGA LUSC -0.072; TCGA OV -0.073; TCGA PAAD -0.134; TCGA SARC -0.065; TCGA THCA -0.154; TCGA STAD -0.099; TCGA UCEC -0.125 |
hsa-miR-141-3p | CREB5 | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.413; TCGA BRCA -0.421; TCGA COAD -0.295; TCGA HNSC -0.271; TCGA KIRC -0.224; TCGA KIRP -0.388; TCGA LUAD -0.261; TCGA LUSC -0.136; TCGA PAAD -0.22; TCGA PRAD -0.204; TCGA THCA -0.369; TCGA STAD -0.282 |
hsa-miR-141-3p | FOXO1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.085; TCGA BRCA -0.42; TCGA CESC -0.194; TCGA COAD -0.18; TCGA ESCA -0.143; TCGA HNSC -0.214; TCGA LIHC -0.078; TCGA LUAD -0.111; TCGA LUSC -0.222; TCGA OV -0.099; TCGA PAAD -0.264; TCGA PRAD -0.284; TCGA STAD -0.118; TCGA UCEC -0.188 |
hsa-miR-141-3p | FER | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.183; TCGA BRCA -0.261; TCGA COAD -0.161; TCGA ESCA -0.106; TCGA HNSC -0.134; TCGA LGG -0.085; TCGA LUAD -0.151; TCGA LUSC -0.154; TCGA PAAD -0.132; TCGA PRAD -0.352; TCGA SARC -0.055; TCGA THCA -0.202; TCGA STAD -0.2; TCGA UCEC -0.08 |
hsa-miR-141-3p | WWC2 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.18; TCGA BRCA -0.227; TCGA COAD -0.42; TCGA ESCA -0.115; TCGA HNSC -0.228; TCGA LUAD -0.258; TCGA LUSC -0.609; TCGA PAAD -0.151; TCGA PRAD -0.302; TCGA STAD -0.157; TCGA UCEC -0.107 |
hsa-miR-141-3p | GFRA1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.393; TCGA BRCA -0.167; TCGA CESC -0.767; TCGA COAD -0.985; TCGA ESCA -0.567; TCGA HNSC -0.561; TCGA LGG -0.389; TCGA LIHC -0.255; TCGA LUAD -0.346; TCGA LUSC -0.809; TCGA OV -0.542; TCGA PAAD -0.356; TCGA PRAD -0.57; TCGA THCA -1.001; TCGA STAD -0.712; TCGA UCEC -0.43 |
hsa-miR-141-3p | DST | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.123; TCGA BRCA -0.385; TCGA CESC -0.159; TCGA COAD -0.219; TCGA ESCA -0.118; TCGA HNSC -0.147; TCGA LGG -0.106; TCGA LUAD -0.283; TCGA PRAD -0.416; TCGA SARC -0.198; TCGA THCA -0.404; TCGA STAD -0.309; TCGA UCEC -0.229 |
hsa-miR-141-3p | CAMK4 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.287; TCGA BRCA -0.084; TCGA CESC -0.16; TCGA COAD -0.35; TCGA ESCA -0.165; TCGA HNSC -0.218; TCGA LGG -0.318; TCGA LUAD -0.247; TCGA LUSC -0.261; TCGA PAAD -0.284; TCGA PRAD -0.565; TCGA THCA -0.567; TCGA STAD -0.182; TCGA UCEC -0.206 |
hsa-miR-141-3p | PDE1C | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.511; TCGA BRCA -0.513; TCGA COAD -0.317; TCGA ESCA -0.433; TCGA HNSC -0.398; TCGA LUAD -0.292; TCGA LUSC -0.796; TCGA PAAD -0.197; TCGA PRAD -0.896; TCGA SARC -0.331; TCGA THCA -0.199; TCGA STAD -0.437; TCGA UCEC -0.33 |
hsa-miR-141-3p | EIF4E3 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.091; TCGA BRCA -0.217; TCGA CESC -0.08; TCGA COAD -0.153; TCGA ESCA -0.232; TCGA HNSC -0.223; TCGA KIRP -0.059; TCGA LUAD -0.136; TCGA LUSC -0.461; TCGA PRAD -0.229; TCGA STAD -0.258; TCGA UCEC -0.176 |
hsa-miR-141-3p | FYCO1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.12; TCGA BRCA -0.176; TCGA CESC -0.07; TCGA COAD -0.124; TCGA ESCA -0.184; TCGA HNSC -0.297; TCGA LUAD -0.076; TCGA LUSC -0.287; TCGA PRAD -0.291; TCGA SARC -0.133; TCGA THCA -0.1; TCGA STAD -0.301; TCGA UCEC -0.184 |
hsa-miR-141-3p | GRIK3 | 12 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.341; TCGA COAD -0.547; TCGA ESCA -0.808; TCGA HNSC -0.302; TCGA KIRC -0.812; TCGA LGG -0.073; TCGA LUAD -0.215; TCGA LUSC -0.338; TCGA PAAD -0.26; TCGA PRAD -0.404; TCGA THCA -0.281; TCGA STAD -0.814 |
hsa-miR-141-3p | HEYL | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.213; TCGA CESC -0.311; TCGA COAD -0.39; TCGA ESCA -0.229; TCGA HNSC -0.32; TCGA KIRC -0.214; TCGA LUAD -0.137; TCGA LUSC -0.511; TCGA OV -0.195; TCGA PAAD -0.222; TCGA PRAD -0.092; TCGA THCA -0.247; TCGA STAD -0.235; TCGA UCEC -0.22 |
hsa-miR-141-3p | CTSB | 9 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD | mirMAP | TCGA BLCA -0.172; TCGA COAD -0.151; TCGA HNSC -0.101; TCGA KIRC -0.064; TCGA KIRP -0.093; TCGA LUAD -0.121; TCGA LUSC -0.142; TCGA PAAD -0.168; TCGA PRAD -0.235 |
hsa-miR-141-3p | GPRC5B | 9 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LUAD; PRAD; UCEC | mirMAP | TCGA BLCA -0.171; TCGA BRCA -0.227; TCGA CESC -0.152; TCGA COAD -0.39; TCGA HNSC -0.266; TCGA LGG -0.067; TCGA LUAD -0.116; TCGA PRAD -0.465; TCGA UCEC -0.097 |
hsa-miR-141-3p | GFRA2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.445; TCGA BRCA -0.575; TCGA CESC -0.399; TCGA COAD -0.611; TCGA ESCA -0.613; TCGA HNSC -0.428; TCGA LIHC -0.171; TCGA LUAD -0.376; TCGA LUSC -0.734; TCGA PAAD -0.451; TCGA PRAD -0.372; TCGA STAD -0.545; TCGA UCEC -0.292 |
hsa-miR-141-3p | SHE | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.327; TCGA BRCA -0.487; TCGA CESC -0.395; TCGA COAD -0.639; TCGA ESCA -0.32; TCGA HNSC -0.45; TCGA LUAD -0.164; TCGA LUSC -0.809; TCGA OV -0.172; TCGA PAAD -0.382; TCGA PRAD -0.319; TCGA SARC -0.193; TCGA THCA -0.134; TCGA STAD -0.312; TCGA UCEC -0.395 |
hsa-miR-141-3p | KCNK3 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUSC; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.537; TCGA BRCA -0.286; TCGA CESC -0.248; TCGA COAD -1.15; TCGA ESCA -0.413; TCGA HNSC -0.42; TCGA KIRC -0.344; TCGA LGG -0.487; TCGA LUSC -0.841; TCGA PRAD -0.616; TCGA STAD -0.751; TCGA UCEC -0.389 |
hsa-miR-141-3p | ANO5 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.298; TCGA BRCA -0.341; TCGA CESC -0.269; TCGA COAD -0.859; TCGA ESCA -0.303; TCGA HNSC -0.812; TCGA LGG -0.264; TCGA LUAD -0.146; TCGA LUSC -0.66; TCGA PRAD -0.762; TCGA STAD -0.479; TCGA UCEC -0.309 |
hsa-miR-141-3p | SH3PXD2B | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.18; TCGA BRCA -0.1; TCGA CESC -0.109; TCGA COAD -0.227; TCGA ESCA -0.22; TCGA HNSC -0.226; TCGA KIRC -0.174; TCGA KIRP -0.085; TCGA LUSC -0.136; TCGA PAAD -0.279; TCGA PRAD -0.43; TCGA SARC -0.1; TCGA THCA -0.114; TCGA STAD -0.229; TCGA UCEC -0.09 |
hsa-miR-141-3p | ARL10 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.254; TCGA BRCA -0.256; TCGA CESC -0.223; TCGA COAD -0.518; TCGA ESCA -0.254; TCGA HNSC -0.185; TCGA KIRC -0.12; TCGA LGG -0.169; TCGA LUAD -0.261; TCGA PAAD -0.23; TCGA PRAD -0.455; TCGA SARC -0.081; TCGA THCA -0.421; TCGA STAD -0.324; TCGA UCEC -0.226 |
hsa-miR-141-3p | KBTBD11 | 10 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LUSC; OV; SARC; UCEC | mirMAP | TCGA BLCA -0.208; TCGA BRCA -0.24; TCGA HNSC -0.311; TCGA KIRC -0.068; TCGA KIRP -0.217; TCGA LGG -0.089; TCGA LUSC -0.488; TCGA OV -0.238; TCGA SARC -0.133; TCGA UCEC -0.25 |
hsa-miR-141-3p | FAM26E | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.406; TCGA BRCA -0.341; TCGA CESC -0.285; TCGA COAD -0.672; TCGA ESCA -0.352; TCGA HNSC -0.442; TCGA LUAD -0.326; TCGA LUSC -0.555; TCGA OV -0.229; TCGA PAAD -0.426; TCGA PRAD -0.311; TCGA SARC -0.247; TCGA THCA -0.307; TCGA STAD -0.211; TCGA UCEC -0.301 |
hsa-miR-141-3p | ST6GALNAC3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.272; TCGA BRCA -0.39; TCGA CESC -0.406; TCGA COAD -0.188; TCGA ESCA -0.219; TCGA HNSC -0.356; TCGA LIHC -0.08; TCGA LUAD -0.288; TCGA LUSC -0.589; TCGA OV -0.236; TCGA PAAD -0.175; TCGA PRAD -0.334; TCGA STAD -0.223; TCGA UCEC -0.341 |
hsa-miR-141-3p | TNFAIP8L1 | 9 cancers: BLCA; COAD; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.059; TCGA COAD -0.094; TCGA KIRC -0.142; TCGA LUAD -0.142; TCGA LUSC -0.127; TCGA PAAD -0.157; TCGA PRAD -0.207; TCGA THCA -0.143; TCGA STAD -0.188 |
hsa-miR-141-3p | OLFML2A | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.216; TCGA BRCA -0.255; TCGA CESC -0.303; TCGA COAD -0.356; TCGA ESCA -0.209; TCGA HNSC -0.113; TCGA KIRC -0.351; TCGA LUAD -0.225; TCGA LUSC -0.103; TCGA PAAD -0.143; TCGA PRAD -0.424; TCGA THCA -0.133; TCGA STAD -0.253; TCGA UCEC -0.358 |
hsa-miR-141-3p | TEAD1 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.188; TCGA BRCA -0.263; TCGA COAD -0.157; TCGA ESCA -0.1; TCGA HNSC -0.235; TCGA LGG -0.155; TCGA LUAD -0.13; TCGA LUSC -0.119; TCGA PAAD -0.092; TCGA PRAD -0.401; TCGA SARC -0.072; TCGA THCA -0.18; TCGA STAD -0.329; TCGA UCEC -0.153 |
hsa-miR-141-3p | PRELP | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.584; TCGA BRCA -0.472; TCGA CESC -0.488; TCGA COAD -1.376; TCGA ESCA -0.802; TCGA HNSC -0.58; TCGA LUAD -0.335; TCGA LUSC -0.899; TCGA PAAD -0.397; TCGA PRAD -0.473; TCGA SARC -0.458; TCGA THCA -0.71; TCGA STAD -0.739; TCGA UCEC -0.541 |
hsa-miR-141-3p | AFAP1 | 15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.241; TCGA BRCA -0.088; TCGA COAD -0.097; TCGA ESCA -0.148; TCGA HNSC -0.168; TCGA KIRC -0.072; TCGA LGG -0.152; TCGA LUAD -0.099; TCGA OV -0.137; TCGA PAAD -0.077; TCGA PRAD -0.23; TCGA SARC -0.139; TCGA THCA -0.076; TCGA STAD -0.195; TCGA UCEC -0.136 |
hsa-miR-141-3p | SPN | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA | mirMAP | TCGA BLCA -0.264; TCGA BRCA -0.077; TCGA CESC -0.146; TCGA COAD -0.337; TCGA ESCA -0.171; TCGA HNSC -0.356; TCGA KIRC -0.316; TCGA KIRP -0.069; TCGA LUAD -0.359; TCGA LUSC -0.899; TCGA PAAD -0.432; TCGA PRAD -0.269; TCGA THCA -0.577 |
hsa-miR-141-3p | CALM1 | 9 cancers: BLCA; BRCA; ESCA; LUAD; LUSC; OV; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.065; TCGA BRCA -0.071; TCGA ESCA -0.073; TCGA LUAD -0.092; TCGA LUSC -0.114; TCGA OV -0.077; TCGA PRAD -0.179; TCGA THCA -0.074; TCGA STAD -0.13 |
hsa-miR-141-3p | NEURL1B | 11 cancers: BLCA; BRCA; ESCA; KIRC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.232; TCGA BRCA -0.092; TCGA ESCA -0.142; TCGA KIRC -0.139; TCGA LUAD -0.102; TCGA LUSC -0.145; TCGA PRAD -0.349; TCGA SARC -0.157; TCGA THCA -0.176; TCGA STAD -0.224; TCGA UCEC -0.16 |
hsa-miR-141-3p | MICAL3 | 11 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; LGG; LUAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.063; TCGA BRCA -0.11; TCGA ESCA -0.112; TCGA KIRC -0.147; TCGA KIRP -0.083; TCGA LGG -0.078; TCGA LUAD -0.113; TCGA PRAD -0.052; TCGA SARC -0.112; TCGA STAD -0.144; TCGA UCEC -0.063 |
hsa-miR-141-3p | KCTD7 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.124; TCGA BRCA -0.086; TCGA CESC -0.087; TCGA COAD -0.177; TCGA ESCA -0.144; TCGA KIRP -0.064; TCGA LUSC -0.059; TCGA PAAD -0.132; TCGA PRAD -0.084; TCGA STAD -0.258; TCGA UCEC -0.202 |
hsa-miR-141-3p | NOVA1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.429; TCGA BRCA -0.455; TCGA CESC -0.638; TCGA COAD -0.958; TCGA ESCA -0.674; TCGA HNSC -0.364; TCGA KIRP -0.172; TCGA LGG -0.161; TCGA LUAD -0.179; TCGA LUSC -0.2; TCGA OV -0.366; TCGA PAAD -0.346; TCGA PRAD -0.341; TCGA STAD -0.664; TCGA UCEC -0.449 |
hsa-miR-141-3p | CXCL12 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.582; TCGA BRCA -0.449; TCGA CESC -0.674; TCGA COAD -0.572; TCGA ESCA -0.526; TCGA HNSC -0.688; TCGA LUAD -0.406; TCGA LUSC -0.789; TCGA OV -0.353; TCGA PAAD -0.593; TCGA PRAD -0.32; TCGA THCA -0.592; TCGA STAD -0.461; TCGA UCEC -0.527 |
hsa-miR-141-3p | MAP3K3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.173; TCGA BRCA -0.166; TCGA CESC -0.139; TCGA COAD -0.277; TCGA ESCA -0.243; TCGA HNSC -0.256; TCGA LUAD -0.193; TCGA LUSC -0.323; TCGA PAAD -0.227; TCGA PRAD -0.111; TCGA SARC -0.081; TCGA THCA -0.159; TCGA STAD -0.238; TCGA UCEC -0.199 |
hsa-miR-141-3p | SPRED1 | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; UCEC | miRNATAP | TCGA BLCA -0.173; TCGA BRCA -0.161; TCGA CESC -0.142; TCGA HNSC -0.176; TCGA KIRC -0.092; TCGA LUAD -0.223; TCGA LUSC -0.295; TCGA PAAD -0.073; TCGA PRAD -0.316; TCGA UCEC -0.151 |
hsa-miR-141-3p | PCDH17 | 14 cancers: BLCA; CESC; COAD; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.148; TCGA CESC -0.21; TCGA COAD -0.405; TCGA HNSC -0.392; TCGA KIRC -0.27; TCGA LGG -0.149; TCGA LUAD -0.217; TCGA LUSC -0.546; TCGA OV -0.241; TCGA PAAD -0.273; TCGA PRAD -0.283; TCGA THCA -0.155; TCGA STAD -0.135; TCGA UCEC -0.172 |
hsa-miR-141-3p | MAF | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.308; TCGA BRCA -0.28; TCGA CESC -0.245; TCGA COAD -0.48; TCGA ESCA -0.22; TCGA HNSC -0.152; TCGA KIRC -0.216; TCGA KIRP -0.081; TCGA LUAD -0.197; TCGA LUSC -0.139; TCGA PAAD -0.241; TCGA PRAD -0.168; TCGA THCA -0.077; TCGA STAD -0.217; TCGA UCEC -0.397 |
hsa-miR-141-3p | SETBP1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.348; TCGA BRCA -0.201; TCGA CESC -0.307; TCGA COAD -0.612; TCGA ESCA -0.429; TCGA HNSC -0.27; TCGA LGG -0.124; TCGA LUAD -0.088; TCGA LUSC -0.197; TCGA PAAD -0.234; TCGA PRAD -0.321; TCGA SARC -0.122; TCGA THCA -0.191; TCGA STAD -0.521; TCGA UCEC -0.261 |
hsa-miR-141-3p | SLC6A17 | 10 cancers: BLCA; COAD; ESCA; HNSC; LUAD; LUSC; OV; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.282; TCGA COAD -0.653; TCGA ESCA -0.251; TCGA HNSC -0.528; TCGA LUAD -0.179; TCGA LUSC -0.177; TCGA OV -0.287; TCGA SARC -0.248; TCGA THCA -0.231; TCGA STAD -0.348 |
hsa-miR-141-3p | SVIL | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.254; TCGA BRCA -0.187; TCGA CESC -0.177; TCGA COAD -0.337; TCGA ESCA -0.296; TCGA HNSC -0.196; TCGA KIRP -0.057; TCGA LUAD -0.116; TCGA PAAD -0.168; TCGA PRAD -0.479; TCGA SARC -0.191; TCGA THCA -0.086; TCGA STAD -0.563; TCGA UCEC -0.293 |
hsa-miR-141-3p | JUN | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.202; TCGA BRCA -0.265; TCGA CESC -0.141; TCGA ESCA -0.103; TCGA HNSC -0.099; TCGA KIRC -0.059; TCGA LUAD -0.118; TCGA LUSC -0.175; TCGA PRAD -0.129; TCGA STAD -0.135; TCGA UCEC -0.099 |
hsa-miR-141-3p | EPB41L3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.293; TCGA BRCA -0.193; TCGA CESC -0.301; TCGA COAD -0.573; TCGA ESCA -0.357; TCGA HNSC -0.31; TCGA LUAD -0.305; TCGA LUSC -0.463; TCGA PAAD -0.285; TCGA PRAD -0.389; TCGA SARC -0.27; TCGA THCA -0.344; TCGA STAD -0.259; TCGA UCEC -0.288 |
hsa-miR-141-3p | RAPGEF6 | 11 cancers: BLCA; BRCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.078; TCGA BRCA -0.088; TCGA HNSC -0.258; TCGA LGG -0.075; TCGA LUAD -0.157; TCGA LUSC -0.277; TCGA PAAD -0.141; TCGA PRAD -0.324; TCGA SARC -0.116; TCGA THCA -0.358; TCGA UCEC -0.102 |
hsa-miR-141-3p | CTTNBP2 | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LUAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.237; TCGA BRCA -0.484; TCGA CESC -0.269; TCGA ESCA -0.264; TCGA HNSC -0.217; TCGA KIRP -0.189; TCGA LGG -0.231; TCGA LUAD -0.231; TCGA PRAD -0.585; TCGA SARC -0.19; TCGA THCA -0.202; TCGA STAD -0.342; TCGA UCEC -0.13 |
hsa-miR-141-3p | NMNAT2 | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LGG; LUSC; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.225; TCGA BRCA -0.459; TCGA COAD -0.434; TCGA HNSC -0.236; TCGA KIRC -0.109; TCGA LGG -0.291; TCGA LUSC -0.444; TCGA PRAD -0.167; TCGA SARC -0.25; TCGA STAD -0.335; TCGA UCEC -0.112 |
hsa-miR-141-3p | ZYG11B | 11 cancers: BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BRCA -0.118; TCGA CESC -0.057; TCGA ESCA -0.095; TCGA HNSC -0.184; TCGA LIHC -0.096; TCGA LUAD -0.087; TCGA LUSC -0.12; TCGA PAAD -0.117; TCGA PRAD -0.183; TCGA STAD -0.178; TCGA UCEC -0.148 |
hsa-miR-141-3p | THRB | 10 cancers: BRCA; CESC; COAD; HNSC; LGG; LIHC; SARC; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BRCA -0.282; TCGA CESC -0.171; TCGA COAD -0.555; TCGA HNSC -0.159; TCGA LGG -0.095; TCGA LIHC -0.102; TCGA SARC -0.186; TCGA THCA -0.142; TCGA STAD -0.306; TCGA UCEC -0.284 |
hsa-miR-141-3p | UBASH3B | 9 cancers: BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA | MirTarget; TargetScan | TCGA BRCA -0.07; TCGA COAD -0.34; TCGA ESCA -0.114; TCGA HNSC -0.141; TCGA LUAD -0.372; TCGA LUSC -0.378; TCGA PAAD -0.328; TCGA PRAD -0.28; TCGA THCA -0.32 |
hsa-miR-141-3p | SECISBP2L | 12 cancers: BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.141; TCGA COAD -0.101; TCGA ESCA -0.077; TCGA HNSC -0.21; TCGA LGG -0.061; TCGA LUAD -0.072; TCGA LUSC -0.381; TCGA PAAD -0.067; TCGA PRAD -0.109; TCGA SARC -0.064; TCGA STAD -0.162; TCGA UCEC -0.091 |
hsa-miR-141-3p | OSBPL11 | 10 cancers: BRCA; HNSC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD | MirTarget; TargetScan; miRNATAP | TCGA BRCA -0.074; TCGA HNSC -0.079; TCGA KIRP -0.082; TCGA LGG -0.129; TCGA LUAD -0.157; TCGA PAAD -0.158; TCGA PRAD -0.192; TCGA SARC -0.051; TCGA THCA -0.131; TCGA STAD -0.068 |
hsa-miR-141-3p | CREB3L2 | 11 cancers: BRCA; COAD; ESCA; HNSC; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.062; TCGA COAD -0.097; TCGA ESCA -0.151; TCGA HNSC -0.215; TCGA LUSC -0.182; TCGA PAAD -0.126; TCGA PRAD -0.105; TCGA SARC -0.061; TCGA THCA -0.111; TCGA STAD -0.136; TCGA UCEC -0.141 |
hsa-miR-141-3p | AHR | 9 cancers: BRCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; THCA | MirTarget | TCGA BRCA -0.159; TCGA HNSC -0.118; TCGA KIRC -0.112; TCGA KIRP -0.092; TCGA LIHC -0.075; TCGA LUAD -0.152; TCGA LUSC -0.135; TCGA PRAD -0.417; TCGA THCA -0.17 |
hsa-miR-141-3p | IGF2 | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.526; TCGA CESC -0.31; TCGA COAD -0.69; TCGA ESCA -0.284; TCGA HNSC -0.431; TCGA LUAD -0.285; TCGA LUSC -0.429; TCGA OV -0.802; TCGA PAAD -0.377; TCGA PRAD -0.343; TCGA THCA -0.691; TCGA STAD -0.271; TCGA UCEC -0.319 |
hsa-miR-141-3p | TXNIP | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.37; TCGA CESC -0.203; TCGA COAD -0.196; TCGA ESCA -0.335; TCGA HNSC -0.211; TCGA LGG -0.052; TCGA LUAD -0.217; TCGA LUSC -0.488; TCGA PRAD -0.166; TCGA SARC -0.135; TCGA THCA -0.097; TCGA STAD -0.336; TCGA UCEC -0.205 |
hsa-miR-141-3p | RAPGEF2 | 12 cancers: BRCA; CESC; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BRCA -0.19; TCGA CESC -0.07; TCGA HNSC -0.216; TCGA KIRC -0.056; TCGA LGG -0.086; TCGA LIHC -0.072; TCGA LUAD -0.082; TCGA LUSC -0.377; TCGA PRAD -0.068; TCGA THCA -0.071; TCGA STAD -0.081; TCGA UCEC -0.057 |
hsa-miR-141-3p | PRTG | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LUSC; OV; PAAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.292; TCGA CESC -0.424; TCGA COAD -0.717; TCGA ESCA -0.161; TCGA HNSC -0.419; TCGA LGG -0.18; TCGA LUSC -0.708; TCGA OV -0.26; TCGA PAAD -0.38; TCGA STAD -0.415; TCGA UCEC -0.379 |
hsa-miR-141-3p | ANO6 | 14 cancers: BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.282; TCGA CESC -0.119; TCGA COAD -0.121; TCGA ESCA -0.153; TCGA HNSC -0.224; TCGA LIHC -0.065; TCGA LUAD -0.196; TCGA LUSC -0.262; TCGA PAAD -0.128; TCGA PRAD -0.474; TCGA SARC -0.077; TCGA THCA -0.223; TCGA STAD -0.167; TCGA UCEC -0.239 |
hsa-miR-141-3p | ST3GAL5 | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LIHC; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.164; TCGA CESC -0.219; TCGA COAD -0.338; TCGA ESCA -0.155; TCGA HNSC -0.152; TCGA KIRC -0.087; TCGA LGG -0.119; TCGA LIHC -0.052; TCGA LUSC -0.505; TCGA PAAD -0.157; TCGA PRAD -0.271; TCGA STAD -0.148; TCGA UCEC -0.188 |
hsa-miR-141-3p | DNAJC13 | 10 cancers: BRCA; CESC; HNSC; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BRCA -0.052; TCGA CESC -0.057; TCGA HNSC -0.071; TCGA LUAD -0.061; TCGA PAAD -0.087; TCGA PRAD -0.167; TCGA SARC -0.066; TCGA THCA -0.065; TCGA STAD -0.07; TCGA UCEC -0.085 |
hsa-miR-141-3p | KIDINS220 | 12 cancers: BRCA; CESC; COAD; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.106; TCGA CESC -0.111; TCGA COAD -0.068; TCGA HNSC -0.121; TCGA LGG -0.115; TCGA LUAD -0.053; TCGA LUSC -0.052; TCGA PAAD -0.066; TCGA PRAD -0.153; TCGA THCA -0.132; TCGA STAD -0.116; TCGA UCEC -0.111 |
hsa-miR-141-3p | SESTD1 | 11 cancers: BRCA; COAD; HNSC; KIRP; LGG; LUSC; OV; PRAD; SARC; THCA; STAD | MirTarget | TCGA BRCA -0.092; TCGA COAD -0.106; TCGA HNSC -0.122; TCGA KIRP -0.083; TCGA LGG -0.061; TCGA LUSC -0.117; TCGA OV -0.157; TCGA PRAD -0.217; TCGA SARC -0.14; TCGA THCA -0.163; TCGA STAD -0.161 |
hsa-miR-141-3p | WDFY3 | 10 cancers: BRCA; CESC; COAD; HNSC; LGG; LUAD; LUSC; PRAD; THCA; STAD | MirTarget; TargetScan; miRNATAP | TCGA BRCA -0.094; TCGA CESC -0.083; TCGA COAD -0.115; TCGA HNSC -0.148; TCGA LGG -0.138; TCGA LUAD -0.054; TCGA LUSC -0.063; TCGA PRAD -0.124; TCGA THCA -0.084; TCGA STAD -0.114 |
hsa-miR-141-3p | ANKFY1 | 10 cancers: BRCA; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA | MirTarget; TargetScan | TCGA BRCA -0.086; TCGA ESCA -0.053; TCGA HNSC -0.057; TCGA KIRP -0.06; TCGA LGG -0.068; TCGA LUAD -0.068; TCGA LUSC -0.144; TCGA PAAD -0.083; TCGA PRAD -0.115; TCGA THCA -0.053 |
hsa-miR-141-3p | TRHDE | 9 cancers: BRCA; CESC; HNSC; LGG; LUAD; LUSC; OV; PRAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.882; TCGA CESC -0.627; TCGA HNSC -0.7; TCGA LGG -0.253; TCGA LUAD -0.672; TCGA LUSC -1.155; TCGA OV -0.391; TCGA PRAD -0.739; TCGA UCEC -0.509 |
hsa-miR-141-3p | CLASP2 | 10 cancers: BRCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan; miRNATAP | TCGA BRCA -0.052; TCGA HNSC -0.111; TCGA LGG -0.145; TCGA LUAD -0.077; TCGA LUSC -0.141; TCGA PAAD -0.059; TCGA PRAD -0.064; TCGA THCA -0.051; TCGA STAD -0.11; TCGA UCEC -0.067 |
hsa-miR-141-3p | DAPK1 | 9 cancers: BRCA; COAD; ESCA; HNSC; LGG; LUSC; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.066; TCGA COAD -0.331; TCGA ESCA -0.176; TCGA HNSC -0.263; TCGA LGG -0.068; TCGA LUSC -0.538; TCGA THCA -0.319; TCGA STAD -0.072; TCGA UCEC -0.068 |
hsa-miR-141-3p | RNF168 | 9 cancers: BRCA; HNSC; LGG; LUAD; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BRCA -0.095; TCGA HNSC -0.09; TCGA LGG -0.095; TCGA LUAD -0.134; TCGA PAAD -0.118; TCGA PRAD -0.289; TCGA SARC -0.113; TCGA THCA -0.359; TCGA UCEC -0.077 |
hsa-miR-141-3p | ADAM22 | 12 cancers: BRCA; COAD; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.326; TCGA COAD -0.356; TCGA HNSC -0.263; TCGA LGG -0.279; TCGA LUAD -0.311; TCGA LUSC -0.334; TCGA PAAD -0.329; TCGA PRAD -0.701; TCGA SARC -0.28; TCGA THCA -0.439; TCGA STAD -0.2; TCGA UCEC -0.261 |
hsa-miR-141-3p | PIKFYVE | 9 cancers: BRCA; CESC; COAD; HNSC; LGG; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BRCA -0.136; TCGA CESC -0.062; TCGA COAD -0.055; TCGA HNSC -0.104; TCGA LGG -0.128; TCGA PAAD -0.088; TCGA PRAD -0.158; TCGA THCA -0.118; TCGA UCEC -0.067 |
hsa-miR-141-3p | BDP1 | 9 cancers: BRCA; HNSC; LGG; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.074; TCGA HNSC -0.089; TCGA LGG -0.105; TCGA LUSC -0.082; TCGA PRAD -0.109; TCGA SARC -0.051; TCGA THCA -0.071; TCGA STAD -0.06; TCGA UCEC -0.076 |
hsa-miR-141-3p | GLDN | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | MirTarget | TCGA BRCA -0.486; TCGA CESC -0.172; TCGA COAD -0.269; TCGA ESCA -0.214; TCGA HNSC -0.18; TCGA LUAD -0.402; TCGA LUSC -0.55; TCGA PAAD -0.189; TCGA PRAD -0.567; TCGA THCA -0.759; TCGA STAD -0.367 |
hsa-miR-141-3p | PURA | 9 cancers: BRCA; HNSC; LGG; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.062; TCGA HNSC -0.086; TCGA LGG -0.1; TCGA LUAD -0.103; TCGA LUSC -0.085; TCGA PRAD -0.138; TCGA THCA -0.097; TCGA STAD -0.094; TCGA UCEC -0.056 |
hsa-miR-141-3p | AFF1 | 9 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUSC; SARC; STAD; UCEC | TargetScan | TCGA BRCA -0.168; TCGA CESC -0.062; TCGA COAD -0.057; TCGA ESCA -0.063; TCGA HNSC -0.114; TCGA LUSC -0.168; TCGA SARC -0.141; TCGA STAD -0.146; TCGA UCEC -0.076 |
hsa-miR-141-3p | ARHGAP23 | 11 cancers: BRCA; CESC; COAD; ESCA; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BRCA -0.235; TCGA CESC -0.225; TCGA COAD -0.347; TCGA ESCA -0.14; TCGA LUAD -0.209; TCGA PAAD -0.194; TCGA PRAD -0.536; TCGA SARC -0.067; TCGA THCA -0.15; TCGA STAD -0.292; TCGA UCEC -0.261 |
hsa-miR-141-3p | C20orf194 | 12 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | TargetScan; mirMAP | TCGA BRCA -0.24; TCGA CESC -0.2; TCGA COAD -0.757; TCGA ESCA -0.245; TCGA HNSC -0.067; TCGA LUAD -0.121; TCGA LUSC -0.134; TCGA PAAD -0.108; TCGA PRAD -0.414; TCGA SARC -0.053; TCGA STAD -0.372; TCGA UCEC -0.162 |
hsa-miR-141-3p | GCNT4 | 11 cancers: BRCA; CESC; COAD; HNSC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BRCA -0.365; TCGA CESC -0.204; TCGA COAD -0.458; TCGA HNSC -0.23; TCGA LUAD -0.324; TCGA LUSC -0.435; TCGA PRAD -0.802; TCGA SARC -0.213; TCGA THCA -0.492; TCGA STAD -0.131; TCGA UCEC -0.298 |
hsa-miR-141-3p | GNAI1 | 9 cancers: BRCA; CESC; COAD; LGG; LIHC; OV; SARC; STAD; UCEC | TargetScan | TCGA BRCA -0.408; TCGA CESC -0.156; TCGA COAD -0.235; TCGA LGG -0.093; TCGA LIHC -0.085; TCGA OV -0.142; TCGA SARC -0.09; TCGA STAD -0.297; TCGA UCEC -0.147 |
hsa-miR-141-3p | HNMT | 12 cancers: BRCA; CESC; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BRCA -0.222; TCGA CESC -0.265; TCGA HNSC -0.4; TCGA LGG -0.103; TCGA LIHC -0.109; TCGA LUAD -0.064; TCGA LUSC -0.529; TCGA PRAD -0.088; TCGA SARC -0.107; TCGA THCA -0.318; TCGA STAD -0.081; TCGA UCEC -0.177 |
hsa-miR-141-3p | JAG1 | 9 cancers: BRCA; CESC; HNSC; KIRC; LUAD; PRAD; SARC; THCA; UCEC | TargetScan; miRNATAP | TCGA BRCA -0.181; TCGA CESC -0.249; TCGA HNSC -0.074; TCGA KIRC -0.086; TCGA LUAD -0.205; TCGA PRAD -0.129; TCGA SARC -0.094; TCGA THCA -0.192; TCGA UCEC -0.053 |
hsa-miR-141-3p | KLHDC10 | 9 cancers: BRCA; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; THCA; UCEC | TargetScan | TCGA BRCA -0.052; TCGA HNSC -0.177; TCGA LGG -0.109; TCGA LIHC -0.138; TCGA LUAD -0.09; TCGA LUSC -0.075; TCGA PRAD -0.211; TCGA THCA -0.221; TCGA UCEC -0.062 |
hsa-miR-141-3p | KRT222 | 10 cancers: BRCA; CESC; COAD; KIRP; LGG; LUAD; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BRCA -0.072; TCGA CESC -0.115; TCGA COAD -0.195; TCGA KIRP -0.121; TCGA LGG -0.132; TCGA LUAD -0.061; TCGA PAAD -0.16; TCGA PRAD -0.171; TCGA STAD -0.501; TCGA UCEC -0.163 |
hsa-miR-141-3p | MPPED2 | 10 cancers: BRCA; CESC; COAD; ESCA; LGG; LIHC; LUAD; OV; PRAD; STAD | TargetScan | TCGA BRCA -0.294; TCGA CESC -0.324; TCGA COAD -0.797; TCGA ESCA -0.206; TCGA LGG -0.123; TCGA LIHC -0.092; TCGA LUAD -0.097; TCGA OV -0.25; TCGA PRAD -0.203; TCGA STAD -0.51 |
hsa-miR-141-3p | NCOA2 | 9 cancers: BRCA; COAD; HNSC; LGG; LUAD; LUSC; PRAD; SARC; THCA | TargetScan | TCGA BRCA -0.084; TCGA COAD -0.144; TCGA HNSC -0.322; TCGA LGG -0.192; TCGA LUAD -0.098; TCGA LUSC -0.156; TCGA PRAD -0.387; TCGA SARC -0.177; TCGA THCA -0.357 |
hsa-miR-141-3p | PPP1R3G | 9 cancers: BRCA; ESCA; KIRC; KIRP; LIHC; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BRCA -0.303; TCGA ESCA -0.265; TCGA KIRC -0.27; TCGA KIRP -0.255; TCGA LIHC -0.198; TCGA PRAD -0.139; TCGA SARC -0.208; TCGA STAD -0.343; TCGA UCEC -0.064 |
hsa-miR-141-3p | PPP2R2B | 11 cancers: BRCA; COAD; ESCA; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BRCA -0.316; TCGA COAD -0.866; TCGA ESCA -0.319; TCGA LGG -0.078; TCGA LUAD -0.261; TCGA PAAD -0.167; TCGA PRAD -0.556; TCGA SARC -0.248; TCGA THCA -0.271; TCGA STAD -0.402; TCGA UCEC -0.201 |
hsa-miR-141-3p | PRKCE | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BRCA -0.126; TCGA CESC -0.098; TCGA COAD -0.1; TCGA ESCA -0.084; TCGA HNSC -0.068; TCGA LGG -0.165; TCGA LUAD -0.211; TCGA LUSC -0.314; TCGA PAAD -0.083; TCGA PRAD -0.167; TCGA THCA -0.129; TCGA STAD -0.122; TCGA UCEC -0.069 |
hsa-miR-141-3p | RASA2 | 10 cancers: BRCA; COAD; HNSC; LGG; LUAD; PAAD; PRAD; SARC; THCA; UCEC | TargetScan | TCGA BRCA -0.115; TCGA COAD -0.088; TCGA HNSC -0.117; TCGA LGG -0.101; TCGA LUAD -0.125; TCGA PAAD -0.132; TCGA PRAD -0.321; TCGA SARC -0.105; TCGA THCA -0.33; TCGA UCEC -0.132 |
hsa-miR-141-3p | RBMS1 | 12 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | TargetScan; miRNATAP | TCGA BRCA -0.218; TCGA CESC -0.175; TCGA COAD -0.591; TCGA ESCA -0.177; TCGA HNSC -0.067; TCGA LUAD -0.103; TCGA LUSC -0.078; TCGA PAAD -0.261; TCGA PRAD -0.358; TCGA THCA -0.123; TCGA STAD -0.233; TCGA UCEC -0.186 |
hsa-miR-141-3p | RNF11 | 12 cancers: BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | TargetScan; miRNATAP | TCGA BRCA -0.088; TCGA CESC -0.081; TCGA COAD -0.094; TCGA ESCA -0.066; TCGA HNSC -0.089; TCGA LIHC -0.068; TCGA LUAD -0.114; TCGA LUSC -0.099; TCGA PAAD -0.068; TCGA PRAD -0.114; TCGA STAD -0.136; TCGA UCEC -0.123 |
hsa-miR-141-3p | SLC14A1 | 12 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD | TargetScan | TCGA BRCA -0.324; TCGA CESC -0.231; TCGA COAD -0.403; TCGA ESCA -0.346; TCGA HNSC -0.343; TCGA LUAD -0.192; TCGA LUSC -0.669; TCGA OV -0.36; TCGA PRAD -0.669; TCGA SARC -0.263; TCGA THCA -0.205; TCGA STAD -0.191 |
hsa-miR-141-3p | SLC38A2 | 11 cancers: BRCA; CESC; HNSC; LGG; LIHC; LUAD; PAAD; PRAD; SARC; THCA; UCEC | TargetScan | TCGA BRCA -0.085; TCGA CESC -0.096; TCGA HNSC -0.086; TCGA LGG -0.073; TCGA LIHC -0.094; TCGA LUAD -0.101; TCGA PAAD -0.087; TCGA PRAD -0.093; TCGA SARC -0.053; TCGA THCA -0.159; TCGA UCEC -0.085 |
hsa-miR-141-3p | TOM1L2 | 9 cancers: BRCA; CESC; HNSC; LGG; LUAD; LUSC; SARC; STAD; UCEC | TargetScan; miRNATAP | TCGA BRCA -0.103; TCGA CESC -0.108; TCGA HNSC -0.061; TCGA LGG -0.096; TCGA LUAD -0.074; TCGA LUSC -0.138; TCGA SARC -0.109; TCGA STAD -0.183; TCGA UCEC -0.139 |
hsa-miR-141-3p | ZFAND5 | 10 cancers: BRCA; ESCA; HNSC; LGG; LIHC; LUSC; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BRCA -0.116; TCGA ESCA -0.088; TCGA HNSC -0.058; TCGA LGG -0.061; TCGA LIHC -0.109; TCGA LUSC -0.081; TCGA PAAD -0.053; TCGA PRAD -0.161; TCGA STAD -0.14; TCGA UCEC -0.06 |
hsa-miR-141-3p | ZNF704 | 12 cancers: BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BRCA -0.255; TCGA CESC -0.209; TCGA ESCA -0.15; TCGA HNSC -0.445; TCGA LGG -0.163; TCGA LUAD -0.103; TCGA LUSC -0.272; TCGA PRAD -0.282; TCGA SARC -0.146; TCGA THCA -0.168; TCGA STAD -0.232; TCGA UCEC -0.073 |
hsa-miR-141-3p | EHD3 | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.087; TCGA CESC -0.265; TCGA COAD -0.468; TCGA ESCA -0.215; TCGA HNSC -0.253; TCGA LGG -0.144; TCGA LUAD -0.132; TCGA LUSC -0.08; TCGA PAAD -0.272; TCGA PRAD -0.226; TCGA THCA -0.239; TCGA STAD -0.218; TCGA UCEC -0.088 |
hsa-miR-141-3p | P2RX6 | 9 cancers: BRCA; CESC; HNSC; LGG; LUAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.449; TCGA CESC -0.178; TCGA HNSC -0.292; TCGA LGG -0.19; TCGA LUAD -0.166; TCGA PRAD -0.215; TCGA SARC -0.156; TCGA STAD -0.35; TCGA UCEC -0.133 |
hsa-miR-141-3p | SMAD4 | 9 cancers: BRCA; CESC; HNSC; LGG; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.067; TCGA CESC -0.068; TCGA HNSC -0.067; TCGA LGG -0.056; TCGA PAAD -0.077; TCGA PRAD -0.066; TCGA SARC -0.051; TCGA STAD -0.09; TCGA UCEC -0.09 |
hsa-miR-141-3p | PLA2R1 | 9 cancers: BRCA; CESC; COAD; LUAD; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.291; TCGA CESC -0.244; TCGA COAD -0.236; TCGA LUAD -0.172; TCGA PAAD -0.132; TCGA PRAD -0.17; TCGA THCA -0.403; TCGA STAD -0.165; TCGA UCEC -0.14 |
hsa-miR-141-3p | IFNAR2 | 12 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BRCA -0.089; TCGA COAD -0.084; TCGA ESCA -0.061; TCGA HNSC -0.105; TCGA KIRC -0.147; TCGA KIRP -0.07; TCGA LUAD -0.11; TCGA LUSC -0.262; TCGA PAAD -0.065; TCGA PRAD -0.114; TCGA THCA -0.27; TCGA UCEC -0.079 |
hsa-miR-141-3p | PTCHD1 | 10 cancers: BRCA; CESC; COAD; ESCA; LUSC; OV; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.417; TCGA CESC -0.336; TCGA COAD -0.936; TCGA ESCA -0.397; TCGA LUSC -0.441; TCGA OV -0.287; TCGA PRAD -0.807; TCGA SARC -0.341; TCGA STAD -0.918; TCGA UCEC -0.423 |
hsa-miR-141-3p | AR | 14 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BRCA -0.283; TCGA CESC -0.486; TCGA COAD -0.874; TCGA ESCA -0.449; TCGA HNSC -0.75; TCGA KIRP -0.206; TCGA LIHC -0.415; TCGA LUAD -0.186; TCGA LUSC -0.764; TCGA PAAD -0.464; TCGA PRAD -0.266; TCGA SARC -0.345; TCGA THCA -0.523; TCGA STAD -0.639 |
hsa-miR-141-3p | MKL2 | 11 cancers: BRCA; CESC; COAD; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.083; TCGA CESC -0.061; TCGA COAD -0.099; TCGA HNSC -0.105; TCGA LUAD -0.059; TCGA LUSC -0.066; TCGA PAAD -0.089; TCGA PRAD -0.143; TCGA THCA -0.075; TCGA STAD -0.115; TCGA UCEC -0.095 |
hsa-miR-141-3p | ZC3H6 | 11 cancers: BRCA; CESC; ESCA; HNSC; LGG; LIHC; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.114; TCGA CESC -0.103; TCGA ESCA -0.119; TCGA HNSC -0.074; TCGA LGG -0.082; TCGA LIHC -0.053; TCGA LUSC -0.08; TCGA PRAD -0.08; TCGA SARC -0.055; TCGA STAD -0.221; TCGA UCEC -0.107 |
hsa-miR-141-3p | WNK3 | 9 cancers: BRCA; CESC; ESCA; LGG; LIHC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.092; TCGA CESC -0.215; TCGA ESCA -0.247; TCGA LGG -0.151; TCGA LIHC -0.181; TCGA PAAD -0.318; TCGA PRAD -0.138; TCGA THCA -0.328; TCGA STAD -0.426 |
hsa-miR-141-3p | ATXN1L | 11 cancers: BRCA; CESC; COAD; HNSC; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.138; TCGA CESC -0.065; TCGA COAD -0.065; TCGA HNSC -0.109; TCGA LIHC -0.051; TCGA LUAD -0.074; TCGA LUSC -0.064; TCGA PRAD -0.208; TCGA THCA -0.107; TCGA STAD -0.096; TCGA UCEC -0.09 |
hsa-miR-141-3p | FRY | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.2; TCGA CESC -0.159; TCGA COAD -0.428; TCGA ESCA -0.257; TCGA HNSC -0.308; TCGA LGG -0.217; TCGA LUAD -0.133; TCGA LUSC -0.566; TCGA PRAD -0.362; TCGA SARC -0.294; TCGA THCA -0.132; TCGA STAD -0.247; TCGA UCEC -0.214 |
hsa-miR-141-3p | ZNF608 | 9 cancers: BRCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; STAD | miRNATAP | TCGA BRCA -0.245; TCGA HNSC -0.363; TCGA KIRC -0.111; TCGA KIRP -0.067; TCGA LGG -0.114; TCGA LUAD -0.145; TCGA LUSC -0.421; TCGA PRAD -0.163; TCGA STAD -0.068 |
hsa-miR-141-3p | ZSCAN23 | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BRCA -0.367; TCGA CESC -0.28; TCGA COAD -0.803; TCGA ESCA -0.255; TCGA HNSC -0.254; TCGA LGG -0.277; TCGA LUAD -0.174; TCGA PAAD -0.279; TCGA PRAD -0.211; TCGA STAD -0.502; TCGA UCEC -0.351 |
hsa-miR-141-3p | RPS6KA6 | 9 cancers: CESC; ESCA; HNSC; LGG; LUAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA CESC -0.307; TCGA ESCA -0.432; TCGA HNSC -0.367; TCGA LGG -0.272; TCGA LUAD -0.155; TCGA PRAD -0.172; TCGA THCA -0.269; TCGA STAD -0.489; TCGA UCEC -0.432 |
hsa-miR-141-3p | SCUBE2 | 11 cancers: CESC; COAD; ESCA; HNSC; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA CESC -0.392; TCGA COAD -0.638; TCGA ESCA -0.449; TCGA HNSC -0.289; TCGA LUSC -0.351; TCGA OV -0.203; TCGA PAAD -0.429; TCGA PRAD -0.441; TCGA SARC -0.148; TCGA THCA -0.21; TCGA STAD -0.463 |
hsa-miR-141-3p | ANKRD50 | 13 cancers: CESC; COAD; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA CESC -0.142; TCGA COAD -0.182; TCGA HNSC -0.136; TCGA LGG -0.066; TCGA LUAD -0.091; TCGA LUSC -0.076; TCGA OV -0.119; TCGA PAAD -0.097; TCGA PRAD -0.184; TCGA SARC -0.075; TCGA THCA -0.136; TCGA STAD -0.145; TCGA UCEC -0.11 |
hsa-miR-141-3p | GPR137B | 11 cancers: CESC; COAD; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; THCA; UCEC | TargetScan | TCGA CESC -0.134; TCGA COAD -0.172; TCGA HNSC -0.062; TCGA KIRC -0.053; TCGA KIRP -0.071; TCGA LGG -0.052; TCGA LUAD -0.135; TCGA PAAD -0.169; TCGA PRAD -0.135; TCGA THCA -0.067; TCGA UCEC -0.159 |
hsa-miR-141-3p | MR1 | 10 cancers: CESC; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA CESC -0.107; TCGA COAD -0.169; TCGA ESCA -0.079; TCGA LIHC -0.091; TCGA LUAD -0.068; TCGA LUSC -0.14; TCGA PAAD -0.111; TCGA PRAD -0.472; TCGA THCA -0.11; TCGA STAD -0.14 |
hsa-miR-141-3p | TMEM110 | 9 cancers: COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; THCA | MirTarget; TargetScan; miRNATAP | TCGA COAD -0.088; TCGA ESCA -0.079; TCGA HNSC -0.085; TCGA LIHC -0.082; TCGA LUAD -0.102; TCGA LUSC -0.193; TCGA PAAD -0.088; TCGA PRAD -0.067; TCGA THCA -0.134 |
hsa-miR-141-3p | GNA13 | 9 cancers: COAD; HNSC; KIRC; LUAD; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA COAD -0.065; TCGA HNSC -0.092; TCGA KIRC -0.062; TCGA LUAD -0.128; TCGA PAAD -0.141; TCGA PRAD -0.186; TCGA THCA -0.152; TCGA STAD -0.07; TCGA UCEC -0.09 |
hsa-miR-141-3p | RANBP6 | 11 cancers: ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA ESCA -0.06; TCGA HNSC -0.116; TCGA LGG -0.077; TCGA LUAD -0.09; TCGA LUSC -0.067; TCGA OV -0.082; TCGA PAAD -0.072; TCGA PRAD -0.089; TCGA THCA -0.135; TCGA STAD -0.079; TCGA UCEC -0.074 |
Enriched cancer pathways of putative targets